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Background: There are inequalities in healthcare access and outcomes in the English NHS 
which raise concerns about both quality of care and justice.  In 2012, the NHS was given a 
statutory duty to consider reducing these inequalities 
 
Objectives: 
 To develop indicators of socioeconomic inequality in healthcare access and outcomes 
at different stages of the patient pathway 
 To develop methods for monitoring local NHS equity performance in tackling 
socioeconomic healthcare inequalities 
 To produce prototype equity indicators at national and local (clinical commissioning 
group) level, with appropriate adjustment for need and risk 
 To develop “equity dashboards” for communicating equity indicator findings to 
decision makers in a clear and concise format 
 
Design: Longitudinal whole-population study at small area level 
 
Setting: England from 2001/2 to 2011/12 
 
Participants: 32,482 small area neighbourhoods (lower super output areas) of approximately 
1,500 people  
 
Main outcome measures: Slope index of inequality gaps between the most and least 
deprived neighbourhoods in England, adjusted for need or risk, for: (1) patients per family 
doctor, (2) primary care quality, (3) inpatient hospital waiting time, (4) emergency 
hospitalisation for chronic ambulatory care sensitive conditions, (5) repeat emergency 
hospitalisation in the same year, (6) dying in hospital, (7) mortality amenable to healthcare 
and (8) overall mortality 
 
3 
Data sources: Practice level workforce data from the general practice census (Indicator 1), 
practice level quality and outcomes framework data (Indicator 2), inpatient hospital data from 
hospital episode statistics (Indicators 3-6), mortality data from ONS (Indicators 6-8) 
 
Results:  Between 2004/5 and 2011/12, primary care was strengthened and more deprived 
neighbourhoods gained larger absolute improvements on all indicators except waiting time 
and repeat hospitalisation. Inequality gaps decreased by: 193 patients per family doctor (95% 
confidence interval 173 to 213), 0.42 preventable hospitalisations per 1,000 people (0.29 to 
0.55) and 0.23 amenable deaths per 1,000 people (0.15 to 0.31).  In 2011/12, there was little 
measurable inequality in primary care supply and quality but inequality was associated with 
171,119 preventable hospitalisations and 41,123 deaths amenable to healthcare.  Indicators 
(1) through (5) above found that more than twenty percent of CCGs performed statistically 
significantly better or worse on equity than the England average in 2011/12 
 
Conclusions:  NHS actions can have a measurable impact on socioeconomic inequality in 
both healthcare access and outcomes.  Reducing inequality in healthcare outcomes is more 
challenging than reducing inequality of access to healthcare. Monitoring of local NHS equity 
against a national benchmark can now be performed using any administrative geography 
comprising 100,000 or more people, both to help managers learn quality improvement 
lessons and to improve public accountability 
 
Future work:  Exploration of quality improvement lessons from local NHS areas doing 
better and worse than the national equity benchmark, development of better measures of need 
and risk and other methodological refinements, and monitoring of other dimensions of equity.  
Research using these indicators is also needed to evaluate the healthcare equity impacts of 
interventions and to make international healthcare equity comparisons 
 
Funding: The National Institute for Health Research Health Services and Delivery Research 
Programme 
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Plain English Summary 
 
There are social inequalities in healthcare access and outcomes, which raise important 
concerns about both quality of care and justice. People living in more deprived 
neighbourhoods are diagnosed at a later stage of their disease, are less likely to see a 
specialist, and are more likely to die from treatable conditions.  NHS policymakers and 
managers have a legal duty to consider reducing such inequalities.  However, reliable 
information on healthcare inequalities is scarce, because monitoring currently focuses on the 
average patient rather than illuminating systematic differences between patients.  Local 
information is especially scarce, because it is hard to establish reliable facts about healthcare 
access and outcomes in every single neighbourhood within a local area. 
 
In consultation with NHS and public health officials and members of the public, we 
developed eight indicators of social inequality in healthcare access and health outcomes. We 
also developed a visual way of communicating these indicators clearly and concisely, called 
“equity dashboards”.  Our indicators suggest that the NHS succeeded in reducing healthcare 
inequalities between 2004 and 2011, but that inequality reduction was larger in primary care 
access and quality than healthcare outcomes. Five indicators are suitable for local as well as 
national inequality monitoring – number of patients per GP, primary care quality, hospital 
waiting time, preventable emergency hospitalisation and repeat emergency hospitalisation.  
These indicators could be used to help managers learn quality improvement lessons, to help 
regulators and others hold the NHS to account, and to help inform the public about healthcare 
inequalities within their local area. 
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Scientific Summary 
 
Background 
 
There are inequalities in healthcare access and outcomes in the English NHS which raise 
concerns about both quality of care and justice.  Between 2004 and 2011, the NHS made 
substantial investments to strengthen primary care and reduce health inequalities.  This 
included the introduction of a substantial primary care pay for performance programme, 
investment in opening new family medical practices in deprived communities, and a 
programme of guidance and support for local healthcare managers to help them meet national 
targets for reducing health inequality.  In 2012, the NHS was given a statutory duty to 
consider reducing inequalities of healthcare access and outcomes, which applies both 
nationally and at the local level of Clinical Commissioning Groups (CCGs).  However, the 
NHS does not yet monitor these inequalities systematically and, in particular, lacks a method 
for detailed local monitoring of healthcare inequalities within CCG areas. 
 
Objectives 
 To develop indicators of socioeconomic inequality in healthcare access and outcomes 
at different stages of the patient pathway 
 To develop methods for monitoring local NHS equity performance in tackling 
socioeconomic healthcare inequalities 
 To produce prototype equity indicators from 2001/2 to 2011/12 at national and local 
(CCG) level, with appropriate adjustment for need and risk 
 To develop “equity dashboards” for communicating equity indicator findings to 
decision makers in a clear and concise format 
 
Methods 
Indicator selection 
The indicator selection process included (i) reviewing existing indicators used by the NHS to 
monitor healthcare quality, (ii) consulting health indicator experts about technical feasibility, 
(iii) consulting a diverse range of NHS and public health experts about policy relevance 
through 1:1 conversations and an online expert survey, and (iv) consulting members of the 
public through a full day citizens panel meeting and an online public survey. 
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Our main indicator selection criteria were (1) face validity to NHS and public health 
stakeholders as well as the general public, (2) sensitivity to healthcare intervention, (3) likely 
impact on population health, (4) data availability at small area level from the early 2000s, and 
(5) statistical confidence for monitoring within local areas as well as nationally.  Our criteria 
for selecting an appropriate mix of indicators were (1) coverage of inequality in both access 
and outcomes, (2) coverage of inequality at all main stages of the patient pathway, (3) 
coverage of inequality in multiple domains of the NHS Outcomes Framework, (4) synergy 
between indicators, and (5) relevance to potential future quasi experimental evaluations of the 
impacts of interventions on healthcare inequalities.  Our criteria for selecting the two disease 
domains were: (1) substantial disease burden and cost to the NHS, (2) data availability for 
national monitoring, and (3) synergy between the two domains. 
 
Indicator definitions 
We selected eight general indicators for production at both national and local levels: 
(1) primary care supply: patients per full time equivalent general practitioner, need adjusted 
for age, sex and ill-health,  
(2) primary care quality: composite score based on quality and outcomes framework 
population achievement on clinical indicators weighted by importance in terms of estimated 
lives saved, 
(3) hospital waiting time: waiting time from outpatient decision to admit to inpatient 
admission, risk adjusted for specialty,  
(4) preventable hospitalisation: proportion of people with emergency hospitalisation for 
chronic ambulatory care sensitive conditions (NHS Outcomes Framework list), risk adjusted 
for age and sex,  
(5) repeat hospitalisation: proportion of people discharged from hospital who have a repeat 
emergency hospitalisation within the same year, risk adjusted for age and sex,  
(6) dying in hospital: proportion of deaths that occur in hospital,  
(7) amenable mortality: mortality from causes considered sensitive to healthcare (NHS 
Outcomes Framework list), risk adjusted for age and sex, 
(8) overall mortality: all-age all-cause mortality, risk adjusted for age and sex. 
 
To illustrate the scope for additional disease-specific monitoring at national level, we also 
produced versions of indicators 2, 4 and 7 for coronary heart disease and diabetes. 
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Data sources 
We used four main health datasets: practice level data on GP supply from the annual National 
Health Service General and Personal Medical Services (GMS) workforce census (Indicator 
1), practice level data on primary care quality from the quality and outcomes framework 
(Indicator 2), inpatient hospital data from hospital episode statistics (Indicators 3-6), 
mortality data from ONS (Indicators 6-8).  We produced indicators from 2001/2 to 2011/12 
except for indicators 1 and 2 which only started in 2004/5.  The basic small area geographical 
unit provided in these datasets was the 2001 “lower super output area” (LSOA). The 2001 
census defined 32,482 of these small area neighbourhoods to cover approximately 1,500 
people each (minimum 1,000 and maximum 3,000).  Indicators were produced using 2001 
LSOAs then mapped to the updated LSOA geography from the 2011 census, resulting in 
32,844 neighbourhoods which could be aggregated to clinical commissioning group level. 
We measured deprivation using a time-fixed deprivation score to ensure that time trends 
reflect real changes in healthcare rather than changes in deprivation measurement 
methodology or the composition of neighbourhoods in particular quantile groups.  We used 
the 2010 Index of Multiple Deprivation overall deprivation rank, which combines data on 
multiple domain of deprivation mostly relating to the year 2007 in the middle of our analysis 
period.  For indicators 1 and 2 we used the NHS Attribution Data Set (ADS) of GP-registered 
populations to map the number of GPs and quality scores provided at practice level to small 
area level. For all indicators requiring a general population denominator, including indicator 
1, we used time-varying mid-year population estimates from the ONS at 2001 LSOA level 
rather than GP-registered populations.  The ONS figures estimate the total resident 
population including homeless people and people living in institutions such as prisons, 
barracks and nursing homes.  For age breakdowns and risk adjustment we used seven age 
groups 0-4, 5-15, 16-24, 25-39, 40-59, 60-74 and 75+ to minimise the number of subgroups 
while distinguishing key life stages of policy interest.  We cleaned the assembled LSOA level 
data using national year-specific trimming of outliers 6 standard deviations from the mean.  
This excluded less than 0.15 of one percent of LSOAs in any year for any indicator and did 
not disproportionately exclude deprived neighbourhoods. 
 
Data analysis 
For national monitoring, we computed the slope index of inequality (SII) which measures the 
gap between the most and least deprived neighbourhoods in England, allowing for the 
gradient in between.  We also computed the relative index of inequality (RII): the SII divided 
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by the England mean.  We computed adjusted indicators for each LSOA in England, along 
with fractional deprivation rank “ridit score” from 0 (least deprived) to 1 (most deprived).  
We used the Carr-Hill workload adjustment to need adjust indicator 1, and indirect 
standardisation to risk adjust indicators 3, 4, 5, 7 and 8.  We used LSOA level ordinary least 
squares regression to model the association between the adjusted indicator and fractional 
deprivation rank, and used the slope coefficient to estimate the SII and its associated 95% 
confidence interval.  We also performed tests of change in the SII over time using time-series 
cross-section regression with year interactions.  For local monitoring, we used the same 
approach based on national fractional deprivation rank, except using only LSOAs within the 
local clinical commissioning group area.  We term the local slope coefficient the “absolute 
gradient index” (AGI), to avoid confusion with the different local slope index approach used 
to monitor inequalities in population health in the Public Health Outcomes Framework, 
which uses local within-area deprivation rank rather than national deprivation rank.  We also 
constructed a local “relative gradient index” (RGI) that can be compared with the national 
RII.  We tested the difference between the local AGI and the national SII, allowing for 
uncertainty around both variables.  In sensitivity analysis we also used more sophisticated 
regression approaches including non-linear models and empirical Bayes random effect 
models to shrink the local AGI towards the national SII.   
 
Results 
National equity trends 
Between 2004/5 and 2011/12, more deprived neighbourhoods gained larger absolute 
improvements on all indicators except waiting time and repeat hospitalisation. Inequality 
gaps decreased by: 193 patients per family doctor (95% confidence interval 173 to 213), 0.42 
preventable hospitalisations per 1,000 people (0.29 to 0.55) and 0.23 amenable deaths per 
1,000 people (0.15 to 0.31).   
 
National equity findings in 2011/12 
 There was no evidence of “pro-rich” inequality in primary care supply. Deprived 
neighbourhoods had slightly more GPs relative to measured need than less deprived 
neighbourhoods.  However, the Carr-Hill formula may under-estimate additional needs in 
deprived neighbourhoods so there may be “pro-rich” inequality that we are unable to 
measure. 
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 There was a small amount of “pro-rich” inequality in primary care quality, with an 
estimated slope index of inequality gap of 1.45 percentage points (confidence interval 
1.37 to 1.53) between the most and least deprived neighbourhood in England. 
 
 There was a small amount of “pro-rich” inequality in inpatient hospital waiting time, with 
an estimated inequality gap of 2.29 days waiting (confidence interval 1.95 to 2.62). 
 
 There was substantial “pro-rich” inequality in preventable hospitalisation, with an 
estimated inequality gap of 6.50 hospitalisations per 1,000 (confidence interval 6.40 to 
6.59). 
 
 There was substantial “pro-rich” inequality in repeat hospitalisation, with an estimated 
inequality gap of 6.97 percentage points of people hospitalised (confidence interval 6.85 
to 7.09). 
 
 There was substantial “pro-rich” inequality in dying in hospital, with an estimated 
inequality gap of 5.95 percentage points of people dying in hospital (confidence interval 
5.26 to 6.63). 
 
 There was substantial “pro-rich” inequality in amenable mortality, with an estimated 
inequality gap of 1.56 amenable deaths per 1,000 (confidence interval 1.50 to 1.62). 
 
 There was substantial “pro-rich” inequality in overall mortality, with an estimated 
inequality gap of 5.17 deaths per 1,000 (confidence interval 5.03 to 5.31). 
 
Indicators 4, 5, 7 and 8 adjust for age and sex but not for morbidity and other health risk 
factors outside NHS control which increase the risk of poor healthcare outcomes in deprived 
neighbourhoods.  So they over-estimate the extent of “pro-rich” inequality in healthcare 
outcomes for which the NHS can reasonably be held responsible. 
 
Local equity findings in 2011/12  
In 2011/12, over twenty percent of CCGs performed significantly differently on equity than 
the national benchmark for indicators (1) through (5), with at least ten percent better and ten 
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percent worse.  For indicator (6) Dying in Hospital, only eight percent of CCGs were 
significantly different from average – three percent worse and five percent better.  For 
indicator (7) Amenable Mortality, eleven percent were significantly different from average – 
eight percent worse and three percent better.  Finally, for indicator (8) Overall Mortality, 
seventeen percent were significantly different from the national average, but most of these 
were significantly worse – only three percent were significantly better.  Pooling additional 
years of data did not improve substantially the ability to detect significant differences, and 
more sophisticated regression approaches including empirical Bayes random effects models 
made little difference to the list of CCGs performing significantly better or worse than the 
national average. 
 
Visualisation tools 
We developed three main visualisation tools: 
 Equity dashboards – a one page summary for decision makers at national and local 
levels, including an Excel tool that can display findings for any CCG in England 
 Equity chartpacks – a standard set of slides with tables and graphs showing the 
underlying inequality patterns and trends in a common format for each indicator, 
including a PDF creating tool that can create slides for any CCG in England 
 Equity custom graphs – a web based interactive chart tool that allows the user to draw 
their own customised graphs and see how equity changes over time by selecting 
variables and chart styles 
 
We found that eight or nine indicators could comfortably fit on a single page “equity 
dashboard” in landscape orientation.  The NHS and public health officials we consulted 
wanted to see information about average performance alongside equity performance, to put 
the equity findings into context.  They also wanted equity findings to be presented in “real” 
units – e.g. numbers of GPs, hospitalisations, deaths – as well as percentages, to help them 
interpret the size and importance of the inequality problem.  
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Conclusions 
Implications for healthcare 
1. NHS actions can have measurable impacts on socioeconomic inequality in both 
healthcare access and healthcare outcomes 
2. Expanding the primary care workforce and paying for quality may have small impacts on 
reducing inequality in healthcare outcomes, but further reductions will require new 
approaches and improved system-wide co-ordination between different service providers 
3. Our methods for monitoring healthcare inequalities within local areas can usefully be 
applied to any administrative geography comprising 100,000 or more people, both to 
facilitate quality improvement and to improve transparency through public reporting 
4. Currently, the most useful indicators for local NHS equity monitoring are primary care 
supply, primary care quality and preventable hospitalisation 
5. National NHS monitoring of change over time in NHS equity can usefully be done using 
a much wider range of indicators of healthcare access and outcomes, including disease-
specific indicators 
6. Equity indicators are more useful to decision makers if they are presented together on the 
same page, alongside average performance indicators, and accompanied by graphs 
showing the underlying inequality patterns 
7. Variants on our equity indicators could be used for international comparisons of equity in 
healthcare and for evaluating the impacts of interventions on equity in healthcare 
 
Research recommendations 
Research is needed: 
1. To investigate potential explanations for variation in healthcare equity performance 
between local NHS areas, so that healthcare managers can learn quality improvement 
lessons 
2. To perform experimental and quasi-experimental evaluations of the impacts of complex 
interventions on socioeconomic inequalities in healthcare access and outcomes, including 
interventions to improve system-wide co-ordination between different specialties, 
healthcare settings and public services 
3. To make international healthcare equity comparisons using these indicators of healthcare 
access and outcomes 
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4. To develop better measures of small area level need for primary care, by investigating 
how multiple morbidity and disadvantage combine to generate additional healthcare 
needs 
5. To develop convincing methods for risk adjusting small area level healthcare outcomes 
for exogenous morbidity factors beyond the control of healthcare services 
6. To develop methods for monitoring other social dimensions of healthcare inequality 
7. To improve these indicator methods by refining and adding indicators, decomposing 
national inequality into between-area and within area components, and exploring the use 
of statistical process control methods, direct standardisation methods and non-linear 
functional forms 
8. To develop sources of small area level data on the supply, utilisation, quality and 
outcomes of public and private social care and other goods and services that may 
influence healthcare outcomes.   
 
 
Word count: 2,379 words (max 2,400) 
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Chapter 1 Introduction 
 
“the isolation of disparities from mainstream quality assurance has 
impeded progress in addressing them”  
Fiscella and Franks 2000
1
 
1.1 Overview 
 
This report describes the findings of independent research to develop health equity indicators 
for monitoring socioeconomic inequalities in healthcare access and outcomes in England.  
Inequalities of this kind persist, raising important public policy concerns about both quality of 
care and social justice.  However, progress in addressing these concerns is hampered because 
socioeconomic inequalities in healthcare access and outcomes are not yet monitored 
systematically in England at either national or local levels
2
.   
 
We developed an integrated suite of equity indicators for two different kinds of monitoring: 
1. Annual monitoring of change in national healthcare equity. 
2. Annual monitoring of local within-area healthcare equity against a national equity 
benchmark, for clinical commissioning groups (CCGs) or other sub-national areas 
comprising 100,000 people or more.   
 
Our equity indicators are designed to help national and local decision makers in England 
discharge the NHS health inequalities duties introduced in the Health and Social Care Act 
2012. The local duty for CCGs is as follows: 
“Each clinical commissioning group must, in the exercise of its functions, have regard 
to the need to –  
(a) reduce inequalities between patients with respect to their ability to access health 
services, and 
(b) reduce inequalities between patients with respect to the outcomes achieved for 
them by the provision of health services.” 
 
The national duty for NHS England is phrased in the same way, and the national duty for the 
Secretary of State is as follows: 
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“In exercising functions in relation to the health service, the Secretary of State must 
have regard to the need to reduce inequalities between the people of England with 
respect to the benefits that they can obtain from the health service.”  
 
Our indicators will also help to monitor the health inequalities elements of the NHS duties as 
to promoting integration of care that were introduced in the Health and Social Care Act 2012.  
Improving the integration of care is a central policy priority for the English NHS, including 
not only integration within NHS funded services across different specialties and different 
primary and acute care settings, but also integration between NHS funded services and other 
services that impact on patient outcomes.  NHS England announced in 2013 the 
establishment of a “Better Care Fund” for integrated care across healthcare and social care 
boundaries, and announced in 2014 a programme of “new models of care” or “vanguard 
sites” for integrating care between specialties and settings.3 The relevant local duties on 
integration and inequalities are phrased as follows: 
“(1) Each clinical commissioning group must exercise its functions with a view to 
securing that health services are provided in an integrated way where it considers that 
this would — 
(a) improve the quality of those services (including the outcomes that are achieved 
from their provision), 
(b) reduce inequalities between persons with respect to their ability to access those 
services, or 
(c) reduce inequalities between persons with respect to the outcomes achieved for 
them by the provision of those services. 
 
(2) Each clinical commissioning group must exercise its functions with a view to 
securing that the provision of health services is integrated with the provision of 
health-related services or social care services where it considers that this would — 
(a) improve the quality of the health services (including the outcomes that are 
achieved from the provision of those services), 
(b) reduce inequalities between persons with respect to their ability to access those 
services, or 
(c) reduce inequalities between persons with respect to the outcomes achieved for 
them by the provision of those services. 
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(3) In this section —  
“health-related services” means services that may have an effect on the health of 
individuals but are not health services or social care services;  
“social care services” means services that are provided in pursuance of the social 
services functions of local authorities (within the meaning of the Local Authority 
Social Services Act 1970).” 
 
The phrasing of the Health and Social Care Act makes it clear that the NHS health 
inequalities duties (1) include concern for reducing inequalities in the health outcomes or 
benefits of healthcare, as well as concern for reducing inequalities of access to healthcare, 
and (2) include concern for improving the co-ordination of healthcare with social care and 
other public services which impact on health outcomes.  These two concerns go to the heart 
of what it means to be a national health service, rather than a national sickness service, and 
are also reflected in the NHS Constitution, published in 2012 
(www.gov.uk/government/publications/the-nhs-constitution-for-england).  The first principle 
of the NHS Constitution is that: “The NHS provides a comprehensive service, available to 
all…At the same time, it has a wider social duty to promote equality through the services it 
provides and to pay particular attention to groups or sections of society where improvements 
in health and life expectancy are not keeping pace with the rest of the population.”   The fifth 
principle is that: “The NHS works across organisational boundaries and in partnership with 
other organisations in the interest of patients, local communities and the wider population. 
The NHS is an integrated system of organisations and services bound together by the 
principles and values reflected in the Constitution. The NHS is committed to working jointly 
with other local authority services, other public sector organisations and a wide range of 
private and voluntary sector organisations to provide and deliver improvements in health and 
wellbeing.” 
 
These concerns relate to wider health equity concern for reducing social inequality in 
population health.  Social inequality in life expectancy and health raise important concerns 
about social justice, because health is essential to human flourishing.
4
  In economic terms, 
health is both a consumption good that people value for its own sake, and a capital good that 
allows people to do the things they value in life.  Healthcare is of course only one of many 
social determinants of health and survival over the lifecourse, along with in utero and 
childhood circumstances, income, education, working and living conditions, social support 
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networks, long-term care, lifestyle factors such as smoking, poor diet and physical inactivity, 
and many other factors.
5-7
  But although healthcare cannot eliminate social inequalities in 
health, it can play a role in helping to reduce them.
8-10
  We therefore sought to ensure that our 
equity indictors are relevant from a wider population health perspective, as well as from a 
health care perspective, and that our indicators are relevant to the integration of care across 
different specialties, settings and services. 
 
Our equity indicators are intended for use by NHS and local authority decision makers for 
quality improvement purposes, to help policymakers and managers learn how to improve the 
delivery of healthcare services including integration with social care and other health-related 
services.  They are also intended for use by a wide range of organisations which play external 
scrutiny roles in helping to hold the NHS to account, including Public Health England and 
local Health and Wellbeing Boards, health sector regulators such as the National Audit Office 
and the Health Select Committee, professional associations such as the NHS Confederation, 
British Medical Association and Royal Colleges, think tanks such as the Health Foundation, 
Kings Fund and Nuffield Trust, and national and local media organisations.  Our indicators 
are also intended for public reporting, to facilitate more direct forms of public accountability.  
In principle, our equity indicators can also be used to monitor healthcare equity in other high 
income countries with well-developed administrative health datasets, to make international 
comparisons of equity in healthcare, and to help evaluate the healthcare equity impacts of 
interventions in trials and quasi-experimental studies. 
 
The aims of our study were: 
 To develop indicators of socioeconomic inequality in healthcare access and outcomes 
at different stages of the patient pathway 
 To develop methods for monitoring local NHS equity performance in tackling 
socioeconomic healthcare inequalities 
 To produce prototype equity indicators at national and local (clinical commissioning 
group) level, with appropriate adjustment for need or risk 
 To develop “equity dashboards” for communicating equity indicator findings to 
decision makers in a clear and concise format 
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The main contributions of our study were as follows.  First, we have developed the first 
indicators for local NHS equity monitoring against a national NHS equity benchmark, 
including new methods for national benchmarking as well as a new suite of indicators.  This 
aspect of our work was cited by the independent think tank, the Kings Fund, as being a 
potentially useful way of incorporating equity into routine CCG performance monitoring by 
NHS England, in a report commissioned by the Department of Health
11
, and the University 
College London Institute of Health Equity are discussing piloting the use of these local equity 
indicators to monitor progress in Vanguard sites.  Second, we have developed a more 
comprehensive suite of national NHS equity indicators than the inequalities breakdowns 
currently produced in the NHS Outcomes Framework, by including indicators of inequality in 
healthcare access as well as healthcare outcomes. Third, by producing our indicators from 
2001/2 to 2011/12, we have provided the first comprehensive assessment of healthcare equity 
trends during a key period of sustained effort by the NHS to reduce socioeconomic health 
inequalities through primary care strengthening.  Finally, we have developed a 
comprehensive suite of visualisation tools for presenting and communicating our equity 
indicator findings to decision makers.  This includes a one-page “equity dashboard” 
presenting summary information, automated “equity chartpacks” providing in-depth 
information underpinning the dashboard, and a web-based tool for creating your own graphs.  
Visualisation is an essential component of equity monitoring, because inequality is a complex 
concept and judgements about “fairness”, “justice” or “equity” often involve controversial 
value judgements about which reasonable people can disagree.  A single “one-size-fits-all” 
headline inequality measure can therefore be misleading.  So it is essential to show people the 
underlying inequality patterns and trends, to help them understand the meaning and 
importance of the trends and draw their own conclusions about equity based on their own 
value judgements. 
 
We have developed eight general indicators of healthcare equity that examine socioeconomic 
inequalities in healthcare access and outcomes at different stages of the patient pathway: (1) 
Primary Care Supply, (2) Primary Care Quality, (3) Hospital Waiting Time, (4) Preventable 
Hospitalisation, and (5) Repeat Hospitalisation, (6) Dying in Hospital, (7) Amenable 
Mortality, and (8) Overall Mortality.  We did not include general indicators of socioeconomic 
inequality in healthcare utilisation, such as the total number of non-emergency inpatient or 
outpatient hospital visits, because when diverse healthcare services are grouped together it is 
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hard to tell whether more utilisation reflects better access to care, worse quality of care, or 
worse health. 
 
All eight of our general indicators are potentially suitable for national equity monitoring.  
However, we found that the last three indicators do not fully meet the more demanding data 
requirements for local equity monitoring.  The main issue was that there are relatively few 
deaths in any given local CCG area in any given year, making it hard to tell from a statistical 
perspective whether observed differences in social gradients between different local areas are 
merely due to chance.  We recommend three indicators as a high priority for local equity 
monitoring against a national equity benchmark – Primary Care Supply, Primary Care 
Quality and Preventable Hospitalisation.  Two other indicators could also be used for local 
equity monitoring – Hospital Waiting Time and Repeat Hospitalisation.  However, as 
explained in Chapters 8 and 9, these indicators may require further validation and refinement 
before being used for routine monitoring purposes. 
 
Our general indicators measure socioeconomic inequality across the full range of healthcare 
activity, rather than focusing on one particular condition.  General indicators can be used for 
local monitoring against a national benchmark, whereas at the present time disease-specific 
indicators can only be used for national equity monitoring of healthcare outcomes.  This is 
because the kinds of healthcare outcomes we can currently measure on a comprehensive 
national basis involve rare events – e.g. hospitalisations or deaths.  This is not problematic 
when we examine the total number of events across all disease areas, which can add up to a 
large number.  But when we focus on one specific disease, the numbers become too small to 
detect statistically significant differences between local inequality and the national inequality 
benchmark.  However, to illustrate the potential use of disease-specific indicators at national 
level we have developed national disease-specific indicators of equity in the areas of 
coronary heart disease and diabetes, which are presented in Appendices 2 and 3. 
 
Our indicators can be used to assess the degree to which healthcare equity in England is 
getting better or worse over time.  They can also be used to identify local NHS areas that are 
performing better or worse than the national NHS average in reducing within-area 
socioeconomic inequalities in healthcare access and outcomes.  This information can be used 
to facilitate health care quality improvement efforts, to understand why some areas are doing 
well or badly, to learn lessons, and to share good practice.   
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However, we would caution against using our equity indicators for setting performance 
targets with rewards or penalties attached, at least until further experience and understanding 
of equity monitoring has been built up.  The Health and Social Care Act 2012 suggests the 
use of financial payments to reward clinical commissioning groups that succeed in reducing 
inequalities, as one factor to be taken into account when making end of year payments to 
CCGs to reward quality.  Specifically, section 223k of the act entitled “Payments in respect 
of quality” states that NHS England “may, after the end of a financial year, make a payment 
to a clinical commissioning group…For that purpose, the Board [i.e. NHS England] may also 
take into account either or both of the following factors— (a) relevant inequalities identified 
during that year; (b) any reduction in relevant inequalities identified during that year (in 
comparison to relevant inequalities identified during previous financial years).” (italics 
added).  The process of paying clinical commissioning groups for quality was subsequently 
implemented in a process known as the “Quality Premium”, though so far health inequality 
has not been incorporated into this process (www.england.nhs.uk/resources/resources-for-
ccgs/ccg-out-tool/ccg-ois/qual-prem/).  We would caution against too ambitious a timescale 
for incorporating our CCG level equity indicators into decisions on this process, for two 
reasons.  First, healthcare equity monitoring is still in its infancy and is less well developed 
than the monitoring of health care quality for the average patient. For example, health care 
decision makers have a reasonably good idea about how to reduce average hospital waiting 
times, supported by a strong evidence base from decades of international policy 
experimentation, monitoring and evaluation.  By contrast, rather less is known about how to 
reduce socioeconomic inequality in hospital waiting times or other forms of healthcare access 
and outcome.  The second reason is that the causal links between policy action and healthcare 
outcome are more complex, delayed and uncertain for some of the healthcare outcomes we 
measure – such as preventable hospitalisation and amenable mortality – compared with 
healthcare outcomes traditionally used for performance management, such as rates of 
antibiotic resistant bloodstream infections in hospitals.  This can make it hard 
straightforwardly to attribute change in inequality in these outcomes to recent actions taken 
by CCG managers or the services they commission.  Given the current state of knowledge, 
therefore, the most appropriate initial uses of our indicators are (1) to hold the NHS to 
account, and (2) to improve quality by helping decision makers learn how to reduce social 
gradients in healthcare and by helping researchers build a stronger evidence base, rather than 
(3) to set high powered financial and managerial incentives. 
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Throughout the study the research team was guided by an advisory group including academic 
and clinical experts, NHS and public health officials, and lay members, whose membership is 
listed at Appendix 5.  All key decisions around indicator selection and the development of 
analytical methods and visualisation tools were taken in consultation with the advisory group.  
The team is grateful for their advice and support, though the responsibility for all decisions 
rests with the research team. 
 
The next two sections of this introductory chapter set out the background to this study and 
present the conceptual framework we developed for monitoring equity in healthcare.  Chapter 
Two of the report describes how members of the public were involved in selecting our 
indicators and designing our visualisation tools, through a public consultation exercise in 
York based on an on-line survey and a citizens’ panel meeting, and through the participation 
of the two lay members of our advisory group.  Chapter Three describes the indicator 
selection process, which included reviewing existing indicators used by the NHS to monitor 
healthcare quality, consulting health indicator experts about technical feasibility and 
consulting NHS and public health experts about policy relevance.  Chapter Four describes the 
data and analytical methods used for healthcare equity indicator production and visualisation 
at both national and local levels.  Chapter Five presents the main results for all eight of our 
general indicators, including national healthcare equity in 2011/12, national healthcare equity 
time trends during the 2000s, and local healthcare equity monitoring in 2011/12 against a 
national benchmark.  Chapter Six describes the NHS engagement process we undertook to 
develop and refine our visualisation tools.  Chapter Seven presents our prototype “equity 
dashboards”.  Finally, Chapter Eight discusses our findings and Chapter Nine summarises our 
conclusions and research recommendations. 
 
The report also contains extensive appendices.  Appendix 1 contains full technical 
specifications of our main general indicators.  Appendices 2 and 3 present national disease-
specific healthcare equity indicators for coronary heart disease and diabetes, respectively.  
Appendix 4 presents sensitivity analysis around different ways of cleaning our data by 
trimming outliers.  Appendix 5 lists the advisory group members.  Appendix 6 contains 
materials from the public consultation exercise.  Finally, Appendix 7 contains letters from the 
three key NHS organisations we consulted during the development process confirming their 
interest in seeing our equity indicators routinely produced and used for NHS quality 
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improvement: the NHS England Inequality and Health Inequalities Unit, Hull CCG and Vale 
of York CCG. 
 
1.2 Background on equity in healthcare 
 
Why monitoring healthcare equity is important 
The World Health Organisation has called for universal healthcare and routine monitoring of 
healthcare equity in all countries
4, 12, 13
.  It is fairly obvious why healthcare equity monitoring 
is needed in countries which lack universal healthcare systems.  In such countries, many 
people cannot afford high quality healthcare and have limited protection against the financial 
risk of catastrophic healthcare costs and impoverishment due to ill-health.  Limited access to 
healthcare and limited financial protection are both typically associated with a low level of 
wealth, ethnicity, rural location and other social variables giving rise to equity concerns.  
Furthermore, there is good evidence that introducing universal healthcare – and, in particular, 
universal primary care – can contribute to reducing wider social inequalities in population 
health
14
.  It is therefore important for countries seeking to establish universal healthcare 
systems to monitor progress in reducing three different kinds of inequality in healthcare: 
1. Inequality in healthcare financing 
2. Inequality in healthcare access 
3. Inequality in healthcare outcomes 
 
But why is healthcare equity monitoring also important in a high income country like 
England, which introduced universal healthcare as long ago as 1948?  The answer is that 
important inequalities in healthcare access and outcomes persist in these countries, even 
though universal healthcare has succeeded in reducing them.  Monitoring of inequality in 
healthcare financing may also be more important in countries with less comprehensive and 
generous systems of universal healthcare than the English NHS.  Detailed local monitoring of 
the unequal impact of out-of-pocket healthcare costs on household finances can be considered 
less important in England, which regularly tops international league tables of fairness in 
healthcare financing and has succeeded in virtually eliminating the threat of catastrophic 
healthcare costs: relatively few people in England report financial difficulties in paying 
healthcare bills or face catastrophic medical expenditures
15, 16
. 
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The fact that social inequalities in healthcare access and outcomes persist in universal 
healthcare systems has been known for some time
17-20
, and the findings of our study provide 
further evidence.  Furthermore, there is a risk that some of these inequalities could potentially 
worsen in future decades as universal healthcare systems come under increasing financial 
strain even in high income countries. Over the next fifty years, rising care costs may make it 
increasingly hard for high income countries to provide fully comprehensive packages of 
healthcare that are fully supported by long-term care and other public services that influence 
patient outcomes
21, 22
.  This is not just a short-term issue relating to public sector austerity in 
the aftermath of the global economic crisis in 2008.  There are also concerns about long-term 
health care cost inflation due to medical innovation, demographic change and wage inflation 
in a labour-intensive high-skill industry.  Health care expenditure has absorbed an increasing 
share of national income in OECD countries over the past fifty years, and this trend is 
projected to continue
23
. A recent study forecast that public spending on healthcare and long-
term care as a share of  national income in OECD countries will more than double over the 
next fifty years, from an average of 5.5% in 2006-10 to between 9.5% and 13.9% by 2060
22
.  
Faced with tensions between the rising cost of public care and what people are willing to pay 
in higher taxes, rich country governments may face increasingly hard choices in the coming 
decades about what services to include in the universal health package at what level of 
quality.  This has the potential to exacerbate existing inequalities of healthcare access and 
outcome, especially inequalities related to income since (a) income inequalities are also 
projected to continue growing in the coming decades
24
 and (b) financial strain on public 
healthcare systems may increase the role of privately funded health and social care in future. 
 
In summary, important inequalities in healthcare access and outcomes remain, and are at risk 
of growing in future decades.  That is why it is important to establish systems for healthcare 
equity monitoring, even in high income countries with universal healthcare systems. 
 
Concepts of equity in healthcare 
This section briefly reviews the main concepts of equity in healthcare that underpin all 
empirical measurement work in this area, including the indicators developed in this study.  
We focus on equity in healthcare delivery, because relatively few people in England report 
financial difficulties in paying healthcare bills or face catastrophic medical expenditures.  We 
focus on socioeconomic inequality, because (a) this is an important type of inequality at risk 
of growing in the coming decades and (b) the available data sources for measuring 
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socioeconomic inequality in healthcare are relatively well developed.  Socioeconomic 
inequality is therefore a useful test case to see if robust equity monitoring systems can be 
developed.  Data sources for measuring other dimensions of equity are improving, and so it 
may be possible in future to apply similar methods to examine healthcare inequalities relating 
to ethnicity, mental health, homelessness and other equity-relevant variables. 
 
The literature on socioeconomic inequality in health care delivery usually adopts a normative 
perspective that seeks to distinguish “appropriate” or “fair” inequalities in health care from 
“inappropriate” or “unfair” inequalities.  To mark this distinction, it is common in the 
literature to use the word “inequities” (in Europe) or “disparities” (in the US) to reflect what 
may be regarded as “unfair” social inequalities in health care. However, there is considerable 
variation in usage, and the term “disparities” is sometimes used to indicate the mere fact of 
variation without any normative implication.  The term “inequity”, however, always has a 
normative connotation, and is the term we use in this report.  The basic idea is to measure 
departures from “horizontal equity” in health care delivery – the equal treatment of people in 
equal need.  We can distinguish three main kinds of healthcare inequality that policymakers 
may be concerned to reduce, based on three different definitions of “equal treatment”: 
1. Inequality of healthcare access between people with equal need for healthcare 
2. Inequality of healthcare utilisation between people with equal need for healthcare 
3. Inequality of healthcare outcome between people with equal need for healthcare 
 
These three types of inequality are progressively more challenging to reduce.  Providing 
equal access to a service does not guarantee the service will be used equally, and using the 
same service does not guarantee the same benefits will be gained.  The first and third 
principles are both central to this report, and so we compare and contrast them in more detail 
below.  First, however, we review the concept of “need for healthcare” which is common to 
all three principles and raises a host of thorny conceptual issues. 
 
One important preliminary issue is how far “need for healthcare” may extend beyond 
traditional healthcare boundaries to include need for other non-healthcare goods and services 
that may improve health.  As mentioned earlier, it is now well-known that healthcare is just 
one of many important social determinants of individual health over the lifecourse, along 
with childhood development, living and working conditions, job control, social status 
anxiety, and all of the lifestyle health behaviours that are causally associated with these social 
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factors.
4
  It might be stretching things to argue that “need for healthcare” is the same thing as 
“need for health”, and that therefore it includes need for all the social and biological 
determinants of health.  This would imply, for example, that healthcare providers are 
responsible for providing people with the strong genes, loving parents and high incomes they 
need in order to live long and healthy lives.  However, it might be reasonable to expect 
healthcare staff to deliver preventive healthcare services including not only narrowly medical 
interventions such as vaccination and immunisation but also a broader range of screening and 
disease awareness services to facilitate the early detection of disease and interventions to help 
reduce behavioural health risk factors such as smoking, physical inactivity and poor diet.  It 
might also be reasonable to expect healthcare staff from different specialties to work together 
in multidisciplinary teams when treating a complex patient with multiple conditions, to co-
ordinate across primary and acute care settings, and to liaise with staff in social care and 
other public services to help improve the patient’s prospects for a sustained recovery.  So 
need for healthcare may extend to need for co-ordinated care efforts by healthcare providers, 
need for travel services that allow people to use healthcare, and need for social services that 
help to improve recovery and long-term patient outcomes such as avoidable episodes of ill-
health.  We return to these boundary issues in more detail below. 
 
Another important debate is about the role of individual preferences, or what we might call 
“subjective need for healthcare” as seen from the patient’s own internal perspective as 
opposed to “objective need for healthcare” as seen from an external clinical or policy 
perspective.
25
  Some authors argue that it is important to respect individual preferences about 
how far to seek, accept and adhere to health care that is only seen as needed from an external 
perspective
26
.  By contrast, other authors emphasise that preferences are socially determined 
and may reflect entrenched deprivations, and so the focus for the purpose of assessing unfair 
inequality should be on “objective” need as assessed from an external perspective.27, 28  There 
is a social gradient in self-reported ill-health, such that poorer individuals generally report 
greater ill-health than richer individuals. However, for a given level of “objective” ill-health 
as assessed by a clinician using biomedical measures, richer individuals are likely to report 
greater subjective ill-health than poorer individuals and to express greater demand for health 
services that are free at the point of delivery.
29, 30
 Those who wish to respect individual 
preferences may be content to use “subjective” measures of ill-health and need for health 
care, or to focus on reducing inequality of healthcare access for people with the same 
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“objective need”.  By contrast, others may prefer to focus on the more demanding equity 
objectives of reducing inequality of healthcare utilisation and  outcome. 
 
A third conceptual issue is whether need for healthcare should be defined in terms of severity 
of illness or capacity to benefit.
31
  Severely ill patients are worse off than other patients in a 
relevant sense, and to that extent may have a greater claim on healthcare resources.  On the 
other hand, if a severely ill patient has zero capacity to benefit from a costly new medical 
treatment – over and above the benefits they receive from their existing package of care – 
then it seems odd to say that they “need” that costly additional treatment.  It may be unfair as 
well as inefficient to spend money on ineffective healthcare for severely ill patients rather 
than effective healthcare for less severely ill patients – though it is of course important to 
adopt a broad view of what counts as “effective” care that does not merely focus on life 
extension and biomedical functioning but also includes broader aspects of quality of life 
including being treated with dignity and compassion, perhaps especially in relation to 
palliative care for severely and terminally ill patients. In relation to equality of healthcare 
outcomes, the case for defining need as capacity to benefit is that it may not be possible for 
the healthcare system to deliver equal outcomes to people with equal severity of illness.  For 
example, imagine one patient has an incurable disease whereas another has an equally severe 
disease with a fully effective remedy.  Further, assume that the incurable nature of the disease 
was not caused by a failure on the part of healthcare services to deliver diagnosis, effective 
treatment and prevention services at an earlier stage in the patient pathway.  In that case, the 
patient with the incurable disease may have less capacity to benefit from healthcare, and so 
the unequal healthcare outcome for these two people with equal severity of illness may not be 
the responsibility of the health service and hence not an indicator of unfair treatment. 
 
This raises a fourth thorny question: should need for healthcare (including preventative 
services) be assessed from the perspective of the current situation, at whatever point the 
patient has currently reached in the disease pathway, or from an earlier point when severity of 
illness may be lower but capacity to benefit greater?  This relates to more general question 
about time perspective.  Should equity in healthcare be assessed from a cross-sectional 
perspective, focusing on healthcare delivery this year for healthcare needs this year, or from a 
longitudinal perspective looking at healthcare delivery over a longer time window that may 
include past, present and future time periods – perhaps even the individual’s entire 
lifecourse?  
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Unfortunately, empirical studies often have limited ability to address these important 
conceptual debates about “need”, because they often rely on imperfect need variables such as 
age, sex and various indicators of morbidity which are typically only measured at a point in 
time or across time in just one part of the system (e.g. primary or secondary care).  The basic 
strategy used in the empirical literature on socioeconomic inequity in healthcare is to measure 
associations between (current) socioeconomic status and (current) healthcare after adjusting 
for (current) need variables.  Our study also follows this strategy, and our need variables are 
also imperfect.  Although we have time series cross sectional data on small area populations 
going back several years, we do not follow each individual within those small areas 
longitudinally to assess their historical levels of need, healthcare delivery and socioeconomic 
status at earlier points in the patient pathway.  The assessment of equity in healthcare from a 
longitudinal perspective is an important avenue for future research using longitudinal or 
linkable data at individual level. 
 
Our need variables are especially imperfect in the case of healthcare outcomes, where we are 
only able to adjust for age and sex but not morbidity.  Failure to adjust for morbidity means 
that we typically under-estimate the risk of poor healthcare outcomes in deprived 
populations.  To put this another way, we typically over-estimate short-term capacity to 
benefit from healthcare and under-estimate level of need in deprived populations from the 
cross-sectional perspective of the current indicator year.  As discussed previously, however, 
capacity to benefit from healthcare from a longitudinal perspective will be greater than short-
term capacity to benefit, due to potential benefits in the past and in the future.  Nevertheless, 
from the cross sectional perspective of the current indicator year we typically over-estimate 
the extent of “pro-rich” socioeconomic inequity in the following three healthcare outcomes: 
preventable hospitalisation, repeat hospitalisation and amenable mortality.  For this reason, 
we usually refer to socioeconomic “inequality” in healthcare outcomes throughout the report, 
rather than socioeconomic “inequity”.  This does not apply to our three indicators of 
inequality of access, however, i.e. primary care supply, primary care quality and hospital 
waiting time.  Indeed, in the case of primary care supply, imperfect measurement of need 
generates a bias that works in the opposite direction.  In this case, as explained in Chapters 4 
and 8, we typically under-estimate need for primary care supply in more deprived 
populations.  This means that we typically under-estimate the extent of “pro-rich” inequality 
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in primary care supply.  These issues are discussed in more detail in Chapters 4 and 7, and 
Appendix 1. 
 
In the health outcomes literature, adjusting for age, sex and other risk factors is usually called 
“risk adjustment” rather than “need adjustment”.  The basic idea is to adjust the observed 
outcomes for exogenous risk factors that are beyond the control of the healthcare provider, so 
that the “risk adjusted outcomes” can be attributed to the actions of the healthcare provider 
and interpreted as an indicator of the quality of care.  However, in our context we can also 
think of this as a form of “need adjustment”, where need is interpreted as short-term capacity 
to benefit from healthcare in the current period.  We adjust the observed outcomes from 
healthcare for exogenous risk factors that determine short-term capacity to benefit from 
healthcare in the current indicator period.  The remaining differences in adjusted outcomes 
then reflect “unfair” differences in the benefit achieved by healthcare rather than “fair” 
differences in the capacity to benefit from healthcare. Since “risk adjustment” is the more 
familiar phrase in relation to health outcomes, however, we use that phrase in the rest of this 
report. 
 
We now return to the question of why reducing socioeconomic inequality of healthcare 
outcomes is a more demanding principle of justice than reducing socioeconomic inequalities 
of access to healthcare.  The basic reason is that access to healthcare is just one input into the 
production of health outcomes
7, 8, 32, 33
.  One set of issues relates to individual resilience.  
Poorer patients may tend to recover more slowly and less completely following healthcare 
intervention due to greater co-morbidity, less biological, physiological and psychological 
resilience, and less supportive home and community environments in which to recover 
including worse access to supportive informal care from friends and relatives (e.g. in noticing 
when public care quality falls short and taking corrective action).  Another set of issues 
relates to individual health-seeking behaviour.  Poorer patients may be less likely to invest 
time and other resources in improving their own health by seeking medical information, using 
medical care and engaging in healthy lifestyle activities, since they face higher opportunity 
costs (e.g. time required at the expense of domestic and work duties, travel costs) relative to 
their more limited wealth and human capital, have less social capital to draw on (e.g. support 
from friends, family and wider social and professional networks) and, more controversially, 
may be less able to find enjoyable jobs, and to afford pleasant and fulfilling leisure activities, 
and so may see less point investing time and money to gain additional days of life.  Other 
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things equal, poorer individuals will tend to use less preventive health care when facing no 
immediate pain or disability, and to present to health care providers at a later stage of illness.  
The quality of medical care received may also depend in part upon the intensity and 
effectiveness of patient care seeking behaviour (e.g. in navigating through a complex health 
care system, lobbying providers for the best quality care) and self-care behaviour (e.g. in 
adhering to medication regimes).  For all of these reasons, poorer patients tend to have 
greater needs for co-ordinated care and support across diverse service providers in order to 
achieve good healthcare outcomes – including co-ordination between primary, secondary and 
community care providers, between specialties, and between healthcare and social care 
services. 
 
Socioeconomic inequalities in healthcare outcomes may therefore arise due to 
socioeconomic-related differences in (i) the life course of the patient, due to the accumulated 
effect of advantage or disadvantage on the risk of ill-health and the prospects of recovery 
from episodes of ill-health, (ii) patient behaviour including healthcare seeking behaviour, 
self-care behaviour and lifestyle behaviour, (iii) the behaviour of primary, secondary and 
community care providers in patient encounters, (iv) informal health and community care 
provided to patients by family and friends, (v) formal long-term care including both publicly 
and privately funded care and social services provided in the home as well as in institutions, 
and (vi) the co-ordination of care between primary, secondary and community care providers, 
between specialties, and between health and non-health services.  Some of these factors may 
be considered “exogenous” capacity to benefit factors that lie entirely outside the remit of the 
health care system.  Others may be considered “endogenous” factors under the control of the 
health care system.  Still others may lie in a “grey area” of overlap, where the boundaries of 
responsibility are not clear-cut.  These boundary issues can raise challenging ethical 
questions for health care providers.  For instance, if a poor patient has a worse post-surgical 
outcome than a rich patient due to their lack of a supportive home environment in which to 
recover, how far should health care providers be held responsible for stepping in to remedy 
the situation?   One view is that healthcare providers are indeed responsible for stepping in, 
since the poor patient needs additional support during their recovery period whereas the rich 
patient does not.  Another view might be that providing a supportive home environment 
including reminders to take medication, follow physiotherapy regimes and other medical 
advice is not properly the responsibility of the health service.  Our report does not seek to 
take a prescriptive ethical view on such matters.  Rather, we seek to provide data and 
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evidence to help decision makers draw their own conclusions about equity based on their own 
value judgements. 
 
Monitoring of equity in health and healthcare in England 
This section briefly reviews the recent history of monitoring of equity in health and 
healthcare in England since the early 2000s, and summarises the equity indicators that are 
already produced by Public Health England and NHS England.  By way of comparison, it 
then reviews the system of healthcare equity monitoring in the USA, which at the current 
time is arguably the most comprehensive in the world as explained below. 
 
Monitoring of equity in healthcare is in its infancy, and remains isolated from mainstream 
quality assurance. Whilst health care policymakers, regulators, purchasers and providers have 
become accustomed to paying close attention to routine comparative data on health care 
quality for the average patient, they lack routine comparative data on social inequalities in 
healthcare quality.
2
 This hampers efforts to improve equity, since what is not measured may 
be marginalised.
1
  So although NHS decision makers know that healthcare inequalities exist, 
they do not yet have a routine approach to quantifying the influence of the NHS on those 
inequalities. They cannot routinely pinpoint changes in health care inequalities at local level, 
and do not know what impact their actions are having on such inequalities.  Prior to 2015, 
there was essentially no routine monitoring of equity in healthcare in the English NHS.  The 
NHS Outcomes Framework started producing national breakdowns of inequalities in selected 
healthcare outcomes for internal use in 2015, and plans to start publishing these breakdowns 
from 2016.
34
  However, there is currently no national monitoring of inequality in health care 
access, and no local monitoring of equity in the NHS.
2
 
 
By contrast, monitoring of inequality in health is more advanced and monitoring of health 
inequalities within local areas started in the early 2010s, as explained below.  In the early 
2000s, England introduced national health inequality targets as part of the world’s first cross-
government strategy for tackling health inequality.
35, 36
  However, these targets were limited 
from a healthcare quality improvement perspective. First, they focused on life expectancy and 
infant mortality, over which health care providers have little direct control since they are 
strongly influenced by non-NHS social and economic factors (e.g. living and working 
conditions) and related lifestyle behaviours (e.g. smoking, diet and exercise).  Second, they 
were defined in terms of inequalities between local government areas – known as “spearhead 
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areas” – and the rest of the country, thus masking important inequalities within these areas.  
This second issue was noted in the 2010 Marmot Review of health inequalities in England, as 
follows: “around half of disadvantaged individuals and families live outside spearhead 
areas…“By measuring changes only at local authority level, we cannot tell whether any 
improvements being made are confined only to the more affluent members of a generally 
deprived population”6   
 
Subsequently, in the early 2010s, a more comprehensive and sophisticated set of local 
authority level health inequality indicators were developed by the Institute of Health Equity 
in collaboration with London Health Observatory, known as the “Marmot indicators”37.  
These include indicators of average health and the social determinants of health that broadly 
correspond to the policy recommendations proposed in the Marmot Review, Fair Society, 
Healthy Lives.  Importantly, they also include indicators of inequality in life expectancy 
within each local authority level, based on small area level data.  The Public Health 
Outcomes Framework (PHOF) has also produced local as well as national indicators of 
inequality in life expectancy.
38
  These local indicators use a local version of the slope index 
of inequality, based on ranking small areas into local deprivation decile groups by deprivation 
score within the local authority.  This is a different approach to the one used in the present 
study, which is based on national deprivation rank within England as a whole; as explained 
later in the report in Chapter 4 Methods .  The primary aim of the PHOF local health 
inequality indicators is to compare change over time in each local authority, rather than to 
compare local performance against a national benchmark.  The PHOF local deprivation 
approach is not appropriate for the latter task since local deprivation ranks cannot be 
compared with national deprivation ranks for the country as a whole.  For that reason, we use 
national deprivation ranks so that we can compare the local gradient in healthcare outcomes 
within the local area with the national gradient.  To distinguish our approach from the PHOF 
approach, we label our local inequality index the “absolute gradient index” rather than the 
slope index. 
 
In contrast to England, the USA has had a fairly comprehensive system of national healthcare 
equity monitoring since 2003.  The US healthcare equity monitoring system was initiated 
following landmark reports by the US Institute of Medicine on the safety of care
39
, the quality 
of care
40
 and racial disparities in both
41
.  Since 2003, the Agency for Healthcare Research and 
Quality (AHRQ) has published an annual report on healthcare disparities within the general 
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US population by racial, ethnic and socioeconomic groups and by state
42
.  In 2014, this was 
integrated with the AHRQ annual report on healthcare quality to form the National 
Healthcare Quality and Disparities Report
43
.  This report summarises national US time trends 
in more than 250 different indicators of healthcare access, process quality and outcomes.  The 
indicators mostly focus on indicators of healthcare access and process quality, in line with 
relatively narrowly defined healthcare quality improvement objectives.  However, there are 
also some indicators of healthcare outcomes that go under the heading of “care co-
ordination” indicators, such as preventable hospitalisation for ambulatory care sensitive 
conditions.  Although these are likely to be more sensitive to variations in healthcare access 
in a US setting, compared to a country like England with universal healthcare, these 
indicators may also pick up concerns for population health improvement and the co-
ordination of care across different healthcare settings and between healthcare and long-term 
care.  Most of the indicators in the 2014 report published in May 2015 end in 2012 – i.e. more 
than a two year data lag – though some indicators such as the proportion of Americans with 
healthcare insurance are measured up to 2014.  The AHRQ also publishes a web-based 
“States Snapshots” tool for comparing quality and disparities between states44.  This focuses 
mainly on comparisons of average quality between states, though also compares racial 
disparities between states by dividing the average of the Black, Hispanic, and Asian scores by 
the White score, ranking states on this ratio, and then listing states by quartile group.  
However, there is still no attempt to compare socioeconomic disparities between states, or to 
perform statistical tests of whether states are performing significantly differently from the 
national average on racial disparity. 
 
1.3 Conceptual framework 
 
Our monitoring framework has the following general design objectives: 
1. To monitor equity in both healthcare access and outcomes, after appropriate need or 
risk adjustment 
2. To monitor overall equity in healthcare for the general population, while allowing 
disaggregation by age, sex and disease category 
3. To monitor the equity performance of the health service as a whole, including the 
integration of care across different specialties, different primary and acute care 
settings, and different healthcare, social care and other public services 
4. To monitor equity at all main stages of the patient pathway 
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5. To monitor local equity performance against a national equity benchmark 
6. To monitor equity trends alongside equity levels, and average performance alongside 
equity performance 
7. To summarise all key findings in a one-page summary (“equity dashboard”) 
8. To provide visual information about underpinning inequality patterns and trends 
(“equity chartpacks”) 
9. To provide a battery of inequality measures that are easy to understand and capture 
importantly different concepts of inequality that can trend in different directions 
10. To ensure indicators can be understood by members of the general public 
 
Figure 1 illustrates our framework for monitoring inequality in healthcare access and 
outcomes at key stages of the patient pathway, and shows how our eight general indicators fit 
into this framework. 
 
Figure 1 Conceptual framework for monitoring inequality in healthcare access and 
outcomes at key stages of the patient pathway 
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Figure 2 illustrates how we monitor national equity trends, using Indicator 1: Primary Care 
Supply as an example.  The top panel shows a breakdown of patients per full time equivalent 
GPs by deprivation quintile group, allowing for need and population change, and the bottom 
panel shows how this translates into two standard inequality measures that look at the whole 
of the social gradient in healthcare – the slope index and the relative index of inequality.  
These measures and graphs are explained in more detail in Chapter 4: Methods. 
 
Figure 2 National monitoring of change in equity over time 
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Figure 3 Local equity monitoring against a national benchmark 
 
Finally, figure 3 illustrates our framework for local equity monitoring against a national 
benchmark.  This figure shows socioeconomic inequality in preventable hospitalisation 
within a fictional local NHS area called “Any Town”.  The basic idea is to compare the social 
gradient in healthcare within Any Town against the social gradient in healthcare within 
England as a whole.  The social gradient shows the “pro-rich” link between socioeconomic 
status and preventable hospitalisation, after allowing for exogenous risk factors influencing 
preventable hospitalisation that are not under the control of the NHS – in this case, age and 
sex.  As explained above in the section on equity concepts, we would ideally also want to 
adjust for morbidity – or, more precisely, that part of morbidity that is not under the control 
of the NHS – but were unable to do so due to data limitations.  The relevant NHS equity 
objective is to reduce the social gradient in healthcare – both within Any Town and within 
England as a whole. 
 
Any Town has a population of about 200,000 people.  Each dot represents one of the 125 
neighbourhoods in Any Town, each containing about 1,500 people.  Neighbourhoods are 
ranked by deprivation, with more deprived neighbourhoods to the right.  The Any Town 
England Average
Any Town Gradient
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England Inequality 
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Preventable hospitalisation in 
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NHS area (“Any Town”)
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“inequality gradient” is simply a regression line fitted through these 125 dots.  The England 
inequality gradient is a regression line fitted through all 32,482 neighbourhoods in England.  
In this example, Any Town is doing better than England as a whole both for the average 
patient (a lower average line) and in terms of reducing inequality (a flatter inequality 
gradient).  In this example, these differences are statistically significant and unlikely to be 
merely due to the random play of chance.  The NHS may therefore be able to learn lessons 
from Any Town about how to tackle inequality in preventable hospitalisation. 
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Chapter 2 Public Involvement   
2.1 Introduction 
Public involvement was important to our study because one of the main purposes of our 
indicators is public reporting for democratic accountability, as well as facilitating quality 
improvement efforts by national and local decision makers.  We therefore wanted to select 
indicators of socioeconomic inequality in healthcare that members of the general public will 
consider meaningful and important.  Before selecting our indicators, we therefore considered 
it important to ask the general public about what they view as the most unfair socioeconomic 
inequalities in health care. We also sought feedback from members of the public to help 
refine our visualisation tools for communicating the findings of our indicators, and to ensure 
that members of the public are capable of understanding our indicators. 
 
This chapter describes how members of the public were involved in this study. They were 
involved in two ways.  First, through a small-scale public consultation exercise in York 
conducted at the beginning of the study to give us a better understanding of what kinds of 
socioeconomic inequality in health care are of most concern to members of the public.  This 
involved both an on-line survey (with 155 responses) and a full-day “citizens’ panel” meeting 
(with 29 participants) to gather more in-depth views.  Second, two members of the public, 
recruited via our public consultation exercise, gave feedback throughout the project through 
their membership of our advisory group. 
 
The primary aim of the public consultation was to identify a list of priority areas for 
monitoring NHS equity performance. This was achieved by asking the public to consider 
different types of socioeconomic inequality in health and health care and assess which ones 
they thought were the most unfair. Our key finding was that the public are concerned to 
reduce inequality in healthcare outcomes, but that their concern for reducing inequalities of 
access – specifically, for GP supply and hospital waiting times – is at least as strong. This 
finding influenced the selection of equity indicators for our subsequent analysis.  At the 
inception of the project we had presumed that our indicators would focus on healthcare 
utilisation and outcomes, which are the focus of much current academic literature on equity 
in healthcare.  However, as a result of our public consultation exercise as well as further 
development of our conceptual framework in monitoring equity at multiple stages of the 
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patient pathway, we ensured that both GP supply and hospital waiting time were selected for 
inclusion in our suite of equity indicators.   
 
A secondary aim of the public consultation was to identify two lay members of the public to 
join our advisory group to contribute further to the indicator selection process and provide 
feedback on the design of equity dashboards and other visualisation tools for monitoring 
equity performance. 
 
This chapter is organised as follows. We start with consultation exercise methods, including 
the sampling approach, development of questionnaire and data collection. We then present 
the main quantitative results of the public consultation in terms of people’s responses to 
questions asking them to assess and rank different kinds of inequality in health and health 
care by degree of unfairness. The results are presented separately for our on-line survey and 
citizens’ panel. We then discuss the process of recruitment of lay members and their 
contribution to the advisory group and, in particular, the design of visualisation tools. Finally, 
we conclude by discussing the implications of public involvement for our indicator selection. 
 
2.2 Methods of public consultation 
 
Sampling 
The survey was conducted in the York area using two modes of administration: (a) a one day 
face-to-face Citizens’ Panel event (n = 29), and (b) an online survey (n = 155).  Participants 
in both forms of public consultation were recruited in the same way, through advertising and 
leafleting in the York area as described below. The Citizens’ Panel event was held in York 
City on Saturday 21st September 2013. The online survey was administered between July and 
September 2013, using a web portal called Smart Survey. Citizens’ Panel members were paid 
expenses and an honorarium for devoting a whole day of their time to this, according to 
NIHR and INVOLVE guidance, whereas online survey participants were unpaid.  The 
sampling strategies for both approaches are described below. 
 
The Citizens’ Panel meeting was advertised in a local monthly magazine called Your Local 
Link in July and August 2013.  The magazine is free and distributed to all homes and 
businesses across York (35 postcode sectors), targeting all socio-demographic groups. In 
addition, we distributed 810 leaflets door-to-door to 10 of the most deprived streets in York 
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(identified as being within the most deprived fifth of neighbourhoods in England according to 
the IMD 2010 deprivation index) to reach a diverse groups of participants. We also 
distributed flyers at two public events as part of the University of York’s Festival of Ideas 
which was held in June 2013. Finally, we also put out a University of York press release 
about the Citizens' Panel event.  A selection of our recruitment materials, together with the 
participant consent form, are presented in Appendix 6. 
 
A total of 103 individuals made contact with the project administrator for the Citizens’ Panel 
event. The contact was made either by telephone, e-mail or completion of an online 
registration form. Thirty places were offered after stratifying respondents based on age, sex 
and socioeconomic background (established using respondents’ postcode data and 
information on the ONS "neighbourhood statistics" website derived from IMD 2010 
deprivation score) and then selecting participants on a ‘first-come-first-served’ basis. A total 
of 29 participants attended the Citizens’ Panel event.  This resulted in a sample which was 
41.3% male (n=12) and 58.7% female (n=17), and had approximately a quarter from each 
main age group 18-34, 35-49, 50-64 and 65+, though slightly more (around 30%) in the 50-
64 category, and had respondents in all five deprivation quintile groups with a mean 
deprivation rank of around three i.e. about average for the England population – see the 
demographic breakdown table in the next section for more details. 
 
The online survey was publicised on Your Local Link magazine, on door-to-door leaflets, the 
Centre for Health Economics website and the jiscmail mailing list for health economists. It 
was also advertised on social media from June 2013, particularly using the Twitter handle of 
the Centre for Health Economics, the University of York, and Facebook. In addition, 
individuals who contacted us for the Citizens’ Panel but were not offered a place, were also 
informed about the online questionnaire.  
 
Questionnaire 
The questionnaire focused on socioeconomic inequality in the supply, process and outcomes 
of healthcare. Statements about inequalities in general (non-disease-specific) health and 
health care were presented to all participants who were asked to rate them on a scale of 1 to 
10, where 1 is not at all unfair and 10 is extremely unfair (see Appendix 7). In order to elicit 
views about the unfairness of different kinds of inequality, we developed a questionnaire 
based on the following statements about different general kinds of socioeconomic inequality 
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in healthcare access and outcome. Our selection was based on statements about inequalities 
that can in principle be monitored using available data, which constrained our choices 
considerably, but this was a necessary step as the ultimate aim was to measure and monitor 
inequality. We piloted these statements on a sample of administrative staff members at the 
University of York.  Based on their feedback, we improved the presentation and clarity of the 
statements. 
 
 The richest fifth of people in England are more likely than the poorest fifth to have a 
healthy diet and a healthy level of physical exercise  
 The richest fifth of people in England are served by more GPs than the poorest fifth  
 The richest fifth of people in England are more likely than the poorest fifth to receive 
routine screening tests (e.g. for bowel cancer)  
 The richest fifth of people in England are more likely than the poorest fifth to see a 
medical specialist when they are ill  
 The richest fifth of people in England wait less time for NHS surgery than the poorest 
fifth  
 The richest fifth of people in England are less likely than the poorest fifth to die after 
high-risk surgery (e.g. heart or cancer surgery)  
 The richest fifth of people in England are less likely than the poorest fifth to have an 
emergency hospitalisation preventable by good quality healthcare  
 The richest fifth of people in England are less likely than the poorest fifth to die from 
conditions preventable by good quality healthcare  
 
Respondents were then asked to indicate which of the above inequalities they saw as the most 
and least unfair.  This rating question and a screenshot of the on-line questionnaire are 
reproduced in Appendix 6. 
 
We did not present statements about specific clinical disease areas because it was not possible 
to provide members of the public with adequate clinical and epidemiological information 
about all the different possible disease area domains that we could select.  This would require 
a series of clinical tutorials that would take up more than the full day of discussion. 
Furthermore, asking people to compare disease areas would likely change the focus of 
discussions to which diseases are more important, rather than on socioeconomic inequality 
and fairness in health and healthcare within each disease area. 
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Data collection 
There were two samples: the “Citizens’ Panel” sample and the online sample.  The Citizens’ 
Panel event involved presentations by facilitators to introduce the questionnaire, interactive 
discussions in small and large groups, and individual completion of a paper version of the 
questionnaire. Respondents were split into 5 pre-arranged groups (4 groups of 5 and 1 group 
of 4) which were mixed according to age, gender and socio-economic background. The 
following people each facilitated a group: Shehzad Ali, Miqdad Asaria, Richard Cookson, 
Paul Toner and Aki Tsuchiya.  A gift payment of £70 was offered to all participants of the 
Citizens’ Panel event which was accepted by all except one who asked to donate it to charity. 
 
The online survey was posted on a web host called Smart Survey with the following weblink: 
http://www.smart-survey.co.uk/s/NHSFairness. The survey included the same inequality 
statements as the Citizens’ Panel questionnaire and followed the same format (see Appendix 
7). Our online questionnaire was active between June 2013 and September 2013. 
Respondents could complete the survey anonymously, or leave their name and e-mail address 
to receive a copy of the findings. No financial incentive was offered for taking part in the 
online survey because of budget limitations and technical difficulty of arranging payments. 
 
2.3 Results of public consultation 
 
Survey sample 
In total, 29 individuals participated in the Citizens’ Panel event in York and 159 individuals 
completed the online survey. The baseline characteristics of the sample are presented in Table 
1.  The majority of respondents were female: 62.1% in the Citizens’ Panel and 66.5% in the 
online group. The age distribution in both groups was similar and reflects that the survey 
represented a diverse group of participants. Based on respondents’ postcode information, we 
calculated their deprivation level using the Index of Multiple Deprivation 2010 data available 
at small area level. Respondents in the two groups were from all five deprivation quintile 
groups – with the mean deprivation quintile group rank being 3.2 and 3.3 for the Citizens’ 
Panel and online groups respectively, i.e. the average person was in the middle of the five 
deprivation groups. Respondents were also asked to complete standard questions from the 
British Attitudes Survey about attitudes to the welfare state and income redistribution (1 = 
strong agree and 5 = strongly disagree). The average score on the statement “The creation of 
the welfare state is one of Britain's proudest achievements” was 1.4 showing a high level of 
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agreement (93.1% and 94.8% of respondents agree or strong agree with this statement in the 
Citizens’ Panel and online samples respectively). This is much higher than the findings of the 
British Attitude Survey results for 2014 which found that 56% of respondents agree or 
strongly agree with this statement. This reflects the general point that public consultation 
exercises about equity are more likely to recruit individuals who care about equity issues. 
 
Table 1 Respondent characteristics of Citizens’ Panel and online groups 
  
Citizens’ Panel 
(N = 29) 
Online group  
(N = 155) 
Baseline  Statistic n Statistic n 
Male (%) 37.9% 11 33.5% 52 
Age (%)     
Under 18 0.0% 0 0.6% 1 
18-34 27.6% 8 24.5% 38 
35-49 20.7% 6 23.2% 36 
50-64 31.0% 9 34.8% 54 
65+ 20.7% 6 16.8% 26 
Deprivation quintile     
Most deprived quintile 13.8% 4 16.2% 19 
Quintile 2 20.7% 6 17.1% 20 
Quintile 3 20.7% 6 18.8% 22 
Quintile 4 20.7% 6 19.7% 23 
Most affluent quintile 24.1% 7 28.2% 33** 
Social attitude statements* (mean) 
(1= strongly agree; 5= strongly disagree) 
    
The creation of the welfare state is one of 
Britain's proudest achievements. 
1.4 29 1.4 154 
Government should redistribute income from 
the better-off to those who are less well off. 
3.0 29 2.2 154 
*1 suggests most egalitarian and 5 suggests most non-egalitarian 
** 38/155 online respondents did not provide correct postcode information; hence, their 
deprivation score was not available. 
 
Ranking of unfair inequalities 
All participants responded to the question about the most unfair socioeconomic inequalities in 
health and healthcare. Figure 4 presents the full distribution of responses to the question 
about the most unfair inequality. The Citizens’ Panel group ranked socioeconomic inequality 
in waiting time for surgery as the most unfair (31%) while the online group ranked inequality 
in death from conditions preventable by good quality healthcare as most unfair (33%).  
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Figure 4 Choice of the most unfair type of inequality in the Citizens’ Panel and online samples 
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Citizens' Panel Online
A. The richest fifth of people in England are more likely than the poorest fifth to have a healthy diet and a healthy level of physical exercise
B. The richest fifth of people in England are served by more GPs than the poorest fifth
C. The richest fifth of people in England are more likely than the poorest fifth to receive routine screening tests (e.g. for bowel cancer)
D. The richest fifth of people in England are more likely than the poorest fifth to see a medical specialist when they are ill
E. The richest fifth of people in England wait less time for NHS surgery than the poorest fifth
F. The richest fifth of people in England are less likely than the poorest fifth to die after high-risk surgery (e.g. heart or cancer surgery)
G. The richest fifth of people in England are less likely than the poorest fifth to have an emergency hospitalisation preventable by good quality healthcare
H. The richest fifth of people in England are less likely than the poorest fifth to die from conditions preventable by good quality healthcare
A B D C E F G H B D A C E F G H 
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However, the following three types of inequalities were identified as the most important 
unfair inequalities by both Citizens’ Panel participants and online survey respondents: 
 The richest fifth of people in England wait less time for NHS surgery than the poorest 
fifth (31% of Citizens’ Panel participants and 19% of online respondents ranked this 
as the most unfair inequality) 
 The richest fifth of people in England are less likely than the poorest fifth to die from 
conditions preventable by good quality healthcare (24% of Citizens’ Panel 
participants and 33% of online respondents ranked this as the most unfair inequality) 
 The richest fifth of people in England are served by more GPs than the poorest fifth 
(21% of Citizens’ Panel participants and 24% of online respondents ranked this as the 
most unfair inequality)  
 
Rating of unfair inequalities 
We also asked respondents to rate how unfair they think each type of inequality is on a scale 
of 1 to 10, where 1 is ‘not at all unfair’ and 10 is ‘extremely unfair’. All respondents in the 
Citizens’ Panel and online groups completed the rating scale. Table 2 summarises the results 
of the level of perceived unfairness of different types of inequality. The table shows that all 
forms of socioeconomic inequalities in health and healthcare were considered unfair by both 
the Citizens’ Panel and online groups. Based on mean scores, the Citizens’ Panel group rated 
the following inequalities as particularly unfair: waiting time for NHS surgery; supply of 
GPs; and routine screening tests. Similarly, based on average scores, the online group rated 
the following inequalities as particularly unfair: waiting time for NHS surgery; supply of 
GPs; and death from conditions preventable by good quality healthcare. 
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Table 2 Rating of unfairness of different types of inequalities in health and healthcare* 
Statements 
Citizens’ Panel Online sample 
Mean Median 
% of 
responses 
with 
score ≥ 6 
Mean Median 
% of 
responses 
with score 
≥ 6 
A. The richest fifth of people 
in England are more likely 
than the poorest fifth to have 
a healthy diet and a healthy 
level of physical exercise 
6.69 7 62% 6.52 7 60% 
B. The richest fifth of people 
in England are served by 
more GPs than the poorest 
fifth 
8.07 8 83% 8.67 10 91% 
C. The richest fifth of people 
in England are more likely 
than the poorest fifth to 
receive routine screening 
tests (e.g. for bowel cancer) 
8.1 8 83% 7.92 9 80% 
D. The richest fifth of people 
in England are more likely 
than the poorest fifth to see a 
medical specialist when they 
are ill  
7.31 8 76% 8.02 9 83% 
E. The richest fifth of people 
in England wait less time for 
NHS surgery than the 
poorest fifth 
8.41 8 86% 8.76 10 91% 
F. The richest fifth of people 
in England are less likely 
than the poorest fifth to die 
after high-risk surgery (e.g. 
heart or cancer surgery) 
7.79 9 79% 7.51 8 72% 
G. The richest fifth of people 
in England are less likely 
than the poorest fifth to have 
an emergency 
hospitalisation preventable 
by good quality healthcare 
7.34 8 79% 7.99 9 82% 
H. The richest fifth of people 
in England are less likely 
than the poorest fifth to die 
from conditions 
preventable by good quality 
healthcare 
7.93 9 79% 8.05 9 82% 
*1=not at all unfair and 10=extremely unfair 
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2.4 Role of the lay members of the advisory group 
 
Two participants at the Citizens’ Panel event were invited to join our Advisory Group as lay 
members, to contribute to the research design and in particular the process of indicator 
selection and design of dashboards and other visualisation tools for monitoring changes in 
NHS equity performance. The selection of lay members was based on their interest in the 
subject of inequalities in health and healthcare, willingness to contribute to this project, 
experience of using NHS health services, ability to communicate with members of the team 
and availability to join meetings in York and London. Based on these criteria, one male and 
one female participant were invited to join the Advisory Group. 
 
The lay members attended all three Advisory Group meetings in London and were involved 
in additional face-to-face discussions and reviewing and commenting on relevant documents. 
More specifically, the lay members contributed to the project in the following ways: 
 They contributed to discussions on the choice of equity indicators that matter to the 
general public and therefore should be considered for monitoring equity performance. 
 They provided useful advice about dashboard design to improve presentation and 
interpretation. 
 
The lay members commented on the prototype NHS equity dashboard designs, as a result of 
which we revised and simplified the designs to reduce "clutter" on the graphical displays, and 
added arrows as well as traffic light colours to help colour blind users and people who print 
out in black and white.  The lay members also commented on the different types of graph in 
the chartpack, and reassured us that our graphs were clear and informative to non-expert 
audiences. 
 
Our lay members agreed in the final project meeting that the current 1-page summary 
dashboard style presents useful information to NHS and public health experts.  However, 
they thought that this concise format may not be appropriate for communication to the public, 
as it provides too much information in a small space.  They advised that public reporting 
would require a different kind of infographic design tailored to public audiences.  They 
suggested that the dashboard presentation would be useful to health experts once they are 
familiar with the dashboard design and have read the accompanying material, but proposed 
that clear notes accompanying the dashboard would be useful to help interpretation. 
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2.5 Conclusion 
 
We conducted a small-scale public consultation exercise in York to inform the choice of 
priority indicators of healthcare equity. The consultation was conducted through a one-day 
Citizens’ Panel event in York and an online questionnaire, both of which aimed to gauge the 
strength of public concern for different types of socioeconomic inequality in healthcare 
access and outcomes. The consultation showed that that public considered inequalities in 
health behaviours, such as healthy diet and healthy level of physical exercises, to be less 
unfair than inequalities in healthcare access and outcomes. This indicated that, at least from a 
public perspective, the focus of NHS equity measurement should be on indicators that are 
amenable to changes in the way healthcare is organised and delivered rather than indicators 
of individual lifestyle behaviour – though, of course, the former may influence the latter.  The 
consultation found that the general public perceived the following three socioeconomic 
inequalities in healthcare as particularly unfair: supply of GPs; hospital waiting time for 
surgery; and death due to causes preventable by good quality healthcare. Our finding suggests 
that the public care about inequalities in both access and outcome, and that indicators of 
inequality in access to health care are an essential component of NHS equity monitoring for 
the purpose of public transparency and accountability. 
 
The two lay members of our advisory group also provided useful feedback and advice on 
indicator selection and on the design of visualisation tools.  As well as helping to improve our 
visualisation tools in various ways, one of the most helpful pieces of feedback was a negative 
lesson.  It is clear that our one-page equity dashboard tool is appropriate for communicating 
to decision makers but is not appropriate for public reporting.  We therefore recommend 
further work on public reporting of our equity indicators, involving infographic design 
specialists and public relations experts. 
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Chapter 3 Indicator Selection 
 
3.1 Introduction 
 
This chapter describes the iterative process through which we selected our eight main 
indicators of equity and our two disease-specific indicator domains (coronary heart disease 
and diabetes).  We produced the following prototype equity indicators at both national and 
local levels: (1) primary care supply, (2) primary care quality, (3) hospital waiting time, (4) 
preventable hospitalisation, (5) repeat hospitalisation, (6) dying in hospital, (7) amenable 
mortality, and (8) overall mortality.  The first seven are indicators of equity in healthcare; the 
eighth is an indicator of equity in health that provides useful contextual information to place 
the other indicators into perspective. 
 
The definitions of these indicators are provided elsewhere in the report: 
 Non-technical overviews of each indicator, summarising what they mean and why 
they are worth measuring are in Chapter 5 Results 
 Short two-line indicator definitions are in Chapter 7 Prototype Equity Dashboards 
 Full technical indicator definitions are in Appendix 1 Indicator Definitions 
 
We also produced prototype equity indicators at national level for our two disease-specific 
domains, which are described in Appendix 2: Coronary heart disease indicators, and 
Appendix 3: Diabetes indicators. 
 
The indicator selection process included (i) reviewing existing indicators used by the NHS to 
monitor healthcare quality, (ii) consulting with health indicator experts about technical 
feasibility, (iii) consulting with a diverse range of NHS and public health experts about policy 
relevance through 1:1 conversations and an online survey, and (iv) consulting with members 
of the public (see Chapter 2).  Indicator selection decisions were made in consultation with 
our advisory group, the membership of which is listed in Appendix 5. 
 
Based on the indicator review and consultation process, we developed (i) an indicator 
framework around different stages of the patient pathway, (ii) a longlist of potential general 
healthcare equity indicators, and (iii) a shortlist of potential disease-specific indicator 
56 
domains together with examples of potential equity indicators within each shortlisted domain.  
In consultation with our advisory group, we then selected for prototype indicator production 
(i) a shortlist of general equity indicators and (ii) two disease-specific indicator domains 
(coronary heart disease and diabetes).  The final set of indicators and their detailed technical 
specifications were subsequently selected and refined in an iterative process of data analysis 
and re-analysis in response to feedback from a series of presentations of emerging findings to 
members of our advisory group and a range of other healthcare and public health experts. 
 
The rest of this chapter contains sections on the indicator selection criteria, the indicator 
review, and the indicator consultation.  It concludes with a section describing potential quasi 
experiments and additional indicators that were suggested during the indicator selection 
process and that may be worth considering in future work. 
 
3.2 Indicator selection criteria  
 
Our indicator selection criteria are listed below, together with supplementary notes on how 
the criteria were assessed.  There are four sets of criteria: (1) General criteria for each 
individual indicator, (2) Technical criteria for each individual indicator, (3) Criteria for 
selecting an appropriate mix of indicators within each domain, and (4) Criteria for selecting 
the two disease-specific indicator domains. 
 
General criteria for each individual indicator 
1) Face validity to NHS and public health stakeholders.  The indicator should be 
considered credible, meaningful and important by NHS and public health 
policymakers, managers, clinicians, patients and the general public. 
2) Sensitivity to healthcare intervention.  The indicator should potentially respond to 
healthcare interventions, broadly defined to include actions by healthcare 
organisations to improve the co-ordination of care between different health care 
professionals and between healthcare, social care and public health professionals. 
3) Impact on population health. The indicator should potentially impact on population 
health and social inequalities in population health. 
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Supplementary notes:  
(i) These criteria were assessed by the project team and advisory group based on 
information from our indicator review and consultation with these stakeholder groups. 
(ii) To help satisfy the first two criteria, we sought where appropriate to use standard, 
well validated indicators that the NHS already uses for monitoring average healthcare 
quality.  However, we did not treat conformity to current NHS indicator specifications 
as an independent and over-riding criterion.  So in some cases we selected non-
standard indicators, or used indicator specifications that depart slightly from current 
NHS technical definitions.  For example, our indicator of mortality amenable to 
healthcare is based on numbers of deaths (in total, and per 1,000 people) rather than 
potential years of life lost, because our consultees felt this was easier to explain to 
policymakers, managers and the public.  Our definition of hospital waiting time is 
based on inpatient waiting time from the point of specialist decision-to-treat rather 
than the earlier point of GP referral to a specialist, since official NHS “referral-to-
treatment” waiting time statistics are not available at small area level.  And our 
definition of repeat hospitalisation differs from standard 30-day or 90-day all-cause 
emergency re-admission statistics, because we wish to capture the quality of co-
ordinated care and rehabilitation services over a longer time period following 
discharge.  All departures from standard NHS indicator definitions are described and 
justified in Appendices 1, 2 and 3. 
 
Technical criteria for each individual indicator 
1) Data availability for national monitoring.  The indicator should allow annual 
monitoring of social deprivation gradients over time from the early 2000s. 
2) Statistical confidence for national monitoring.  To be useful for monitoring 
national NHS performance, national indicators require sufficiently small confidence 
intervals to be capable of detecting a feasible change in inequality over a two year 
time period. 
3) Data availability for local monitoring.  The indicator should allow social 
deprivation gradients to be computed for each large sub-national area (clinical 
commissioning group), and back in time to the early 2000s. 
4) Statistical confidence for local monitoring.  To be useful for local quality 
improvement purposes, indicators at clinical commissioning group (CCG) level 
require sufficiently small confidence intervals to detect at least five or ten CCGs with 
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social gradients that are better (flatter) than the national social gradient and five or ten 
that are worse (steeper). 
 
Supplementary notes:  
(i) In practice, the data availability criteria restricted our attention to indicators that can 
be computed using health datasets providing comprehensive practice level or small 
area level data on the entire English population going back to the early 2000s, in 
particular the primary care workforce census, the quality and outcomes framework 
(QOF), hospital episode statistics (HES) and Office of National Statistics (ONS) 
mortality register data.  Other comprehensive health datasets were considered but 
rejected.  For example, the National GP Patient Survey from 2006/7 was rejected 
since variations in practice level response rates might lead to sample selection bias 
when comparing social gradients between sub-national areas. 
(ii) The statistical criteria were assessed by producing prototype indicators and examining 
confidence intervals around social gradients.  The size of a feasible change in the 
national social gradient within two years was assessed by examining the historical 
speed and magnitude of change over time.  Confidence intervals around social 
gradients depend on nuanced features of the data (including the spread of events 
across the gradient as well as the total number of events) and nuanced methodological 
choices about inequality index specification, error specification, indicator 
specification, risk adjustment, and data pooling across years.  The size and speed of 
historical change in the social gradient depends, in addition, on change in population 
denominator and adjustment variables as well as change in outcome variables. 
(iii) We found that hospitalisation and mortality rates related to a single condition – even a 
common condition such as coronary heart disease – are generally too low to allow 
detection of statistically significant differences between local and national absolute 
gradient indices of inequality.  So for local equity monitoring we focused on general 
equity indicators which have much higher rates of hospitalisation and mortality since 
they provide an overall system-wide assessment of equity in the full range of NHS 
activity across multiple conditions. 
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Criteria for selecting an appropriate mix of indicators within each domain 
1) Coverage of inequality in both access and outcome 
2) Coverage of inequality at all main stages of the patient pathway 
3) Coverage of inequality in multiple domains of the NHS Outcomes Framework 
The NHS Outcomes Framework has five domains: 1. preventing people from dying 
prematurely, 2. enhancing quality of life for people with long term conditions, 3. 
helping people to recover from episodes of ill health or following injury, 4. ensuring 
that people have a positive experience of care, and 5. treating and caring for people in 
a safe environment and protecting them from harm. 
4) Synergy between indicators.  We aimed to select a coherent basket of indicators that 
complement one another, such that levels and changes in some indicators can 
potentially be used to help understand levels and changes in other indicators. 
5) Relevance to quasi experiments.  Other things equal, we preferred indicators that 
can potentially be used for quasi experimental evaluation of the impacts of NHS 
interventions. 
 
Supplementary notes: 
(i) In assessing criterion one, we interpreted “access” broadly to include measures of 
structure (e.g. GP supply), process (e.g. the proportion of diagnosed patients receiving 
appropriate medical care) and “intermediate” outcomes (e.g. blood pressure control 
and hospital waiting time) indicative of access. In this way, three of our seven main 
indicators of equity in healthcare can be interpreted as “access” indicators (GP supply, 
GP quality and hospital waiting time) and four as “outcome” indicators (preventable 
hospitalisation, repeat hospitalisation, dying in hospital and amenable mortality). 
(ii) We assessed criterion two using our framework for monitoring inequality at different 
stages of the patient pathway (see Chapter 1 Introduction) 
(iii) In relation to criterion three, we only managed to include indicators from the first 
three domains due to data availability constraints. Almost all indicators in domains 
four and five failed our criterion of data availability for local equity monitoring, 
because they rely on data from sample surveys and/or administrative data only 
provided at organisational rather than small area level. 
(iv) Criterion four led us to select diverse indicators that measure distinct concepts.  For 
example, our measures of access include one “structure” measure (GP supply), one 
“process” measure (GP process quality) and one “intermediate outcome” (waiting 
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time).  Our measures of outcome include measures of NHS impacts on both morbidity 
(preventable and repeat hospitalisation) and mortality (amenable mortality) and a 
measure of end-of-life care (dying in hospital).  We considered indicators of 
inequality in early-life care outcomes, such as low birthweight, birth defects and child 
mortality, but did not explore these further due to concerns about small number 
problems for local equity monitoring and concerns that such indicators may be more 
sensitive to socioeconomic variation in maternal health, lifestyle and social support 
than socioeconomic variation in the quality of NHS care. 
(v) We assessed criterion five based on our own views about potential quasi experiments, 
supplementary by information from our survey of NHS and public health experts (see 
below).  A suitable quasi experiment requires the existence of relevant NHS 
interventions in the 2000s which (a) were likely to influence socioeconomic health 
inequality, (b) allow the construction of a suitable control group due to geographical 
variation in delivery such as differential timing of intervention roll out in different 
geographical areas, and (c) are relevant to the design and implementation of potential 
future NHS interventions. 
 
Criteria for selecting the two disease-specific indicator domains 
1) Substantial disease burden and cost to the NHS.  Substantial disease burden and 
cost to the NHS are measurable though imperfect proxies for two underlying criteria: 
(a) domains should reflect conditions that NHS stakeholders consider important 
(which helps assure general criterion 1: face validity), and (b) domains should have 
sufficiently large patient populations to meet technical criterion 2: statistical 
confidence for national monitoring. 
2) Data availability for national monitoring.  The domain should allow the 
construction of an appropriate mix of indicators for annual monitoring of social 
deprivation gradients over time from the early 2000s (as per technical criterion 1 and 
the criteria for selecting an appropriate mix of indicators). 
3) Availability of quasi experiments.  We wanted our indicators to form a “data 
platform” for retrospective “quasi experiments” to provide useful evidence about the 
effects of past NHS interventions on health inequality. 
4) Synergy between the domains.  We only had research capacity to examine two 
condition specific domains in addition to the general domain.  So we sought to select 
a synergistic pair of domains that can fruitfully be compared and contrasted. 
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Supplementary notes: 
(i) The first criterion was assessed using information on burden of disease in the UK45 
and NHS programme budget expenditure for 2011/12 by disease category.
46
  
Disorders were considered to have a “substantial” burden of disease if they were in 
one or more of the three published “top 25” burden of disease lists for the UK in 
2010: (1) by years of life lost for both sexes and all ages, (2) by years of life lost for 
both sexes and ages 20-54, and (3) by years lived with disability for both sexes and all 
ages.  Diseases were considered to have a “substantial” cost if the NHS spent more 
than £250m treating them in 2011/12 (just over one quarter of one percent of total 
NHS expenditure) according to programme budgeting sub-category data (which has to 
be treated with caution and which under-estimates total cost since most primary care 
expenditure cannot be attributed).  Coronary heart disease (labelled ischaemic heart 
disease by the burden of disease study authors) was the number 1 cause of years of 
life lost for all ages and for ages 20-54, the number 19 cause of years lived with 
disability, and absorbed £1,890m of NHS expenditure in 2011/12.  Diabetes was the 
number 26 cause of years of life lost for all ages and for ages 20-54, the number 18 
cause of years lived with disability, and absorbed £1,550m of NHS expenditure in 
2011/12. 
(ii) The second criterion was assessed based on whether a suitable mix of indicators (i.e. 
covering both access and outcome and all main stages of the patient pathway) could 
be constructed using the comprehensive health datasets listed above. 
(iii)The third criterion was assessed based on our own views about potential quasi 
experiments supplemented by information from our survey and 1:1 conversations with 
healthcare and public health experts. 
(iv) The fourth criterion was assessed subjectively in consultation with our advisory 
group.  Following our review and consultation process, we produced a shortlist of five 
candidate disease-specific indicator domains – colorectal cancer, coronary heart 
disease, diabetes, severe mental illness and stroke – together with example indicators 
in each domain.  Of these, the two disease-specific domains selected for production 
were coronary heart disease and diabetes.  Once coronary heart disease had been 
selected on the grounds of being the strongest domain on all of the first three criteria, 
62 
it was felt that a comparison with diabetes would add more synergy value than a 
comparison with any of the other shortlisted domains.  This is because diabetes shares 
many risk factors with coronary heart disease but is growing in burden and cost of 
illness while coronary heart disease is declining, because well validated primary care 
process quality indicators are available for both domains in the quality and outcomes 
framework, and because both domains were central to NHS efforts to tackle 
socioeconomic inequality in adult mortality in the late 2000s. 
 
 
3.3 Indicator review process 
 
We reviewed available indicators in order (i) to identify a full range of indicators that can 
potentially be used for monitoring average healthcare quality in the NHS, (ii) to identify 
which of these indicators could feasibly be converted into equity indicators, based on our 
technical indicator selection criteria, (iii) to select candidate indicators based on our general 
indicator selection criteria and (iv) to select candidate disease-specific indicator domains 
based on our indicator domain selection criteria. 
 
We started by reviewing all indicators currently used for monitoring average healthcare 
quality in the NHS, as published on the Health and Social Care Information Centre (HSCIC) 
Indicator Portal (https://indicators.ic.nhs.uk/webview).  This web-based portal hosts a wide 
range of indicators, including all of the indicators in the NHS Outcomes Framework, the 
Public Health Outcomes Framework and the Adult Social Care Outcomes Framework.  We 
then considered further indicators by (i) checking an unpublished list of indicators from an 
internal review by the HSCIC in 2011, and (ii) seeking suggestions from advisory group 
members, co-applicants and colleagues.  Finally, we generated proposals for new equity 
indicators based on our own knowledge of available health datasets in England and 
suggestions from consultees. 
 
3.4 Indicator consultation process 
 
As well as the public consultation process described in Chapter Two, the indicator 
consultation process included (i) 1:1 conversations with NHS and public health experts, (ii) 
an online survey of NHS experts, and (iii) consultation with members of our advisory group 
(listed in Appendix A5).  Our aim was to obtain a range of views from NHS and public health 
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experts with appropriately diverse backgrounds and perspectives, rather than a representative 
national sample. 
 
Conversations were held with a range of experts, including: 
 Academic experts in health inequality, primary care, mental health, circulatory 
disease, cancer, epidemiology, health geography, sociology of health, and health 
economics 
 Analysts and health inequality experts at NHS England and the Department of Health, 
including analysts supporting the NHS Outcomes Framework 
 Analysts and health inequality experts at Public Health England 
 Board members of two Clinical Commissioning Groups (Vale of York and Hull) 
 Public health directors in two local authorities (City of York and Hull City Council) 
 Board members of two NHS hospital trusts (York and Morecombe Bay) 
 Public health, health policy and performance indicator experts at leading national 
think tanks (the Kings Fund and Nuffield Trust) 
 
The conversations focused on the credibility and policy importance of our proposed equity 
indicators, the identification of potential new indicators, and the perceived impacts of past 
NHS interventions on socioeconomic inequalities in health.  The questions and topics were 
tailored to the type and role of the respondent, rather than following a “one-size-fits-all” 
structured interview format.  
 
The online survey was conducted to supplement these conversations with a range of views 
focusing specifically on the perceived impacts of past NHS interventions on socioeconomic 
inequalities in health.  This specific focus was chosen to help the research team select equity 
indicators that NHS experts consider to be sensitive to NHS healthcare delivery and that 
provide a platform for future “natural experiment” studies of the health inequality impact of 
NHS interventions.  Accordingly, the online survey asked two main questions: 
 “In the boxes below, please list up to THREE national or local NHS interventions in 
the past decade or so that you think had a measurable impact on socioeconomic 
inequalities in health care access or outcomes in England.” 
 “For each NHS intervention, what primary outcome(s) would you use to measure 
impact on socioeconomic health inequality?” 
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The survey was emailed to 164 senior individuals from diverse organisations and clinical 
specialities, with email addresses identified via the personal contacts of the research team and 
advisory group and web searching.  Invitees could respond directly by email, by filling in a 
Word form, or by filling in an online survey form via the web-based survey tool, 
“SmartSurvey”. One reminder email was sent to non-responders.  Only 14 response sets were 
received (a 8.5% response rate).  This low response rate is about average for surveys of this 
kind, given the challenging and time-consuming nature of these open ended questions and 
that we were seeking responses from busy, senior professionals. 
 
3.5 Potential quasi experiments and additional indicators 
 
Potential quasi experiments 
This section lists a selection of NHS interventions implemented in the 2000s that the experts 
we consulted suggested may have had an impact on health inequality that could potentially be 
identified using quasi experimental evaluation, based on the indicators of the kind we have 
developed in this project.  This list helped inform the selection of our two disease-specific 
domains, since a number of them relate to coronary heart disease and diabetes.  It may also 
provide researchers with useful ideas for future work using quasi-experiments to identify the 
effects of NHS interventions on social inequalities in health and healthcare. 
The list includes interventions which have already been at least partially evaluated, but that 
one or more experts felt warrant further and more rigorous quasi experimental evaluation.  As 
well as NHS interventions, the list also includes some public health interventions that go 
beyond healthcare services and/or NHS funding, but that may nevertheless impact upon some 
of the healthcare outcome indicators we measure in this project, such as preventable 
hospitalisation and amenable mortality. 
 The Health Inequality National Support Team programme 2007-9 for improving 
primary care for cardiovascular disease and diabetes in disadvantaged adults 
 The Equitable Access to Primary Medical Care Programme 2008-10 which invested 
in opening new GP practices in under-doctored areas 
 The two-week cancer waiting time target from GP referral to specialist consultation, 
introduced in 2007 
65 
 Changes in sub-national (PCT level) NHS expenditure during the 2000s and changes 
in sub-national (CCG level) NHS expenditure during the 2010s 
 The impacts on socioeconomic inequality in preventable hospitalisation and amenable 
mortality for coronary heart disease and diabetes of the quality and outcomes 
framework primary care pay for performance scheme introduced from 2004 
 Changes to the quality and outcomes framework incentive payments in the late 2000s 
 Diffusion of primary percutaneous coronary intervention (PPCI) following emergency 
admission for acute ST-elevation myocardial infarction, during the 2000s 
 The national NHS Bowel Cancer Screening Programme from 2006 (this may be an 
example of “intervention-generated inequality”: this intervention is cost-effective but 
may have increased health inequality due to lower uptake in deprived groups) 
 NHS intensive smoking cessation services in England from 1999 
 Cuts in particular local areas to community healthcare services disproportionately 
used by disadvantaged groups e.g. community midwifery services, out-of-hours 
primary care services 
 Proactive hospital-based diabetes services introduced in some areas during the 2000s 
 Screening and brief interventions for alcohol misuse 
 Early intervention for psychosis including those identified as 'at risk' 
 
Additional indicators 
We list below a selection of additional equity indicators that were considered but rejected for 
the particular purposes of this project.  We include this list to explain why some indicator 
ideas were not selected for inclusion in our suite of prototype equity indicators, and also to 
inform the deliberations of future researchers and analysts seeking to improve our equity 
indicators and develop new ones. 
 Multi-morbidity according to patient level inpatient hospital records: the 
proportion of the general population with a hospital record of three or more chronic 
conditions from hospital visits in the last two years.  This indicator was rejected for 
the purposes of this project due to potential selection bias, since not all people with 
multi-morbidity are admitted to hospital for inpatient treatment.  However, it could 
nevertheless potentially be useful in future work as a contextual indicator of 
socioeconomic inequality in health, and to improve the risk adjustment of indicators 
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of equity in healthcare outcomes such as preventable hospitalisation and amenable 
mortality. 
 
 Multi-morbidity according to practice level primary care quality and outcomes 
framework data: the proportion of people with two or more chronic conditions based 
on quality and outcomes framework data.  This was rejected due to potential under-
recording in deprived patients which may vary between local areas and over time, 
potentially leading to bias in both time series comparisons and local equity monitoring 
comparisons.  In sensitivity analysis, we also explored ways of using this indicator to 
improve the risk adjustment of indicators of equity in healthcare outcomes.  However, 
because it is only available at practice level rather than individual level, yet is highly 
correlated with age, we found that adding this variable yielded unstable results and 
little explanatory power over risk adjustment for age and sex alone.  At national level, 
however, this indicator could provide a useful convergent validity check on multi-
morbidity according to patient level inpatient hospital records. 
 
 Multi-morbidity according to mortality records: the proportion of people who died 
in the indicator year with two or more chronic conditions based on secondary 
mentions of causes of death.  This was rejected due to lack of reliable coding of 
causes of death on mortality records, and change over time in coding.  It may be 
possible to improve upon this by linking information from hospital records at 
individual level; but again this would still suffer from the bias described above that 
not all individuals visit hospital. 
 
 Post-hospital mortality: 12-month mortality after discharge per 1,000 hospital 
discharges.  This was rejected since it yields a somewhat out-of-date indicator: either 
a one year data lag or a focus on patients admitted the year prior to the indicator year.  
There is also a risk of indicator revision the year after initial release, since we found 
that the HES-ONS mortality link data required to compute this indicator are 
sometimes subject to substantial data revision the following year. 
 
 Excess hospital stays: proportion of inpatients with excess length of stay as defined 
by healthcare resource group (HRG) trim points.  This was rejected due to concerns 
about time series comparability.  HRG coding systems change over time, and HRG 
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trim points only provide a relative definition of an “excess” stay for a particular 
treatment based on the changing year-specific distribution of stays, rather than an 
absolute definition based on clinical judgement.  Data on “delayed discharges”, which 
reflect a more accurate and more absolute definition, are currently only available at 
hospital level rather than the patient level or small area level required for equity 
indicators. 
 
 Experienced access to primary care: the average of a selection of indicators of 
patient reported experiences of primary care access from the National GP Patient 
Survey.  This was rejected for our purposes, since the National GP Patient Survey 
only started in 2006/7 and the response rate of about 30% varies substantially between 
local areas (CCGs) which may hamper local equity comparisons.  This indicator may 
be useful, however, for future national equity monitoring work. 
 
 Specialist doctor visits: annual probability of a first outpatient visit, adjusted for age 
and sex, based on outpatient hospital episode statistics data.  This was rejected since 
whenever diverse forms of utilisation are grouped together it is hard to tell whether 
more utilisation reflects better access to care, worse quality of care or worse health.   
However, more specialised sub-indicators may be worth pursuing – in particular, 
percentage of first outpatient visits with immediate discharge (potentially reflecting an 
unnecessary referral), percentage of first outpatient visits with priority referral, and 
percentage of first outpatient visits the patient “did not attend” (DNA). 
 
 High need service users: rate per 100,000 general population (perhaps distinguishing 
adults and children) of patients with multiple unplanned admissions in the same year 
(say > 10).  This was rejected on the basis of small numbers problems for local 
monitoring.  However, this may be a useful indicator for national monitoring. 
 
 Hospital complications: annual preventable hospital complications, rate per 100,000 
population adjusted for age and sex.  This was rejected since there is no official list of 
“preventable” complications across the full range of hospital activity, and drawing up 
a list of this kind would be a major clinical research task. 
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 Hospital expenditure: annual expenditure per 100,000 general population (all ages), 
based on the total number of outpatient visits and planned and unplanned inpatient 
admissions weighted by HRG prices.  This was rejected since this groups together 
diverse forms of utilisation and so it is hard to tell whether more expenditure reflects 
better access to care, worse quality of care or worse health.    
 
 Bed-days following emergency admission: average person-based cumulative time 
spent in hospital during 12 months following an emergency admission in April to 
June (Quarter 1).  This was rejected since it is similar to repeat hospitalisation within 
the indicator year and without further refinement would yield a longer time lag.  Also, 
by focusing on bed days rather than number of admissions this indicator may tend to 
reflect aspects of social care supply that are outside the control of the NHS, as well as 
the quality of care co-ordination between healthcare and social care settings for which 
the NHS is at least partly responsible. 
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Chapter 4 Methods 
 
4.1 Introduction 
 
This section describes the data and methods underpinning the indicators defined in this study. 
The section has the following structure.  It starts by (i) describing the data sources used; then 
goes on to cover (ii) data linkage and aggregation to construct indicators; next it discusses the 
(iii) data cleaning methods used on the indicators; before discussing (iv) standardisation 
methods used to adjust indicators for need and risk factors; finally it describes the (v) 
estimation of absolute and relative inequality indices at national level; and the (vi) estimation 
of absolute and relative inequality indices at local level. At each stage alternative approaches 
that were considered and sensitivity analyses performed are discussed. 
 
4.2 Data sources 
 
Small Area Geography: The basic small area geographical unit provided in the datasets used 
was the 2001 “lower super output area” (LSOA). There are 32,482 of these small area 
neighbourhoods in England, defined by the 2001 census to cover approximately 1,500 people 
each (minimum 1,000 and maximum 3,000).  LSOA boundary definitions were updated 
following the 2011 census, resulting in 32,844 small area neighbourhoods. These new 2011 
LSOAs form the basic building blocks of the higher level geographies that we aggregate our 
results to, such as clinical commissioning groups. LSOA level indicator production and 
adjustment is conducted at 2001 LSOA level, and the results are then mapped onto 2011 
LSOAs for production of equity measures at national and CCG levels.  The mapping between 
the 2001 and 2011 LSOAs is discussed below in part (ii) of this methods chapter. 
 
Small Area Deprivation - We measured the socioeconomic status of each 2001 LSOA 
neighbourhood using the index of multiple deprivation (IMD). This is a widely used measure 
that combines a wide range of data sources on multiple aspects of social deprivation.  Seven 
indicator domains are combined into a single deprivation score for each small area. The 
indicator domains comprise “income deprivation,” “employment deprivation,” “health 
deprivation and disability,” “education, skills, and training deprivation,” “barriers to housing 
and services,” “living environment deprivation,” and “crime.” Each neighbourhood is ranked 
relative to one another according to their level of deprivation.  Although in theory there is an 
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element of circularity in including the “health deprivation and disability” domain, in practice 
the exclusion of this domain makes little difference since this domain is only one small 
element of the overall index and the domains are all highly correlated.  We used the version 
of IMD published in 2010, which contains data mostly relating to the year 2007 in the middle 
of our analysis period.
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  We used the most informative IMD 2010 index available: overall 
deprivation rank for all 32,482 LSOAs in 2001. We used the same deprivation index for all 
years to ensure that our findings reflected real changes in health care delivery and outcomes, 
rather than artificial changes in the calculation of the deprivation index or the composition of 
neighbourhoods. This does raise the issue, however, of how accurately the deprivation of a 
neighbourhood in 2007 reflects its deprivation in 2001/2 and 2011/12. To assess this, we 
looked at cross tabulations of change over the seven year period between IMD 2004 (data for 
2001) and IMD 2010 (data for 2007). These show that 84% of LSOAs in the most deprived 
fifth remained in the most deprived fifth, that 88% of neighbourhoods in the least deprived 
fifth remained in the least deprived fifth, and that only 14% of LSOAs changed rank by the 
equivalent of one quintile group or more. 
 
Small Area Population – We used mid-year population estimates from the ONS at 2001 
LSOA level. This data provides population totals by age and gender for each of the 32,482 
LSOAs in England for each year between 2001/2 and 2011/12.  This data estimates the total 
resident population, including homeless people and people living in institutions such as 
prisons, barracks and nursing homes.  All indicators requiring a general population 
denominator focus on this resident population, based on ONS estimates, rather than the NHS 
registered population based on GP practice registers, as explained in Appendix A1: Indicator 
Definitions. 
 
ADS: We used the NHS Attribution Data Set (ADS) of GP-registered populations. This data 
maps patients from the GP practices that they are registered with to the 2001 LSOAs they live 
in. We used ADS data for years 2004/5 to 2011/12.  We used this data to map primary care 
supply and quality data provided at practice level to small area level, as described below and 
in Appendix A1: Indicator Definitions. 
 
GMS - Our data on primary care supply were obtained from the annual National Health 
Service General and Personal Medical Services (GMS) workforce census, taken at 30 
September each year. This data reports headcount and full time equivalent numbers of 
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general practitioners (GPs) at practice level for every GP practice in England. The data splits 
the GPs by type (allowing us to exclude trainees).  However it does not include locum GPs or 
details of the supply of emergency primary care services outside of normal office hours. We 
used GMS data for years 2004/5 to 2011/12. 
 
QOF – We took clinical process indicators in the UK “quality and outcomes framework” 
(QOF), the primary care pay-for-performance programme introduced in 2004 and collected at 
GP practice level.  Although the QOF indicators only capture a limited part of clinical 
practice, by international standards they are nevertheless one of world’s most comprehensive 
sets of primary care quality indicators. QOF data reports numbers of patients achieving the 
various outcomes as defined by the indicators as well as the numbers of patients excluded 
from performance calculations for various reasons and so classed as exceptions.  In the base 
case analysis reported in Chapter Five: Results we use the “population achievement” figure 
which includes exception reported patients in the population denominator and hence treats 
them as representing poor quality.  However, we also conducted sensitivity analysis using the 
“reported achievement” figure which excludes exception reported patients.  We used QOF 
data for the year 2004/05 and 2011/12.  Data on “exception reported” patients was not 
available in the first year 2004/5 and hence we see a blip in our “population achievement” 
QOF figures in 2004/5 where these exceptions are excluded from the calculation of the 
primary care quality denominator. Further details including the list of included QOF 
indicators are in Appendix 1: Indicator Definitions. 
 
HES – We used inpatient hospital episode statistics (HES) data on admitted patient care to 
measure hospital waiting time, preventable emergency hospitalisation, repeat emergency 
hospitalisation, and death in hospital. This data set records finished consultant episodes 
(FCEs) i.e. the details of the patient’s period of care under the responsibility of a particular 
specialist. The HES data includes among other things details regarding the patient (age, sex, 
2001 LSOA of residence) , as well as details about the specific hospital admission: admission 
date, type of hospital admission (emergency versus elective), length of hospital stay, reason 
for admission (diagnosis in terms of the tenth revision of the international classification of 
diseases ICD-10), any procedures undertaken during the admission, outcome of the 
admission and date of discharge from care of the specialist. We aggregated this HES data 
from FCE level to continuous inpatient spells that capture the entire hospital stay for the 
patient including hospital transfers – details of this aggregation are provided in section (ii) of 
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this methods chapter. HES data is collected in financial years i.e. from April to April. We 
used HES data from 2001/2 to 2011/12 in our indicators.  
 
ONS Mortality – We used mortality data from the Office for National Statistics (ONS) 
estimates. This data tells us the date of death, cause of death (in terms of ICD-10 code), 2001 
LSOA of residence, age and gender of the deceased for every person who dies in England. 
We used mortality data for the financial years 2001/2 through to 2011/12. 
 
4.3 Linkage and aggregation of data 
 
The GMS and QOF datasets described above collect data at GP practice level while our basic 
geographical unit for our analysis is the 2001 LSOA. The attribution dataset (ADS) details 
the LSOAs in which the patients registered with each GP practice live. We use this 
information to determine the proportions of the practice level variables in GMS and QOF to 
attribute to each of the LSOAs that the patients registered with the practice live in. Applying 
this attribution calculation to each GP practice and then aggregating the practice level 
variables attributed from the different practices at LSOA level gives us our measures of these 
primary care supply and quality indicators at 2001 LSOA level. Practice level populations 
were only used to apportion these practice level variables to 2001 LSOAs – the denominators 
used in the indicators derived at LSOA level based on these variables were then derived using 
ONS data for LSOA level population estimates to maintain comparability with the other 
indicators.  
 
The HES dataset described above provides data at the finished consultant episode level, this 
describes a patient’s period of care under one consultant. We further aggregate this to 
continuous inpatient spell level (CIPS) which groups together the entire hospital stay of the 
patient including transfers between consultants and between hospitals. These are described in 
Lakhani et al 2005.
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Patient level data from HES, ONS Mortality data and ONS mid-year population data are then 
split by sex and into age groups for ages: 0-4, 5-15, 16-24, 25-39, 40-59, 60-74 and 75+ 
before being aggregated into 2001 LSOAs. These age groups were selected to minimise the 
number of subgroups while still capturing key life stages and points at which policy 
interventions are typically targeted in England. 
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Whilst 2001 LSOAs were the basic small area unit of analysis, our target large area 
geographies for indicator production  – in particular, clinical commissioning groups – were 
defined in terms of 2011 LSOA boundaries. Whilst 96.3% of 2001 LSOAs were unchanged 
between the 2001 and 2011 LSOA boundaries (“one-to-one” mappings), the other 3.7% 
(1,192 out of all 32,482 of the 2001 LSOAs) needed to be mapped between these alternative 
LSOA definitions.  When two or more 2001 LSOAs were merged to form a single 2011 
LSOA (“many-to-one mappings”), these multiple 2001 LSOAs were straightforwardly 
aggregated to form results at 2011 LSOA level.  When a 2001 LSOA mapped to more than 
one 2011 LSOA (“one-to-many” and “many-to-many” mappings) then it was assumed that 
the 2001 LSOA was split in equal proportions when attributed to the 2011 LSOA. The 
mappings for 2.7% of small areas (881 out of 32,482 of the 2001 LSOAs) required splitting 
in this way.  We used this algorithm to produce a set of weights to map results at 2001 LSOA 
level to 2011 LSOA level. These weights were then applied to all our indicator results at 
2001 LSOA level before being aggregated to higher geographical levels. 
 
IMD 2010 overall deprivation rank scores defined at 2001 LSOA level were attributed to 
2011 LSOAs which were then ranked according to attributed score.  These integer ranks were 
then normalised to produce a fractional rank “ridit score”49 between 0 (least deprived) and 1 
(most deprived). IMD deprivation ranks at larger geographical levels were produced by 
population weighted aggregation of 2011 LSOA level IMD deprivation ranks to higher levels 
of geography, with normalisation to produce a fractional rank between 0 and 1 at the target 
geographical level. IMD quintile and decile groups were defined as aggregations of 
appropriate sets of deprivation ranked 2011 LSOAs. 
 
4.4 Data cleaning  
 
The administrative health data we use in this study have the advantage of covering the whole 
population of England, but coding errors remain despite all the various cleaning procedures 
and data quality checks conducted by data providers. To guard against data quality issues in 
the source datasets, we trimmed what we considered to be extreme outliers likely to reflect 
measurement error from our LSOA level results. We first trimmed any infinite values and 
values that were highly implausible or logically impossible given the indicator definition (see 
below).  In the case of indicators 3-8, our data cleaning algorithm consisted of calculating the 
mean and standard deviation of each of the indicators at LSOA level for each year of data, 
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and dropping results that fell outside six standard deviations either side of the mean (see see 
Figure A4.1 in Appendix 4: Trimming analysis). This resulted in excluding less than 0.15 of 
one percent of LSOAs in any given year for any given indicator, and for most indicators the 
percentage excluded was substantially lower than this.  For example, there was no exclusion 
for repeat hospitalisation in any year, and the exclusion for preventable hospitalisation was 
around 0.01 of one percent and for amenable mortality around 0.05 of one percent (see Figure 
A4.3 in Appendix 4: Trimming analysis).  In the case of indicator 1 (primary care supply), we 
first excluded patient per GP figures above 10,000, which we judged are likely to reflect data 
error, before applying the 6 standard deviation trimming algorithm.  This resulted in 
excluding around 0.14 of one percent of LSOAs each year.  In the case of indicator 2 
(primary care quality), we implemented a slightly heavier trim using 3 rather than 6 standard 
deviations, after first excluding any logically impossible indicator values below zero and 
above 100.  The heavier trim was used because visual inspection revealed an unexplained 
cluster of apparent data error in between 3 and 6 standard deviations (see Figure A4.3 in 
Appendix 4: Trimming analysis).  This resulted in excluding just over 1% of LSOAs each 
year.  We also checked the distribution of exclusion by deprivation vingtile group 
(twentieths), and this showed no clear pattern except in the case of amenable mortality where 
exclusion only occurred in the two most deprived vingtile groups (see Figure A4.2).  
However, the largest exclusion proportion was 0.25 of one percent in the most deprived 
twentieth, which we judged not to be problematic. 
 
We also conducted sensitivity analysis using a heavier trim of 3 standard deviations for all 
indicators (see Figures A4.4 to A4.6).  This did give rise to an issue of potentially 
disproportionate trimming within the most deprived five to ten percent of small areas for 
indicators with small event counts at LSOA level i.e. preventable hospitalisation, repeat 
hospitalisation, amenable mortality and all-cause mortality (see Figure A4.5).  This may be 
due to disproportionate numbers of extremely high need patients in the most deprived areas, 
suggesting that a 3 standard deviation trim results in trimming away some accurate data as 
well as data errors.  At national level, this would lead to a slight under-estimate of the social 
gradient.  And at CCG level this might lead to bias in CCGs with a disproportionately high 
fraction of exclusions.  Hence we opted for a “light trim” policy of 6 standard deviations for 
these indicators. 
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Finally, we produced results on the raw untrimmed data and were reassured to find very 
similar numerical results, even though some of the graphical summaries were severely 
distorted by extreme outliers. 
 
4.5 Adjustment for need and risk factors 
 
We adjusted indicators for observable need or risk factors such as age and sex which (1) are 
correlated with deprivation (a factual matter) and (2) may be considered “fair” or “legitimate” 
sources of variation in the indicator for which the NHS should not be held responsible (a 
value judgement).  For example, GP supply was adjusted for age, sex and population ill-
health on the basis of the value judgement that small areas with additional healthcare needs 
should have additional GP supply.  By contrast, GP quality and hospital waiting time were 
not adjusted for age and sex, on the basis of the value judgement that age and sex are not 
legitimate justifications for poor quality or longer hospital waiting times.  The standardisation 
of the various indicators is described in detail here. 
 
The GP supply indicator was need adjusted using the workload adjustment aspect of the 2007 
version of the Carr-Hill formula for primary care resource allocation produced by the 
Formula Review Group established by NHS Employers and the BMA.
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  Full details of the 
implementation of the Carr-Hill formula used and the weights it contains can be found in 
appendix A1. In brief, this formula provides weights for age, sex, health deprivation and 
transient patient populations and is used to adjust population sizes for need. We were unable 
to implement the transient patient population element of the adjustment, however, due to a 
lack of patient level data on registration status, linked to age and sex, covering all practices in 
the country.  The adjustment is applied by using the weights to upscale or downscale 
populations at LSOA level to create need adjusted populations and then normalise these 
scaled populations so that they sum to the total population pre-adjustment. We also conducted 
robustness checks using an alternative need formula: the 2013/14 Nuffield index of general 
and acute hospital need which provides need adjusted populations at practice level based on 
hospital utilisation.
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  We used the ADS to attribute these adjusted populations to LSOA 
levels and found that this alternative adjustment gave very similar results to the Carr-Hill 
formula.  However, as explained in more detail in Chapter 8, we believe that the Carr-Hill 
formula under-estimates additional needs for primary care supply in deprived 
neighbourhoods.  This is because it only allows for morbidity and does fully allow for the 
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ways in which multiple morbidity and disadvantage combine to generate additional 
healthcare needs. 
 
For the mortality, amenable mortality, preventable hospitalisation and repeat hospitalisation 
indicators we used indirect standardisation for age and sex groups at LSOA level. We then 
translated these indirectly standardised rates to LSOA level event counts. The standardisation 
procedure used is laid out in the following formulae: 
𝑎𝑑𝑗𝑢𝑠𝑡𝑒𝑑_𝑐𝑜𝑢𝑛𝑡𝑙𝑠𝑜𝑎 = 𝑎𝑑𝑗𝑢𝑠𝑡𝑒𝑑_𝑟𝑎𝑡𝑒𝑙𝑠𝑜𝑎 × 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛𝑙𝑠𝑜𝑎 (1) 
𝑎𝑑𝑗𝑢𝑠𝑡𝑒𝑑_𝑟𝑎𝑡𝑒𝑙𝑠𝑜𝑎 =
𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑𝑙𝑠𝑜𝑎
𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑𝑙𝑠𝑜𝑎
× 𝑟𝑎𝑡𝑒𝑛𝑎𝑡𝑖𝑜𝑛𝑎𝑙 (2) 
𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑𝑙𝑠𝑜𝑎 =∑∑𝑒𝑣𝑒𝑛𝑡𝑠𝑙𝑠𝑜𝑎,𝑎𝑔𝑒,𝑠𝑒𝑥
𝑎𝑔𝑒
𝑠𝑒𝑥
 (3) 
𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑𝑙𝑠𝑜𝑎 =∑∑𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑𝑙𝑠𝑜𝑎,𝑎𝑔𝑒,𝑠𝑒𝑥
𝑎𝑔𝑒
𝑠𝑒𝑥
 (4) 
𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑𝑙𝑠𝑜𝑎,𝑎𝑔𝑒,𝑠𝑒𝑥 = 𝑟𝑎𝑡𝑒𝑛𝑎𝑡𝑖𝑜𝑛𝑎𝑙,𝑎𝑔𝑒,𝑠𝑒𝑥 × 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛𝑙𝑠𝑜𝑎,𝑎𝑔𝑒,𝑠𝑒𝑥 (5) 
𝑟𝑎𝑡𝑒𝑛𝑎𝑡𝑖𝑜𝑛𝑎𝑙,𝑎𝑔𝑒,𝑠𝑒𝑥 =
∑ 𝑒𝑣𝑒𝑛𝑡𝑠𝑙𝑠𝑜𝑎,𝑎𝑔𝑒,𝑠𝑒𝑥
𝑙𝑠𝑜𝑎
∑ 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛𝑙𝑠𝑜𝑎,𝑎𝑔𝑒,𝑠𝑒𝑥
𝑙𝑠𝑜𝑎  (6) 
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𝑟𝑎𝑡𝑒𝑛𝑎𝑡𝑖𝑜𝑛𝑎𝑙 =
∑ ∑ ∑ 𝑒𝑣𝑒𝑛𝑡𝑠𝑙𝑠𝑜𝑎,𝑎𝑔𝑒,𝑠𝑒𝑥
𝑎𝑔𝑒
𝑠𝑒𝑥𝑙𝑠𝑜𝑎
∑ ∑ ∑ 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛𝑙𝑠𝑜𝑎,𝑎𝑔𝑒,𝑠𝑒𝑥
𝑎𝑔𝑒
𝑠𝑒𝑥𝑙𝑠𝑜𝑎  (7) 
𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛𝑙𝑠𝑜𝑎 =∑∑𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛𝑙𝑠𝑜𝑎,𝑎𝑔𝑒,𝑠𝑒𝑥
𝑎𝑔𝑒
𝑠𝑒𝑥
 (8) 
 
The waiting times indicator was indirectly standardised in a similar manner at LSOA level 
but instead of standardising for age and sex this indicator was standardised for the speciality 
code of the treating consultant. This was done in order to risk adjust waiting time for the 
specialty of the admission, on the basis of the value judgement that a difference in the 
patient’s specialty of treatment may be a legitimate justification for a longer waiting time, but 
not a difference in their age or sex.  This implies the following further value judgements: (1) 
the NHS should not be held responsible for eliminating waiting time differences between 
specialties and (2) that the NHS should not be held responsible for eliminating 
socioeconomic patterning in the specialty of treatment. A more sophisticated but also more 
computationally burdensome adjustment could adjust for admission level diagnostic and 
procedure codes.  The current procedure of indirect standardisation at LSOA level was 
already computationally burdensome, due to the large size of the administrative health 
datasets employed, taking several days of high performance computing time.  So we felt that 
for the purposes of this project adjusting for the treating consultant’s specialty was a 
sufficient proxy for these CIPS level codes and opted to leave more detailed need adjustment 
of this indicator for future research in this area. 
 
In line with the current NHS Outcomes Framework indicators,
52
 the risk adjustment process 
we have used where we have access to patient level data rely largely on indirect 
standardisation in favour of direct standardisation. This allowed us to reliably produce 
adjusted event count data at LSOA level adjusted for the event rates of the 14 age-sex 
subgroups in each LSOA. Direct standardisation whilst generally preferable for calculating 
national level indicators,
53
 and as used in the NHS Public Health Outcomes Framework,
54
 
was found to be not sufficiently stable for use at this LSOA level of disaggregation due to 
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small numbers (often zeros) within each LSOA-age-sex band. Adjusting our indicators at 
LSOA level rather than at deprivation decile level allowed us to create comparable inequality 
measures at national and subnational levels – a key objective of our programme of work. 
There were other more sophisticated regression based standardisations accounting for a range 
of variables and their correlations that we considered at individual patient event level
28, 53
 
rather than the indirect standardisation we opted for at LSOA level. These more sophisticated 
approaches were considered to be excessively computationally burdensome for the scale and 
scope of the indicators considered here, without delivering a commensurate gain in accuracy.  
So we felt taking such approaches would limit the likelihood of our proposed indicators being 
operationalised. 
 
However, perhaps the most important factor missing from our risk adjustment process was a 
measure of individual level morbidity and particularly multi-morbidity.  So we would suggest 
identifying and standardising for such variables as a key research priority going forward. 
 
4.6 National inequality indicators 
 
The details of the specific indicator definitions and how these indicators were constructed are 
provided elsewhere in this report. In this section we describe how these indicators were used 
to calculate inequality indices at the national level. 
 
The primary indicator we used in our analysis is our implementation of the slope index of 
inequality (SII) as a measure of absolute inequality; and we also used the corresponding 
relative index of inequality (RII). We chose this indicator as an appropriate compromise 
between simple indicators that are easy for users to understand but potentially misleading, 
such as the gap between top and bottom groups, and more sophisticated indicators that are 
hard for users to interpret, such as the absolute concentration index.
49, 55
  The slope index 
captures the whole social gradient, rather than selecting two arbitrary groups for comparison.  
It also has a reasonably simple interpretation as the modelled healthcare gap between the 
most and least deprived neighbourhoods, allowing for the social gradient in between.  This 
indicator is also already used routinely in England for monitoring inequalities in health by the 
Public Health Outcomes Framework, and has been proposed for routine use by the NHS 
Outcomes Framework for monitoring national inequalities in healthcare outcomes.
56
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Mathematically, the absolute concentration index is the slope index multiplied by twice the 
variance of the socioeconomic variable measured on its original raw scale.
55
  The main 
limitation of the slope index compared with the absolute concentration index, therefore, is 
that it only uses information on the fractional rank of the deprivation variable, and does not 
also take account of variance in the deprivation score measured in its original raw scale.  This 
is an important limitation when cardinal measures of socioeconomic status are available, such 
as income.  However, the Index of Multiple Deprivation is only measured on an ordinal scale 
in the first place, and so converting this variable into a fractional rank does not throw away 
any important information. 
 
To compute the SII we start by taking the standardised indicator data at LSOA level, cleaned 
to ensure data quality as described above, and for each year of data we calculated an ordinary 
least squares regression of LSOA level outcome variable against LSOA level deprivation 
fractional rank  (measured on a 0-1 scale as described in section (ii) above). The coefficient 
on deprivation fractional rank in this regression gave us the SII for the year, and the standard 
error on this coefficient gave us the standard error around the SII. The SII can be interpreted 
as the modelled difference in event count between the least deprived and most deprived 
LSOAs in the country, taking into account the distribution of the outcome variable across the 
deprivation range. For all of our indicators, a positive SII value indicates “pro-rich” absolute 
inequality in the outcome whereas a negative SII indicates a “pro-poor” absolute inequality in 
the outcome.  This is straightforward in almost all cases, since almost all of our outcomes are 
defined as undesirable events.  Since we have defined our deprivation score to run from 0 for 
least deprived to 1 for most deprived, a positive linear association thereby implies that more 
deprived small areas have worse outcomes.  The one exception is primary care quality, which 
is a desirable outcome.  In this case, we simply invert the SII by multiplying by minus one. 
 
Our approach differs a little to some of the other commonly used definitions of the SII, where 
the indicators are first aggregated to deprivation decile group level and then the slope through 
the decile group points is calculated.
54
  We felt that given the availability of the data at LSOA 
level for these indicators we were better able to capture the within decile variation and 
uncertainty in our SII estimate by using LSOA level linear regressions of outcomes against 
LSOA deprivation rank as opposed to national decile level regressions. 
 
80 
The SII is also used to calculate a “real inequity gap”, based on a counterfactual situation of 
full equality in which all neighbourhoods do as well as the least deprived neighbourhood in 
terms of modelled achievement on the indicator. The real inequity gap is measured in the 
same units as the indicator and is calculated as 0.5 * SII * population. This is depicted by the 
shaded area in the figure below which also shows the national average and deprivation decile 
average values of the indicator as well as the SII slope.  We did this due to feedback from our 
consultation process that policymakers and members of the public find it easier to understand 
and relate to “raw” physical units (e.g. numbers of deaths) rather than rates and proportions, 
as explained in Chapter 3 Indicator Selection.  
 
Figure 5 Generic national absolute inequality graph showing the SII slope, inequality 
gap, national and decile averages for the indicator
 
 
We also calculated national average levels of the outcome variables and inequality trends in 
these variables for display in the indicator dashboards, as the year-on-year difference between 
this year’s figure and last year’s figure, with colour coding to show whether or not the trend 
was significant.   We found that a simple one year trend was easier for users to understand 
than a more complex trend involving more than one year.  Though to guard against the risk of 
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over-reacting to a possible one year “blip”, we advise that dashboard users also consult the 
in-depth graphical analysis underpinning the numbers reported in the dashboards, which 
show the year-on-year trend over several years. 
 
As an example, the 2011/12 SII trend can be calculated simply as: 
 
SII_trend[2011/12] = SII[2011/12] - SII[2010/11] 
 
Alternative trend measures were also considered, including differences between multi-year 
moving averages, linear regressions of SII against time, and pooled time series cross section 
regressions involving year dummies interacted with deprivation rank.  However, the simple 
single year change in SII was chosen for its simplicity and the fact that the value calculated as 
a trend in a particular year would be fixed and not be revised as further years of data become 
available. 
 
We analogously calculated the same range of indicators on a relative scale by presenting our 
absolute inequality results as a proportion of the national average achievement for the 
indicator. As almost all of our indicators are measures of undesirable outcomes these can be 
seen as relative shortfall indicators rather than relative attainment indicators.
57
  A relative 
attainment indicator could be calculated by inverting the outcomes e.g. calculating the 
number of people having emergency hospitalisations results in a relative shortfall indicator,  
whilst calculating the number of people not having emergency hospitalisations would result 
in a relative attainment indicator. 
 
Whilst we fitted a linear model for our base case results, we also tested the robustness of our 
conclusions to using alternative non-linear functional forms including log-linear or 
exponential models, Poisson and negative binomial models. These non-linear models still 
allow the computation of a slope index, by predicting outcomes for the most and least 
deprived neighbourhood and taking the gap.  We were reassured to see that these alternate 
model specifications produced the same basic national inequality trends as the linear model, 
and very similar patterns at CCG level. Measuring inequality is not solely a statistical 
exercise in finding the best fitting model but is also partly a normative judgement.  For 
example, consider the situation depicted in figure 5 in which there is a clear non-linear 
“uptick” in adverse outcomes within the two most deprived decile groups.  This is the case, 
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for example, for preventable hospitalisation and amenable mortality.  In this case, a log-linear 
model would give a lower estimate of the predicted absolute gap than the linear model.  It 
would also be less sensitive to healthcare indicator improvements in the most deprived decile 
groups.  This is because a log-linear model allows a closer fit to the non-linear “uptick”.  In 
effect, it assumes that more deprived areas should have more than a linear increase in event 
rates.  This is partly a normative judgement, implying that a non-linear “uptick” in event rates 
in the most deprived end of the spectrum is normal and so NHS organisations should not be 
held to account for eliminating it.  By contrast, the linear model gives greater weight to 
inequality at the two extremes of the distribution, and so is more sensitive to changes at the 
most deprived end of the spectrum.  Mathematically, the ordinary least squares linear model 
yields a weighted average of the gradient between each point and the mean point, with greater 
weight given to points that lie further from the mean.  Gradients towards the more extreme 
end of the spectrum thus receive higher weight, and hence the slope index is more sensitive to 
change the further one moves towards the tails of the deprivation spectrum.  In practice, then, 
use of the linear slope index rather than a non-linear slope index embodies the value 
judgement that the index ought to be more sensitive to change towards the most and least 
deprived ends of the spectrum than change in the middle. 
 
We chose to use the linear model for our base case estimates of the SII as this is the simplest, 
easiest to understand, and most widely used form of the measure in the inequalities literature. 
Where different kinds of non-linearity are evident in the different years of the data for the 
different indicators, these could each in theory be modelled using the best fitting non-linear 
model for that particular instance.  However, we found that the linear model provides a useful 
general method to measure inequality and adequately captures the inequality trends across 
indicators and over time in a comparable manner.  
 
We also produced results using heteroscedasticity robust standard errors and were reassured 
to find that these had little effect on our estimated standard errors in both national and CCG 
level analyses. We chose to use unadjusted standard errors, in the absence of compelling 
empirical evidence for heteroscedasticity at national level or theoretical reasons for expecting 
heteroscedasticity within some sub-national areas but not others. 
 
We did not apply LSOA level population weights either to the computation of the deprivation 
ridit score or to the linear regression in our base case results.  This again was on grounds of 
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simplicity of communication to policy makers, since LSOAs do not vary dramatically in 
population size and application of population weights made little difference to the results. 
 
Finally, we did not allow for influential outliers at CCG level using robust regression 
methods that apply an iterated re-weighted least squares algorithm based on a particular 
weighting function.  Rather, we propose that individual CCGs should visually inspect their 
own within-CCG small area and practice level scatterplots with a view to identifying and 
understanding the role of “unusual” local neighbourhoods and GP practices on a case-by-case 
basis. 
 
4.7 Local inequality indicators  
 
We constructed clinical commissioning group level indicators using similar methods as we 
used to construct the national inequality indicators. Our absolute inequality indicator at CCG 
level is based on running local level regressions using just those LSOAs that fall within a 
CCG, and modelling the “social gradient” relationship between the outcomes of these LSOAs 
and their national deprivation ranks. The deprivation rank we used was the national 
deprivation rank rather than recomputed local within-CCG deprivation rank. We did this in 
order to allow us to compare the within-CCG inequality gradient with the national inequality 
gradient in a straightforward manner. We labelled this indicator the “absolute gradient index” 
(AGI) to distinguish it from variants of the SII at local level that use the local deprivation 
rank.  We also calculated a relative version of this indicator at CCG level, analogous to the 
national RII, that we called the relative gradient index (RGI).  To maintain comparability 
with the national RII, this was computed as the AGI divided by the national mean level of the 
indicator.  Dividing by the local mean would potentially bias comparisons against the 
national RII benchmark by decreasing measured local relative inequality in areas with higher-
than-average mean levels of the indicator outcome (e.g. relatively deprived CCGs with 
above-average levels of preventable hospitalisation), and vice versa.  National and local level 
results were graphically combined to compare the CCG with the national level results as 
shown in the figure below. 
 
This approach differs from the Public Health Outcomes Framework (PHOF) approach
54
 to 
calculating within-CCG SIIs.  The PHOF approach uses local deprivation ranks recalculated 
within CCGs, and then deprivation decile level regressions based on these local ranks.  This 
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difference is due to the difference in purpose between healthcare equity indicators and public 
health equity indicators.  The main difference is that our healthcare equity indicators aim to 
compare local healthcare inequalities against a national benchmark, whereas the public health 
equity indicators focus on comparing the same local area over time. For our purpose of 
making comparisons against a national benchmark, using a common deprivation scale 
between the national and CCG level indicators is appropriate.  A second difference is that our 
indicators focus on role of the NHS in reducing the link between deprivation and ill-health, 
rather than in reducing deprivation and income inequality per se.  By contrast, the PHOF 
indicator seeks to pick up the success of local government both in reducing the deprivation-
health link and also in reducing deprivation and income inequality per se.  Our more specific 
focus is reasonable insofar as changes in local prosperity are largely caused by factors outside 
NHS control – though of course NHS actions can have consequences for people’s wealth by 
protecting them against catastrophic healthcare costs and keeping them economically 
productive.  To measure the deprivation-health link specifically, we need to use the absolute 
national deprivation rank rather than the relative within-CCG deprivation rank.  In principle, 
our measure will then not be sensitive to “gradient preserving” changes in local economic 
prosperity if this leads to precisely corresponding changes in health and healthcare along the 
national social gradient. 
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Figure 6 Absolute inequality graph for a hypothetical CCG showing the AGI slope, 
inequality gap, within CCG LSOA level results, national and CCG average for an 
example indicator (e.g. preventable hospitalisation per 1,000 general population)
 
 
We also plotted the full range of CCG level inequality results against the national inequality 
result on a caterpillar plot, showing data for the most recent year to help us identify areas that 
performed significantly better or worse than the national average in terms of inequality. An 
example of such a plot is shown below. 
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Figure 7 CCG level caterpillar plot comparing absolute inequality at CCG level in 
terms of AGI to absolute inequality at national level in terms of SII
 
 
As a final analytical tool we produced plots of CCG level average achievement and inequality 
achievement by deprivation to get some understanding of the contributions between CCG and 
within CCG inequality to the national inequality results. An example of such a plot is shown 
in the figure below. 
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Figure 8 Correlations between deprivation and average and inequality performance at 
CCG level
 
As with the national inequality indicators, we tested a range of alternative regression models 
to ensure the robustness of our results. We also tested using a random effects specification of 
our model with CCG level random slopes and intercepts. We found that for those indicators 
where we had small event counts at CCG level (in particular, amenable mortality and all-
cause mortality) the random effects specification had trouble converging. However, for the 
indicators where the random effects specification did converge we found that the magnitudes 
of inequality results were, as would be expected, shrunk towards the national average.  
However, the trends and rankings of CCGs in terms of inequality remained very similar to 
those observed with the standard linear model. Our base case results at local level are 
therefore produced using the standard linear model as (i) this could be applied in a consistent 
manner across the full suite of indicators and (ii) this is a simpler approach that is easier for 
decision makers to understand and interpret. 
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Chapter 5 Results 
 
5.1 Introduction 
 
This chapter presents the main results at both national and local level.  Detailed results for 
each of our eight indicators of equity are presented one by one, in the same format, and then a 
final section summarises our findings on local equity monitoring for all eight indicators. 
 
Detailed results for each indicator follow a common format.  An introductory section first 
explains what the indicator means, why it was selected and how it was defined, with special 
attention to any departures from standard NHS indicator definitions.  The main results are 
then presented graphically, using the same four types of graph.  The key findings are then 
summarised.  The four types of graph are as follows:  First, national equity time trend graphs 
showing trends in (i) indicator levels by quintile group of deprivation, (ii) the Slope Index of 
Inequality and (iii) the Relative Index of Inequality.  We present annual time trends for our 
full period of 2001/2 to 2011/12 where possible, though this is not possible for primary care 
supply and quality whose data series only start in 2004/5 (as explained in Appendix A: 
Indicator definitions).  We first present unadjusted time trends and then adjusted time trends, 
after allowing for need or risk factors.  Second, a national equity gradient graph for 2011/12 
showing adjusted indicator levels by decile groups of deprivation, the social gradient (the 
slope of which is the SII), and the area under the social gradient, representing the “inequity 
gap” – see Chapter 4: Methods.  Third, a local equity performance graph for 2011/12 in the 
form of a caterpillar plot showing equity (absolute gradient index) by CCG in 2011/12 in 
rank order, with confidence intervals.  Fourth, a local performance-deprivation correlation 
graph for 2011/12 in the form of a CCG level scatter plot of performance against deprivation 
at CCG level, for both equity performance (e.g. the absolute gradient index in patients per 
GP) and average performance (e.g. the average level of patients per GP).   
 
We start by presenting contextual information on population trends from 2001/2 to 2011/12 
by deprivation group, age group and sex, before turning to the results for our eight equity 
indicators. 
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5.2 Population 
 
Equity is a population level concept, relating to unfair inequality within the relevant 
population of interest.  To help interpret trends in equity over time, it is therefore important to 
understand the nature of changes in population size and socio-demographic composition over 
time.  Our equity indicators are based on ONS mid-year estimates of population, which 
estimate the total resident population including homeless people and people in institutions 
such as nursing homes, prisons and barracks.  We present contextual information on national 
population trends by age, sex and deprivation group in the form of two matrix plots.  The first 
plot has a fixed population range on the y-axes, to facilitate comparisons between age groups 
(rows).  The second plot has variable population ranges on the y-axes, to facilitate 
comparisons between deprivation groups (columns). 
 
Figure 9 Population matrix showing breakdown by deprivation group, age group and 
sex (y axes fixed) 
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Figure 10 Population matrix showing breakdown by deprivation group, age group and 
sex (y axes free) 
 
 
The population matrix plots show that (1) more deprived areas have younger populations than 
more affluent areas and (2) old age populations have been increasing over time in the most 
affluent areas whilst population at younger ages has been increasing over time in more 
deprived areas.   
 
The bulk of the population is between 25 and 74 years of age. There has been substantial 
growth over the period in the populations of 40-59 and 60-74 year olds for all deprivation 
groups. This growth has been most pronounced in the more affluent groups where we also see 
a substantial decline in the numbers of 25-39 year olds.  Women and men follow largely the 
same trends within each age and deprivation group. Men tend to outnumber women up until 
the 16-24 age group after which women outnumber men – with the gender difference 
becoming more noticeable in older age groups. 
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These deprivation-related demographic variations and trends have important implications for 
risk and need adjustment.  The risk of adverse healthcare outcomes (such as hospitalisation 
and mortality) tends to increase with age.  The impact of deprivation-related demographic 
variation – i.e. point (1) above – will therefore be to increase the risk of adverse events in 
affluent areas, and hence to reduce the unadjusted socioeconomic gradient in healthcare 
outcomes.  Similarly, the impact of deprivation-related demographic change – i.e. point 2 
above – will be to increase the relative risk of adverse events in affluent areas compared with 
deprived areas, and hence to reduce the unadjusted socioeconomic gradient in healthcare 
outcomes over time.  Without age adjustment, therefore, socioeconomic inequality in health 
outcomes may appear to reduce over time in a pro-poor direction, even if the NHS did 
nothing to improve inequality. This would be misleading as the resulting inequality would 
reflect the impact of demographic change rather than the impact of the NHS.  Therefore, we 
considered it relevant to adjust for age in our analysis. In cross sectional analysis, adjusting 
for age increases the SII and RII for healthcare outcomes, since more deprived areas are 
younger and hence less at risk of poor outcomes.  In time series analysis, adjusting for age 
adds a growth trend to SII and RII over time, by removing the impact of aging in affluent 
areas on reducing the social gradient over time. 
 
Age is of course not the only factor that influences the risk of adverse healthcare outcomes.  
In particular, morbidity may have larger and potentially opposing impacts since deprived 
populations are sicker than affluent populations and more at risk of adverse events.  
Unfortunately, however, we were not able to adjust for morbidity due to lack of time-varying 
individual level data on both age and morbidity, as explained in Chapter 4: Methods.  The 
morbidity-unadjusted gradient in healthcare outcomes that we observe will therefore be 
substantially larger than the “true” morbidity-adjusted gradient.  Furthermore, there is some 
evidence that socioeconomic inequalities in morbidity have widened during 2000s.
58
  If so, 
this would have the impact of appearing to increase socioeconomic inequalities in the non-
morbidity-adjusted healthcare outcomes that we observe. 
 
5.3 Primary care supply 
 
Access to primary care is a foundation stone of health care quality, and makes a crucial 
contribution both to patient experience and improvement in population health outcomes. 
There is evidence that improved access to primary care can help to prevent illness, manage 
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chronic conditions more effectively and reduced unnecessary utilisation of secondary care
59, 
60
; though evidence on the impact of marginal changes in primary care supply on mortality in 
high income countries is mixed
61, 62,
 
59
.  We use a simple and objective measure of access to 
primary care: the number of patients per primary care physician.  Measures of patients’ 
subjective experiences of primary care access are also available, based on the annual National 
GP Patient survey.  However, this survey only goes back to 2006/7 and has a response rate of 
around 30% which varies substantially between practices and so may hamper comparisons in 
social gradients between sub-national areas. 
 
Previous studies in high income countries, including the UK, have found significant 
geographical variations in the distribution of primary care physicians.
63
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69
 Data 
from England between 1974 and 2006 showed substantial and persistent geographical 
inequalities in supply of general practitioners (GPs) relative to need between NHS 
administrative areas.
70
 
71
 
72
 However, these studies focused on large areas which made it 
difficult to accurately pinpoint primary care shortages in specific disadvantaged 
neighbourhoods. 
 
Our indicator of primary care supply evaluates socioeconomic inequality in GP supply 
between small area populations from 2004/5 to 2013/14. We use LSOA level data which 
allows us to capture changing patterns of socioeconomic inequality in much more fine-
grained detail than previous studies. We define GP supply as the number of patients per full 
time equivalent GP, excluding registrars and retainers, adjusted for age, sex and 
neighbourhood ill-health using the Carr-Hill workload adjustment (see Appendix 1 for 
details). The numerator is the total number of people alive at mid-point in the current 
financial year while the denominator is the number of FTE GPs attributed to each small area 
in the current indicator year. Further technical details of how this index was computed are 
presented in Appendix 1. 
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Figure 11 Unadjusted equity time trends in patients per GP 
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Figure 12 Adjusted equity time trends in patients per GP 
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Figure 13 National social gradient in patients per GP in 2011/12 – adjusted 
 
 
Notes:   
i. Dots represent decile groups.  The inverted U shape pattern indicates that 
neighbourhoods in the middle of the socioeconomic spectrum have less primary care 
supply than the most and least deprived neighbourhoods, after adjusting for 
differences in need. 
ii. The slope of the line is the slope index of inequality.  In this case, the slope is 
negative showing “pro-poor” inequality in patients per GP favouring deprived areas. 
iii. The shaded area shows the “inequity gap”.  In this case, this gap is negative indicating 
that bringing all neighbourhoods to the level of the least deprived would require 
losing some GPs in deprived neighbourhoods. 
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Figure 14 Caterpillar plot of the absolute gradient index of inequality in patients per 
GP in 2011/12 at CCG level 
 
Notes:  
i. CCGs are ranked from least equitable (left) to most equitable (right).  
ii. The dotted horizontal line shows the national average.  CCGs to the left with confidence 
intervals above this line have worse than average equity performance, and vice versa. 
iii. In this unusual case, there are many negative SSIs (at face value indicating “pro-poor” 
inequality) as well as positive SIIs indicating “pro-rich” inequality. However, since we 
under-estimate need in deprived neighbourhoods, as explained in Chapters 4 and 6 and 
Appendix 1, we do not interpret negative SIIs as representing “pro-poor” inequality but 
rather as indicating no measurable “pro-rich” inequality. 
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Figure 15 Scatter plots of CCG performance on patients per GP in 2011/12 against 
deprivation, showing both mean performance and equity performance (absolute 
gradient index)
 
 
Unadjusted trends show that there has been a significant divergence in GP supply between 
the most deprived fifth of areas and the other areas in the country from 2006/07 onwards. 
Since 2006/07 the most deprived fifth of areas experienced a sustained trend of increasing GP 
supply (decreasing numbers of patients per GP) whilst GP supply in all the other areas 
decreased over time.  We prefer the need adjusted findings, however, because in cross section 
the unadjusted findings come up with the potentially misleading message that people living in 
deprived neighbourhoods have substantially more GP supply than others.  This is a 
potentially misleading finding, because it fails to allow for the fact that deprived 
neighbourhoods tend to suffer more ill health than affluent neighbourhoods, and so have 
greater healthcare needs. 
 
Adjusting these results for need using the Carr-Hill workload adjustment changes the levels 
of these lines, but we see a similar equity trend. We see a sustained reduction in both absolute 
and relative inequality as measured by the SII and RII over the period, and by 2010/11 need 
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adjusted GP supply actually becomes pro-poor. This is also evident in the social gradient 
graph for 2011/12, where we see the lowest numbers of patients per GP in the most deprived 
areas and a negative inequity gap. The caterpillar plot shows that there are substantial 
numbers of areas significantly more and less equal than the mean. The correlation plot shows 
that by 2011/12 there is little evidence of a social gradient between CCGs: there is no 
association between mean patients per GP and deprivation at CCG level.  By contrast, there is 
some evidence that more deprived CCGs do better at reducing deprivation-related inequality 
in GP supply within their own patch: there is a clear though weak negative association 
between equity in patients per GP (absolute gradient index) and deprivation at CCG level. 
 
5.4 Primary care quality 
 
Primary care remains the most effective and cost-effective way of delivering accessible care 
in a time of rising prevalence of chronic conditions and multi-morbidity.
73
 This indicator 
focuses on clinical process indicators of the quality of primary care, based on the proportion 
of patients diagnosed with a particular condition receiving appropriate medical care for that 
condition.  The quality of primary care can be measured using structures (such as the supply 
of GPs), processes (such as vaccination, investigation and prescribing) or outcomes (such as 
mortality, morbidity and patient satisfaction).
74
 Combinations of these measures have been 
used in the literature to assess contribution of primary care in improving population health.
59
  
International studies have demonstrated that improving the process quality of primary care is 
associated with reduced emergency admissions, improved patient outcomes and reduced 
costs to the health care system.
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77
  Moreover, small improvements in primary care process 
quality can have significant effects on population health at low cost.
78
 
 
Improving the quality of primary care has been incentivised in several countries, primarily 
using financial incentives.
79
 In the UK, the Quality and Outcomes Framework (QOF) scheme 
was launched in 2004 to monitor and improve the quality of primary care.
80
 This is one of the 
largest pay-for-performance programmes in the world with over £10bn invested since 
inception.
81
 The QOF programme rewards primary care practices based on their performance 
on a comprehensive set of indicators that measure primary care quality. 146 indicators are 
used that cover the management of chronic disease, public health measures, quality and 
productivity of service, and patients' experiences with respect to care.
82
  To measure the 
public health impact of primary care quality, Ashworth (2013) developed a composite 
99 
indicator using 20 QOF indicators weighted by their importance in terms of their potential for 
mortality reduction.
83
 The resulting measure, termed the ‘Public Health Impact’ score, was 
proposed as a measure of primary care quality in terms of population health. 
Our indicator evaluates socioeconomic inequality in primary care quality between small area 
populations from 2004/5 to 2013/14. We selected 16 out of the 20 indicators proposed by 
Ashworth (2013), for which data were available throughout our period of analysis in a 
consistent format. We define primary care quality as weighted average of clinical process 
quality from 16 indicators in the QOF, with weights proportional to importance in terms of 
the estimated number of lives saved per 100,000 patients.
83
 For each clinical indicator in 
QOF, the number of patients deemed appropriate for that indicator is the denominator and the 
number of patients for whom the indicator was met is the numerator. We use “population 
achievement” which puts “exception reported” patients back into the population denominator 
thereby assuming such patients represent poor quality, but as a robustness check we also 
analysed “reported achievement” which excludes “exception reported” patients from the 
population denominator.  Further technical details of how this index was computed are 
presented in Appendix 1. 
 
There are no “adjusted” results to present for this indicator, because the population 
denominator for each indicator already defines the “at risk” patient population as patients 
diagnosed with the relevant condition.  No further risk adjustment was performed, on the 
basis of the value judgement that  age, sex and other patient characteristics are not legitimate 
reasons for failing to deliver high quality care to the “at risk” patient population.  
100 
Figure 16 National equity trends in primary care quality – adjustment not necessary
 
Note:  Data on the number of “exception reported” patients were not provided prior to 
2005/06, which explains the blip in the trends between 2004/05 and 2005/06.  This blip 
disappears when using “reported achievement” after excluding exception reported patients. 
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Figure 17 National social gradient in primary care quality in 2011/12 – adjustment not 
necessary
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Figure 18: Caterpillar plot of the absolute gradient index of inequality in primary care 
quality in 2011/12 at CCG level 
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Figure 19 Scatter plots of CCG performance on primary care quality in 2011/12 against 
deprivation, showing both mean performance and equity performance (absolute 
gradient index)
 
 
Primary care quality steadily improved over the study period.  Both absolute and relative 
inequality in primary care quality steadily decreased, and was almost eliminated by 2011/12. 
The caterpillar plot shows that in 2011/12 there are substantial numbers of CCGs 
significantly more and less equal than the national level of absolute inequality. The 
correlation plots show that by 2011/12 there is no sign of a social gradient in primary care 
quality between CCGs – if anything, more deprived CCGs tend to have slightly better GP 
supply (fewer patients per GP) – and that CCG equity performance on primary care quality is 
not associated with deprivation at CCG level. 
 
5.5 Hospital waiting time 
 
Hospital waiting time is a major health policy issue in many countries, including the UK, and 
an important indicator of health system performance.
84 85 
Moreover, this indicator was 
identified by our Citizens’ Panel participants as an important measure of equity in the NHS 
104 
(see Chapter 3 Indicator Selection). Prolonged hospital waiting time is known to be 
associated with poor health outcomes, increased risk of complications, reduced quality of life 
and high patient dissatisfaction. For example, a systematic review of waiting time for 
radiotherapy found that the risk of local recurrence of cancer increased with increasing 
waiting time.
86
 In another example, a recent English NHS study found that waiting time for 
hip and knee replacement surgery had a statistically significant negative impact on the health 
gains from surgery.
87
 Similar evidence on the impact of hospital waiting time has been found 
for other conditions, including chronic pain,
88
 cataract
89
 and heart transplantation.
90
 
  
We measure hospital waiting time in terms of days from outpatient decision-to-treat to 
inpatient admission-for-treatment.  This is often termed the inpatient waiting time in the 
literature. Another commonly used indicator is the outpatient waiting time, defined as the 
period between referral from a general practitioner to the outpatient appointment with a 
specialist. A third and more comprehensive indicator used in the NHS since the late 2000s is 
the referral-to-treatment waiting time, which measures the time from referral from a general 
practitioner to inpatient admission-for-treatment – including adjustment to allow for “clock 
stop” periods of waiting attributable to patient choices (e.g. not attending an appointment) 
rather than NHS supply.  This can be further divided into admitted and non-admitted waiting 
times, by distinguishing patients who are admitted for inpatient treatment from patients 
whose course of treatment ends at the outpatient stage without requiring inpatient admission. 
 
However, we focus on inpatient waiting time because it is considerably quicker and easier to 
compute, and less subject to bias due to coding and linkage error.  Computing referral-to-
treatment times can be done by linking outpatient and inpatient hospital episode statistics at 
individual level across multiple years and has been done for the particular case of hip and 
knee replacement.
91
  However, this is time-consuming in terms of both coding time and 
computational time, has never previously been done across all possible procedures and 
specialties, and would be subject to an unknown degree of coding bias and selection bias due 
to linkage failures.  It would also be impossible using hospital episode statistics data to fully 
implement the complex “clock stop” rules required to replicate official NHS statistics on 
referral-to-treatment times; and so the resulting indicator would still not precisely match 
official NHS statistics.  Use of inpatient waiting time is also more internationally comparable, 
and is consistent with the definition of waiting time used in most OECD countries to measure 
health system performance.
84
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By all measures, average hospital waiting times have declined significantly from 2001/2002 
in England.
92
 
93
 Sicilliani (2014) reports that waiting times for many procedures have more 
than halved, and that this can partly be attributed to the “targets and terror” policy introduced 
from 2000 as well as increased capacity.
94, 95
 However, there is evidence to suggest that there 
remains significant socioeconomic inequalities in waiting time. For instance, Laudicella and 
colleagues
96
 found that elective hip replacement patients in the poorest two socioeconomic 
quintiles wait about 7% longer than patients in the least deprived quintile across England. In 
another study, Moscelli and colleagues
97
 found significant differences in waiting times 
between public hospitals in non-emergency heart revascularisation procedures in England (up 
to 35% difference between the most and least deprived population quintiles).  These 
inequalities all arose within hospitals rather than across hospitals, and after allowing for 
differences in the number and type of diagnoses as a marker for severity. 
 
Our indicator evaluates socioeconomic inequality in inpatient hospital waiting time between 
small area populations from 2001/2 to 2013/14. We define hospital waiting time as the 
number of days from outpatient decision-to-treat to inpatient admission-for-treatment (i.e. the 
inpatient waiting time). We allow for differences in waiting times by specialty type by 
adjusting for the main specialty of the treating consultant.  We do not additionally allow for 
age and sex, on the basis of the value judgement that (at least in most cases) age and sex are 
not a legitimate justification for making people wait longer for needed treatment. Further 
technical details of how this index was computed are presented in Appendix 1. 
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Figure 20 Matrix plot showing unadjusted trends in inpatient hospital waiting time by 
age, sex and deprivation (fixed axes for comparisons across age groups) 
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Figure 21 Matrix plot showing unadjusted trends in inpatient hospital waiting time by 
age, sex and deprivation (free axes for comparisons across deprivation groups) 
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Figure 22 Unadjusted national equity trends in inpatient hospital waiting time 
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Figure 23 Adjusted national equity trends in inpatient hospital waiting time 
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Figure 24 National social gradient in inpatient inpatient hospital waiting time in 2011/12
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Figure 25 Caterpillar plot of absolute gradient index of inequality in inpatient hospital 
waiting time in 2011/12 at CCG level 
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Figure 26 Scatter plots of CCG performance on inpatient hospital waiting time in 
2011/12 against deprivation, showing both mean performance and equity performance 
(absolute gradient index)
 
 
Inpatient hospital waiting time decreased substantially across all areas in the country from 
2003/04 to 2008/09, after which it began to creep up again.  Inequality appeared to be slightly 
“pro-poor” at the start of our period in 2001/2, and to become even more “pro-poor” up to 
2003/04, after which time more affluent areas steadily started to catch up with some evidence 
of pro-rich inequality emerging by 2011/12 as depicted in the social gradient graph.  The 
caterpillar plot shows there are substantial numbers of CCGs performing significantly better 
and worse than the national average in terms of the absolute gradient index of inequality. 
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5.6 Preventable hospitalisation 
 
Preventable hospitalisation refers to emergency hospital admissions that can be prevented by 
timely and effective provision of primary care.  This is an important indicator of primary care 
access and quality that is widely used in the international literature.
98
 
99, 100
 In England, data 
from 2001 to 2013 showed that preventable hospitalisations make up one in every five 
hospital admissions, and have increased by 48% in the last 12 years.
101
 Common causes of 
preventable hospitalisations include urinary tract infection / pyelonephritis, pneumonia, 
chronic obstructive pulmonary disease (COPD), convulsions and epilepsy, and ear, nose and 
throat infections. Studies suggest that preventable hospitalisation can be reduced by 
improving primary care supply and quality.
102
 These hospital visits not only result in poor 
outcomes, but also result in increased cost to the health care system.
103
 For instance, a recent 
study concluded that better management of patients in primary care could save £1.42 billion 
in England by reducing preventable hospitalisation.
104
 Similar cost estimates have been 
published for other countries.
105
 
106
 Studies have also found that preventable hospitalisations 
are associated with the socioeconomic status of patients.
107
 
108
  
 
Our indicator evaluates socioeconomic inequality in preventable hospitalisation between 
small area populations from 2001/2 to 2013/14. We defined preventable hospitalisation as the 
proportion of people with an emergency admission for a chronic ambulatory care sensitive 
condition – admissions that are potentially avoidable if these chronic conditions are 
appropriately managed in primary care.
109
 This indicator could also be described as 
"emergency hospitalisation sensitive to primary care".  We depart from the corresponding 
NHS Outcomes Framework definition by defining the indicator numerator as the number of 
people with one or more events, rather than the number of events.  This is because (a) we 
have a separate measure of repeat hospitalisation and so want to focus this measure on the 
incidence of hospitalisation (the proportion of people hospitalised) rather than the intensity 
(how many times each individual is hospitalised); and (b) following advice from the two lay 
members of our advisory group, we believe that members of the public find it slightly easier 
to understand and relate to proportions (e.g. ‘x people per 1,000’ or ‘a chance of x in 100’) 
than event rates. We focused on chronic rather than acute ambulatory care sensitive 
conditions, as the former are likely to be more sensitive to changes in primary care supply 
and quality. We used the same list of chronic ambulatory care sensitive conditions as the 
NHS Outcomes Framework (Indicator 2.3i). Our definition of preventable hospitalisation 
114 
uses all ages in both numerator and denominator, as does the NHS OF definition. However, 
the international OECD definition only includes age 15+, i.e. we include children but the 
OECD definition does not. We then indirectly standardised each year of data for age and sex 
at LSOA level. Further technical details of the standardisation procedure are in Chapter 4 
Methods, and further indicator definition details are presented in Appendix 1. 
 
Figure 27 Matrix plot showing unadjusted trends in preventable hospitalisation by age, 
sex and deprivation (fixed axes for comparisons across age groups) 
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Figure 28 Matrix plot showing unadjusted trends in preventable hospitalisation by age, 
sex and deprivation (free axes for comparisons across deprivation groups) 
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Figure 29 Unadjusted national equity trends in preventable hospitalisation 
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Figure 30 Adjusted national equity trends in preventable hospitalisation
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Figure 31 National social gradient in preventable hospitalisation in 2011/12
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Figure 32 Caterpillar plot of the absolute gradient index of inequality in preventable 
hospitalisation in 2011/12 at CCG level 
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Figure 33 Scatter plots of CCG performance on preventable hospitalisation in 2011/12 
against deprivation, showing both mean performance and equity performance (absolute 
gradient index)
 
 
There has been a slight fall in preventable hospitalisation over the study period, though 
substantial inequality persisted throughout. Looking at the age-sex breakdowns in the matrix 
plot in figure 28, the main exception to this trend was in children age 5-15 within the most 
deprived quintile group for whom preventable hospitalisation rose during the 2000s.  The 
unadjusted trends show improvement in inequality in terms of SII and RII.  However, this is 
misleading due to disproportionate ageing of the affluent population which is associated with 
a higher rate of hospitalisation in this quintile group. After age adjustment, the pro-rich trend 
disappears for both SII and RII. This inequality is seen both between CCGs and within CCGs 
as depicted by the correlation plots.  Inequality lines up closely with deprivation, as shown by 
decile points on the scatter plot which all lie along the social gradient line. The caterpillar 
plot shows there are substantial numbers of CCGs performing significantly better and worse 
than the national average in terms of the absolute gradient index of inequality. 
 
121 
In the unadjusted trends, which do not allow for age and sex, both the SII and RII decline (get 
better) over time.  This difference compared with the adjusted trends is due to demographic 
change over time: affluent neighbourhoods aged during the 2000s, while there was an 
increase in younger populations in deprived neighbourhoods.  This demographic shift 
increased preventable hospitalisation in richer neighbourhoods relative to poorer 
neighbourhoods and hence reduced pro-rich inequality in the unadjusted trends.  We think the 
age-sex adjusted trends give a more accurate picture of NHS equity performance, on the basis 
that the NHS should not receive credit for an apparent reduction in pro-rich inequality 
resulting from demographic change largely outside the control of the NHS. 
 
A final point to note is the uptick in preventable hospitalisation in 2003/4, which was 
particularly strong in the two most deprived quintile groups.  The cause of this is not known.  
However, one speculation is that this may be related to change in the supply of GP out of 
hours care.  This uptick in preventable emergency hospitalisation happened around the time 
of the introduction of the new GP contract which, among other things, allowed GPs to opt out 
of providing “out of hours” cover for emergency care outside normal GP practice working 
hours.  This speculation may be worth exploring in future “quasi experimental” studies. 
 
5.7 Repeat hospitalisation 
 
Repeat emergency hospitalisation is known as an important routine indicator of health system 
performance.
110
 
111
 
112
 
113
 Repeat hospitalisation may be due to one or a combination of 
several factors including (but not limited to) quality of care during previous hospitalisation 
(including early discharge), comprehensive discharge planning,
114
 primary and community 
care after discharge (including outpatient follow-up)
115
 and patients’ own social support 
systems and health behaviours. Therefore, repeat hospitalisation is an important indicator of 
the quality of care co-ordination between hospital care, primary care and community care 
settings. 
 
Studies suggest that greater deprivation is associated with an increased risk of emergency 
readmission. For instance, in a study in Greater Manchester, Lyratzopoulos and colleagues
116
 
found that deprivation was significantly and independently associated with increased risk of 
emergency medical readmission at three and twelve months after initial discharge. Other 
studies using specific patient groups found similar socioeconomic patterns of hospital 
122 
readmissions.
117
  Repeat hospitalisation not only results in poor health outcomes for patients, 
it also significantly increases the cost of care for the health care system. Therefore, reducing 
repeat hospitalisation is one of the key indicators used to assess hospital performance and the 
impact of health service organisation for the average patient.
111
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Our indicator evaluates socioeconomic inequality in repeat hospitalisation between small area 
populations from 2001/2 to 2013/14. We define repeat hospitalisation as a proportion of 
inpatients with one or more subsequent any-cause emergency readmission in the same year. 
We focus on all-cause rather than cause-specific repeat hospitalisation and on within-year 
rather than 30-day or 90-day repeat hospitalisation for the following reasons: (a) we are 
interested in whole system co-ordinated care, beyond the primary cause of hospital admission 
and the immediate post-hospital period; and (b) all-cause repeat hospitalisation within the 
indicator year provides a larger number of events for the purpose of detecting statistically 
significant differences between CCG level and national level absolute inequality gradients. 
The denominator for this indicator is the total number of people with an inpatient admission 
from any cause in a given year. The numerator is the number of people with one or more 
repeat hospitalisations from any-cause in the same calendar year. We used repeat 
hospitalisation within the indicator year rather than following patients across years because 
this is less time-consuming in terms of coding and computational burden.  In addition, 12-
month re-admission would result in a less up-to-date indicator by either imposing a one year 
data lag or a focus on patients admitted the year before the indicator year.  The drawback of 
our approach is that it may produce biased estimates of the national social gradient in 12-
month re-admission, though this is unlikely substantially to hamper comparisons between 
CCGs and over time.  The advantage is that this is a simpler, less computationally expensive 
and more timely approach. We indirectly standardised each year of data for age and sex at 
LSOA level. Further technical details of how this index was computed are presented in 
Appendix 1. 
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Figure 34 Matrix plot showing unadjusted trends in repeat hospitalisation by age, sex 
and deprivation (fixed axes for comparisons across age groups) 
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Figure 35 Matrix plot showing unadjusted trends in repeat hospitalisation by age, sex 
and deprivation (free axes for comparisons across deprivation groups) 
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Figure 36 Unadjusted national equity time trends in repeat hospitalisation
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Figure 37 Adjusted national equity time trends in repeat hospitalisation 
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Figure 38 National social gradient in repeat hospitalisation in 2011/12
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Figure 39 Caterpillar plot of absolute gradient index of inequality in repeat 
hospitalisation in 2011/12 at CCG level 
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Figure 40 Scatter plots of CCG performance on repeat hospitalisation in 2011/12 
against deprivation, showing both mean performance and equity performance (absolute 
gradient index)
 
 
Rates of repeat hospitalisation have increased substantially over the study period, coupled 
with an increase in both absolute and relative inequality. By 2011/12 there was substantial 
inequality in repeat hospitalisation as depicted by the national social gradient graph. The 
unadjusted trends show improvement in inequality; however, this is misleading due to 
disproportionate ageing of the affluent population over time. After age adjustment, the 
underlying worsening inequality trend becomes clear for both SII and RII. As discussed in 
more detail in chapter 8, the increase in repeat hospitalisation and associated increase in 
inequality may partly be a sign of success related to increasing multi-morbidity as a result of 
people living longer, though may also partly be a result of shorter lengths of stay in hospital, 
hospital payment reforms that gave hospitals financial incentives to increase emergency 
admissions, and – especially towards the end of the 2000s – reductions in social care supply 
and quality due to financial pressures on local authorities.  This inequality appears to be 
present between CCGs as well as within CCGs, as shown by the left hand panel of the 
correlation plots for 2011/12.  Equity performance on repeat hospitalisation shows a slightly 
positive association with deprivation at CCG level, though most of this association is driven 
by a handful of CCGs with unusually high and low equity performance. The caterpillar plot 
shows there are substantial numbers of CCGs performing significantly better and worse than 
the national average in terms of the absolute gradient index of inequality. 
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5.9 Amenable mortality 
 
Amenable mortality is a standard indicator used internationally to monitor the performance of 
the healthcare system as a whole, and is considered to be particularly useful for monitoring 
the performance of primary care and the coordination of care between primary and secondary 
services.
125, 126, 127
  Amenable mortality refers to deaths that could be avoided by the 
healthcare system through prevention and treatment, given medical knowledge and 
technology available at the time of death.
128,
 
129
  The concept was first formalised by Rutstein 
(1976)
130
 based on treatable causes of death, and subsequently broadened to include causes 
preventable by health care which led to the use of the term ‘amenable mortality’.131, 132  The 
concept of “amenable mortality” is narrower than that of “preventable mortality” however, 
which also includes mortality preventable by public health measures outside the healthcare 
system.
133
 
 
Amenable mortality makes up a significant proportion of total deaths, even in high income 
countries. Nolte and McKee
134
 found that, in 2006/7, amenable mortality accounted for 
nearly a quarter of all deaths under 75 in 16 high income countries, including the UK in 
which the figure was slightly above average at 26.8%. The relationship between amenable 
mortality and socioeconomic status has also been investigated in several studies.
135
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In England, socioeconomic inequality in amenable mortality has increased for both men and 
women between 1990 and 2010; the relative index of inequality for men increased from 2.21 
in 1990 to 2.83 in 2010, and from 1.67 in 1990 to 2.18 in 2010 for women.
139
 
 
This indicator measures socioeconomic inequality between small area populations in 
amenable mortality. We defined amenable mortality as the proportion of people dying from 
causes considered amenable to health care. The numerator for this indicator is the number of 
deaths from causes considered amenable to health care. The denominator is the total number 
of deaths from any cause in a given year. We used the list of causes of death considered 
amenable to health care from the NHS Outcomes Framework (Indicator 1.1),
140
 which in turn 
is based on a list produced by the ONS. The NHS Outcomes Framework turns the resulting 
mortality counts into an estimate of “potential years of life lost” from premature deaths aged 
under 75. However, we have used a simple all-age mortality rate including deaths in those 
aged 75 and over, since (a) our approach is more comprehensive (people over 75 experience 
by far the highest rate of amenable mortality) and (b) based on advice from two lay members 
138 
of our advisory group and a media expert, we believe that mortality rates are easier for the 
public to understand than “potential years of life lost”.  We indirectly standardise amenable 
mortality for age and sex at LSOA level.  Further technical details of how this index was 
computed are presented in Appendix 1. 
 
Figure 47 Matrix plot showing unadjusted trends in amenable mortality by age, sex and 
deprivation (fixed axes for comparisons across age groups) 
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Figure 48 Matrix plot showing unadjusted trends in amenable mortality by age, sex and 
deprivation (free axes for comparisons across deprivation groups) 
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Figure 49 Unadjusted national equity trends in amenable mortality 
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Figure 50 Adjusted national equity trends for amenable mortality  
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Figure 51 National social gradient in amenable mortality in 2011/12 
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Figure 52 Caterpillar plot of absolute gradient index of inequality in amenable 
mortality in 2011/12 at CCG level
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Figure 53 Scatter plots of CCG performance on amenable mortality 2011/12 against 
deprivation, showing both mean performance and equity performance (absolute 
gradient index)
 
 
Amenable mortality has fallen in all deprivation groups over time, with some sign of an 
accelerated decline from 2004/5 when the primary care pay for performance contract was 
implemented (see figure 50).  Once adjusted for age and sex, there is a clear reduction in 
absolute inequality but a clear rise in relative inequality.  The difference is due to the 
substantial declining trend in the mean over time.  Relative inequality is absolute inequality 
divided by the mean, and so the smaller the mean, the larger the relative inequality.  
Inequality appears highly pronounced between CCGs.  There is also a slight positive 
association between equity performance on amenable mortality and deprivation at CCG level, 
though this is much weaker than the association with average levels of amenable mortality.  
The caterpillar plot shows that rather few CCGs are statistically distinguishable from the 
national mean in terms of their absolute inequality performance on amenable mortality.   
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5.10 Overall mortality 
 
Overall all-age all-cause mortality refers to the number of deaths for all ages and all causes in 
a given year as a proportion of the total number of people alive at the start of the year. We 
use all-age all-cause mortality as a contextual indicator of inequality in health, to help 
interpret levels and trends in our seven healthcare equity indicators.  Change in this indicator 
over time may partly reflect change in NHS delivery, but will also reflect change in the 
socioeconomic patterning of risk factors and health behaviours due to wider social 
determinants of health outside the healthcare system. 
 
In the past, some international studies have used all-cause mortality to measure and compare 
the performance of healthcare systems.  For instance, the World Health Organization (WHO) 
has reported all-cause mortality rates to compare health outcomes across countries.
141
 
However, it is by now well established that healthcare is only one of many social 
determinants of health,
4
 and so any credible measure of the role of healthcare in tackling 
these wider health inequalities has to focus on indicators that are more directly sensitive to 
healthcare delivery. 
 
In the UK, the Office of National Statistics (ONS) produces annual statistics for all-cause 
mortality by age and sex groups.
142
 This provides an important indication of the overall 
mortality trend and provides the basis for exploring cause-specific mortality.
143
  A number of 
studies have explored socioeconomic inequalities in all-cause mortality. Studies conducted in 
high income countries, including the UK, found statistically significant evidence of higher 
rate of all-cause mortality in lower socioeconomic groups.
144
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148
  In the case of 
England, while population-level all-cause mortality rates have been decreasing, area-level 
deprivation is associated with higher rates of all-cause mortality.
149
 
 
This indicator measures the socioeconomic inequality between small area populations in all-
cause mortality rate. We define all-cause mortality as the number of deaths per 1,000 people 
from all causes at all ages. The numerator for this indicator is the number of deaths from any 
cause that occurred in a given year. The denominator is the total number of people alive at the 
start of a given year. The indicator was measured for years 2001/2 to 2011/12. Since the age 
and sex structure of each area can affect the mortality rate, using the crude mortality rate 
would be inappropriate. Hence, in line with the literature, we adjust the mortality rate by 
146 
taking account of the age and sex structure of the population. Further technical details of how 
this index was computed are presented in Appendix 1. 
 
Figure 54 Matrix plot showing unadjusted trends in overall mortality by age, sex and 
deprivation (fixed axes for comparisons across age groups) 
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Figure 55 Matrix plot showing unadjusted trends in overall mortality by age, sex and 
deprivation (free axes for comparisons across deprivation groups) 
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Figure 56 Unadjusted national equity trends in mortality 
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Figure 57 Adjusted national equity trends in mortality 
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Figure 58 National social gradient in mortality in 2011/12
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Figure 59 Caterpillar plot of absolute gradient index of inequality in mortality in 
2011/12 at CCG level
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Figure 60 Scatter plots of CCG performance on primary care quality in 2011/12 against 
deprivation, showing both mean performance and equity performance (absolute 
gradient index)
 
 
The trend in overall mortality is similar to that in amenable mortality, having fallen in all 
deprivation groups over time.  Once adjusted for age and sex, absolute inequality in overall 
mortality shows a rise during the early 2000s followed by a fall from 2008 onwards.  Relative 
inequality shows a similar pattern, except inequality merely flattens out from 2008 onwards – 
the difference between the two, as before, being the declining mean.  Inequality appears to be 
highly prominent between CCGs.  As with amenable mortality, there is a positive association 
between equity and deprivation at CCG level, though this is much weaker than the 
association between deprivation and average mortality. The caterpillar plot shows that very 
few CCGs are statistically distinguishable from the national mean in terms of their absolute 
inequality performance on overall mortality. 
 
153 
 
 
5.11 Summary of findings on local healthcare equity monitoring 
 
In 2011/12, in individual statistical comparisons at the 95% level, well over twenty percent of 
CCGs were found to perform significantly differently on equity than the national benchmark, 
including at least ten percent better and ten percent worse, using annual data for the following 
five general indicators: (1) Primary Care Supply, (2) Primary Care Quality, (3) Hospital 
Waiting Time, (4) Preventable Hospitalisation, and (5) Repeat Hospitalisation (see table 3).  
This was not possible for the remaining three indicators.  For indicator (6) Dying in Hospital, 
only eight percent of CCGs were significantly different from average – three percent worse 
and five percent better.  For indicator (7) Amenable Mortality, eleven percent were 
significantly different from average – eight percent worse and three percent better.  Finally, 
for indicator (8) Overall Mortality, seventeen percent were significantly different from the 
national average, but most of these were significantly worse – only three percent were 
significantly better.  Pooling additional years of data did not improve substantially the ability 
to detect significant differences. 
 
Note that our overall findings on the total number of CCGs differing from the national mean 
must be treated with appropriate caution, as we did not perform any statistical correction for 
multiple testing nor did we use statistical control limits to explore the normal range of 
variation in the slope index of inequality in order to distinguish “general-cause” variation 
from “special-cause” variation worthy of concern.150  Rather, we simply examine whether 
each individual CCG is statistically different from the national mean at the 95% level of 
statistical significance.  We might of course expect that up to 5% of CCGs might pass this 
test by chance, due to the normal “general-cause” variation, though not the 20% we observe.  
We leave the further refinement of our statistical methods for future research, as to our 
knowledge an appropriate statistical formula for setting control limits for social gradients has 
not previously been developed. 
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Table 3 Number and percentage of CCGs detected as performing significantly better or 
worse than the national benchmark for healthcare equity in 2011/12 
 
 
Indicator Worse Better Neither 
  
count percent count percent count percent 
1 Primary care supply 39 18% 41 19% 131 62% 
2 Primary care quality 60 28% 39 18% 112 53% 
3 Hospital waiting time 38 18% 21 10% 152 72% 
4 Preventable hospitalisation 45 21% 60 28% 106 50% 
5 Repeat hospitalisation 33 16% 36 17% 142 67% 
6 Dying in hospital 7 3% 10 5% 194 92% 
7 Amenable mortality 17 8% 6 3% 188 89% 
8 Overall mortality 29 14% 6 3% 176 83% 
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Chapter 6 Development of Equity Visualisation Tools 
 
6.1 Introduction 
 
We now turn from the data analytical “engine room” of our equity indicators to the 
communication and knowledge translation “front-end”.  This chapter describes how we 
developed visualisation tools for communicating our equity findings to decision makers and 
health experts.  We developed three main visualisation tools: 
 Equity dashboards – a one page summary for decision makers at national and local 
levels, including an interactive spreadsheet tool (based in Excel) that can display a 
dashboard for any CCG in England 
 Equity chartpacks – a standard set of slides with tables and graphs showing the 
underlying inequality patterns and trends in a common format for each indicator, 
including a PDF creating tool (based in the free statistical programming language, 
“R”) that can create a chartpack for any CCG in England 
 Equity custom graphs – a web based interactive chart tool (based in free software 
provided by Google) that allows the user to draw their own customised graphs and see 
how equity changes over time by selecting from a wide range of variables and chart 
styles 
 
A key objective of our study was to develop visualisation tools for presenting equity findings 
to decision makers and health experts in a clear, concise and informative manner.  Effective 
communication is essential if findings are to be used in practice to inform decision making.  
However, effective communication of findings about equity performance is more challenging 
than effective communication of findings about average performance, for two reasons.  First, 
inequality is a more complex concept than the average, since it depends in more complex 
ways on the underlying distributional patterns.  There are just three main ways of computing 
the average of a distribution (the mean, median and mode), whereas there are hundreds of 
different inequality indices reflecting different aspects of inequality – many of which of 
themselves have an infinite variety of sub-species based on one or more continuous input 
parameters.
151
  Second, conclusions about how far inequality is “unfair” or “equitable” 
involve controversial value judgements and empirical beliefs about the causes of inequality 
about which reasonable people can disagree. 
156 
 
One key role for our equity indicators is to facilitate external NHS scrutiny, as well as to 
facilitate internal NHS management.  In designing our visualisation tools, we therefore 
sought feedback from a range of intended decision making audiences including not only NHS 
commissioning organisations (i.e. NHS England and Clinical Commissioning Groups) but 
also organisations with key NHS scrutiny and oversight roles such as Public Health England 
and Health and Wellbeing Boards.  Our equity indicators are also intended for public 
reporting to enhance democratic accountability, and so we consulted the two lay members of 
our advisory group.  Developing “infographics” for public reporting requires specialised 
artistic and design skills beyond the skill set of our academic research team, and this was not 
part of the funding for the research grant.  In discussions with the lay members of our 
advisory group, we concluded that specialised work of this kind will indeed be necessary in 
future to communicate equity indicator, since members of the public who are unfamiliar with 
using statistics and graphs may struggle to understand our dashboards and chartpacks.  We 
therefore recommend future work to develop suitable “infographic” tools for public 
communication, which will require funding to pay for specialised media and artistic design 
skills. 
 
The development of our visualisation tools has benefited from comments from many different 
people, including those who participated in the following presentations and meetings to 
national and local NHS and public health audiences: 
 Presentations to our advisory group in November 2013, November 2014 and 
September 2015 (see membership in Appendix 5) 
 Teleconference meeting with experts from the Royal College of General Practitioners 
on our GP supply indicators, September 2014 
 Presentation to analysts at NHS England, Quarry House, Leeds, March 2015 
 Presentation to analysts at Public Health England, York, June 2015 
 Meeting with the Chair of Hull Clinical Commissioning Group, April 2015 
 Presentation to NHS and public health officials across the health system in York at 
Vale of York Clinical Commissioning Group, May 2015 
 Presentation to NHS and public health officials across the health system in Hull at 
Hull Clinical Commissioning Group, June 2015 
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 Meeting with the Chief Economist, Public Health England, York City Council, July 
2015 
 Meetings with the health inequalities lead of the Equality and Health Inequalities Unit 
on various occasions in 2015, including a meeting with other senior officials from 
NHS England, Leeds, July 2015 
 Meeting with analysts at Public Health England, Wellington House, October 2015 
 
We have also benefited from comments from health indicator experts from a range of 
disciplines, including those who participated in the following meetings: 
 Seminar at the Institute for Health Policy, Management and Evaluation, University of 
Toronto, Toronto, Canada, May 2015 
 Seminar at the Canadian Institute for Health Information, Ottawa, Canada, May 2015 
 Seminar at the WHO Collaborating Centre for Knowledge Translation and Health 
Technology Assessment in Health Equity, Ottawa, Canada, May 2015 
 Seminar at the Centre for Health Economics and Policy Analysis, McMaster 
University, Canada, May 2015 
 Conference talk at the Health Services Research Network Annual Conference, 
Nottingham, July 2015 
 Meeting with indicator experts at the Kings Fund, London, July 2015 
 Conference talk at the Society for Social Medicine Annual Scientific Meeting, 
Dublin, September 2015 
 Seminar presentation to the Partnership of Junior Health Analysts at the Health and 
Social Care Information Centre, Leeds, September 2015 
 Seminar presentation to City University School of Health Sciences Seminar Series, 
October 2015  
 Conference talk at ISPOR 18th Annual European Congress, Milan, November 2015 
 Seminar presentation to the Centre for Health Economics Seminar Series, University 
of York, November 2015 
 
The rest of this chapter describes the development of our three visualisation tools in turn. 
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6.2 Development of equity dashboards 
 
Our basic design strategy was to review existing dashboard tools for presenting health equity 
indicators in the form of a one page summary, as used by leading health organisations in the 
UK and internationally, to design our own tools by adapting an existing design that the 
research team felt would be helpful for our particular purposes, and then progressively to 
revise our design in the light of feedback from members of our intended audiences. 
 
The main dashboards that we considered were the Marmot Indicators for Local Authorities in 
England, the Yorkshire and Humber Public Health Observatory (YHPHO) Health 
Inequalities Dashboards, the WHO Handbook on Health Equity Monitoring, and the AHRQ 
State Quality Dashboards.  Of these, the research team concluded that the style of the Marmot 
Indicators was the most suitable for our purposes.  The YHPHO style packed a lot of 
information into a small space using “sparklines” and other compact graphing formats.  
However, we felt this was too compact and complex for decision makers as opposed to 
analysts.  The AHRQ style was the opposite extreme in being too simple for our purposes: a 
large dial in the middle of the page summarising overall performance across multiple 
indicators.  The WHO and Marmot styles lay somewhere between these two extremes.  
However, the WHO style did not include information about trends and levels on the same 
page, or any benchmarking information.  By contrast, the Marmot Indicators included 
information on both current levels and trends, on both average and equity performance, and a 
spine plot allowing comparisons between the local area and national or other equity 
benchmarks.  We therefore adopted the Marmot Indicator style as the basis for our dashboard.   
 
However, we made two major modifications to the dashboard design.  First, in response to 
feedback from decision makers about readability, we de-cluttered the dashboard and made it 
easier to read.  We reduced the space taken up by explanatory notes which take up the entire 
top half of the page in the Marmot Indicators.  To make more horizontal room, we created 
three-word summary titles for each of the indicators rather than using long descriptors.  We 
then put the explanatory notes and longer descriptors on a separate one page set of indicator 
notes to be read in conjunction with the dashboard.  We also enlarged the font size to 14 
points, enlarged the spine plot, and allowed larger margins around each cell in the table.  This 
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was done to give particular consideration to those who struggle to read text and numbers that 
are displayed in small font sizes or compact graphics. 
 
Our second major design modification was to add “traffic light” background colours to 
indicate good and bad performance, and arrows to indicate whether performance is getting 
better (an upward arrow) or worse (a downward arrow).  This was suggested to us by a 
number of decision making audiences as being a helpful way quickly to orientate users 
towards the key findings.  Arrows were suggested by the lay members of our advisory group, 
as being helpful for people who are colour blind.  We also received feedback that an upwards 
arrow will naturally be interpreted as “improving” equity performance, even though implies 
that inequality is reducing.  We experimented with a variety of colour schemes for the “traffic 
lights”; but the feedback was that standard red, amber and green colours were easier to 
interpret than other colour schemes. 
 
Using our modified Marmot Indicators dashboard style, we found that up to eight or nine 
indicators could comfortably fit on a single page in landscape orientation.  Two further 
important pieces of feedback from the decision makers we consulted are as follows. First, it is 
important to present information about average performance alongside equity performance.  
For example, when presenting information about socioeconomic inequality in preventable 
hospitalisation within a particular CCG, it is important also to present information about the 
mean level of preventable hospitalisation in that CCG compared with the England mean.  
This information helps to put the equity findings into context.  For example, good equity 
performance may be less impressive in a context of poor average performance; and 
deteriorating equity performance may be less worrying in a context of improving average 
performance in which all social groups are becoming better off.  Furthermore, decision 
makers want to know this information anyway, as in reality average performance is often 
more important to them than equity performance.  Second, it is important to present at least 
one equity finding in “real” units rather than rates or percentages – e.g. numbers of GPs, 
hospitalisations, deaths.  Non-specialists find it easier to understand “real” units than rates or 
percentages.  Furthermore, decision makers deal in “real” units on an everyday basis, and so 
presenting findings in real units helps them to understand both the scale of the equity problem 
and the scale of the required policy response.  We therefore developed an equity measure in 
real units, that we call the “inequity gap”, as described in Chapter 4: Methods.   
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We re-scaled proportions in ways that are (a) easy to read and understand but also (b) help to 
ensure a degree of consistency across indicators.  So for indicators with proportions larger 
than 0.01 we re-scaled in terms of percentages, whereas in other cases we used rates per 
1,000 population.  We also carefully considered the orientation for printing, in thinking about 
how the printed version would need flipping for easy reading, and we piloted the notes pages 
with various audiences to ensure they were clear. 
 
6.3 Development of equity chartpacks 
 
We developed a suite of four main graphs to provide in-depth information about the 
inequality patterns and trends underpinning our dashboards.  First, a “matrix graph” 
comprising a panel of line graphs presenting basic descriptive statistics on the indicator by 
age, sex, deprivation group and year.  Second, a scatter plot at decile group level to show the 
basic cross sectional shape of the social gradient in healthcare.  Third, a panel of line charts to 
show equity time trends.  Fourth, a caterpillar plot to show equity performance comparisons 
between local areas.  All four types of graphs are presented in Chapter 6, and the second, 
third and fourth types of graph are described in more detail in Chapter 4. 
 
For presenting basic descriptive statistics and time trends, we followed the standard practice 
in the health equity literature of presenting information on socioeconomic status using five 
quintile groups.  This is generally sufficient to capture the shape of the social gradient in 
healthcare, which is usually fairly linear – though with some important exceptions for some 
indicators in some years – and does not vary much within particular quintile groups.  
However, for showing the shape of the current social gradient we opted for decile groups, 
since we found that for some healthcare outcomes there were non-linear patterns that only 
became apparent within the top and bottom quintile groups. 
 
For the descriptive statistics, we designed a matrix plot comprised of a panel of time series 
line charts by age and deprivation group, with separate male and female lines on the line 
charts.  This enabled us to present all of this information on a single chart.  When we 
presented this to analysts we received positive feedback that this is a useful way of presenting 
a large amount of information in a small space, and that information on age-sex breakdowns 
is important for decision makers. 
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For the time trends, we used a panel of three line charts showing trends by deprivation 
quintile group on top, and then trends in two inequality indicators underneath.  We 
experimented with various ways of distinguishing the five quintile group lines using different 
colours, line widths, line styles, line shades and marker shapes.  In the light of feedback from 
decision makers and the lay members of our advisory group, we decided (1) not to over-
complicate the graph with multiple ways of distinguishing the lines and (2) to avoid use of 
colour in the chartpacks – partly due to the risk of political overtones, partly because people 
may be colour blind, and partly because some people may wish to print out the chartpacks in 
black and white.  We then arrived at a fairly simple system based on different shades of grey 
and marker shapes, though also a different line style for the three middle quintiles.  This 
system focuses attention on comparing the most and least deprived quintile groups, while 
allowing the reader to distinguish the middle three lines on closer inspection. 
 
For the equity performance charts, we opted for caterpillar plots rather than funnel plots.  
This was for two reasons. First, there is evidence that clinicians, patients and members of the 
public generally find caterpillar plots easier to understand.
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 Second, funnel plots are 
most useful when there is a relationship between volume (on the x axis) and outcome (on the 
y axis).  It is reasonable to expect a volume-outcome relationship in the case of outcomes 
such as hospital surgical mortality.  However, there is no reason to expect a relationship 
between the size of a local area and the extent of inequality; and indeed we observed no such 
relationship. 
 
When presenting the results to local decision makers, a common theme was that they would 
like to see scatterplots at neighbourhood level and practice level (1) so that they can identify 
which neighbourhoods and practices in their local area are performing well or badly, and (2) 
so they can get a clearer sense of the (substantial) variation in performance that is not driven 
by socioeconomic status.  However, we were unable to share data of this kind because it may 
risk disclosing individual level personal information where there are counts of events at 
neighbourhood level of less than five.  This is something that the NHS would need to 
consider carefully when producing these indicators – i.e. how to provide local decision 
makers with the information they require about individual GP practices and small area 
neighbourhoods, without compromising data security.  One partial solution, for example, may 
be to create “anonymised” local scatterplots by censoring counts below 5 and/or by adding a 
“jitter” to the scatterplot whereby each dot is given a small random perturbation. 
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6.4 Development of equity custom graphs 
 
We reviewed the purpose-built web-based tools that various large international and national 
organisations have created for allowing users to draw their own custom graphs, including The 
World Bank DataBank, the OECD Data Lab, the WHO Equity Monitor, the US Institute for 
Health Metrics and Evaluation, and the Public Health England public health profiles 
(http://fingertips.phe.org.uk).  We concluded that it would not be possible to replicate these 
tools within our limited resources.  Instead, we opted to use the freely available chart 
development software provided by google (https://developers.google.com/chart), which is 
based on the “gap minder” tool created by Hans Rosling for displaying inequality trends over 
time (http://www.gapminder.org). 
 
We created a prototype google chart tool for our two primary care indicators: primary care 
supply and primary care quality.  We did not add information on the other indicators since the 
purpose of this work was proof of concept rather than to create a fully comprehensive and up-
to-date tool.  Our prototype tool is available at http://health-inequalities.blogspot.co.uk.  The 
indicators are provided for the years 2004/5 to 2011/12 at the level of England and the four 
NHS Regions, though we did not publish indicators at lower levels due to risk that some of 
the information might be disclosive.  The tool includes a battery of equity measures at both 
quintile and decile group levels and a range of variables including individual clinical 
performance indicators for different types of primary care as well as the composite score.  
Feedback from analysts and decision makers who viewed our google graphs was uniformly 
positive, and people particularly liked the ability of this software to show how equity patterns 
changed over time. 
 
 
  
163 
Chapter 7 Prototype Equity Dashboards 
 
This chapter shows example “equity dashboards” for 2011/12.  These dashboards are 
designed to provide decision makers with concise summary information on all eight of our 
general indicators on a single page.  The dashboards provide information about overall NHS 
performance on the indicator, as well as equity performance, and about the one-year trend in 
performance since last year as well as current levels of performance. 
 
We present example dashboards (1) for England and (2) for one anonymous local clinical 
commissioning group called “Anytown CCG”.  In each case, we start by presenting the 
dashboard and indicator notes in two pages in landscape format, and then present notes on 
how to read the dashboard. 
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  National Indicator Notes   
  Indicator Definitions Inequality Measures   
  
1. Primary care supply: patients per full time equivalent GP, 
excluding registrars and retainers
a,b
 Slope Inequality Index (SII): 
This shows the gap between the most and least deprived 
neighbourhoods in England. 
  
  
2. Primary care quality: clinical performance in the quality and 
outcomes framework (weighted by public health impact) 
  
  
3. Hospital waiting time: days from outpatient decision-to-treat to 
inpatient admission-for-treatment
c
 A positive current SII implies "pro-rich" inequality favouring less 
deprived areas. 
 
A positive SII trend implies the mean SII is larger (more unequal) 
than the mean SII in the year before that. 
 
A clear overall inequality trend requires a statistically significant 
trend in the same direction for both the SII and the RII ("Relative 
Inequality Index") which is the SII divided by the mean. The SII 
and RII can move in different directions when the mean is 
changing. 
  
  
4. Preventable hospitalisation: proportion of people with an 
emergency admission for an ambulatory care sensitive condition
a
 
  
  
5. Repeat hospitalisation: proportion of inpatients with subsequent 
emergency readmission the same year
a
 
  
  
6. Dying in hospital: proportion of deaths in hospital   
  
7. Amenable mortality: proportion of people dying from causes 
considered amenable to health care
a
 
  
  8. Mortality: proportion of people dying from any cause
a
   
  
  
Not clear means that RII and SII trends are not significant or they 
move in different directions. 
  
  
a
 Adjusted for age and sex each year     
  
b 
Adjusted for neighbourhood ill-health in 2007 
 
  
  
c 
Adjusted for treating consultant specialty each year 
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Notes on how to read the national dashboard 
 
To understand the dashboard, it may be helpful to start by considering “preventable 
hospitalisation”, which is a classic indicator of healthcare outcome.  All of the other 
indicators of healthcare outcome (indicators 4 through 8) can be interpreted in a similar way.  
The “Average” columns show overall NHS performance on this indicator.  The current level 
is 5.84 preventable hospitalisations per 1,000 population and there is a downward trend since 
last year of -0.15.  This downward trend is coloured green meaning that health outcomes are 
getting better and that this is a statistically significant finding.  The “Equity” columns show 
equity performance on the Slope Index of Inequality (SII).  The current SII is 6.5 meaning 
that the most deprived neighbourhood in England has 6.5 more preventable hospitalisations 
than the least deprived, allowing for the gradient in between.  The SII trend is -0.10 which 
means that the SII is lower this year than last year i.e. inequality is getting better.  However, 
this box is coloured yellow meaning that this is not a statistically significant finding.  The 
overall equity trend arrow shows “not clear”, meaning that we cannot draw any clear 
conclusion about whether equity is getting better or worse.  Finally, the “Inequity Gap” 
shows that inequality in England is associated with 171,119 preventable hospitalisations. 
 
Now we turn to primary care supply, which is a classic indicator of healthcare access.  This 
has a similar interpretation, though there are two important differences from all the other 
indicators: the current SII is negative.  At face value, this could be interpreted as suggesting 
that there is “pro-poor” inequality i.e. deprived neighbourhoods have more GP supply relative 
to need than affluent neighbourhoods.  However, we do not draw this conclusion because we 
believe that our need adjustment under-estimates need in deprived neighbourhoods, as 
explained in Chapter 4: Methods and in Appendix A1: Indicator Definitions.  So we report 
the inequity gap as showing “no gap” rather than a negative gap.  All of the other columns 
can be interpreted in the same way as usual, however.  So the average level of performance is 
1,687 patients per GP, with a significant negative trend in red of 17.5 – showing that the 
number of patients per GP increased by 17.5 since last year.  And the trend is -100.78 and in 
green, showing that the SII fell significantly by 100 patients per GP since last year.  We 
interpret this as a beneficial reduction in pro-rich inequality, rather than a harmful increase in 
pro-poor inequality, because we believe that need in deprived areas is under-estimated.  
However, assessments of need always rely on value judgements as well as empirical facts, 
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and so we present the current negative SII so that decision makers can draw their own 
conclusions based on their own value judgements about need. 
 
Finally, we turn to primary care quality, which is different from all the other indicators in that 
it presents an attainment measure (more is better) rather than a shortfall measure (more is 
worse).  This only influences the interpretation of average performance, however, since we 
have inverted the SII to ensure that a positive value means “pro-rich” inequality as with the 
other indicators.  So average performance is 77.4%, and the positive trend of 0.58 percentage 
points is coloured in green – an increase in quality means that overall performance is getting 
better; unlike all the other indicators in which an increase means overall performance is 
getting worse.  Whereas the positive SII of 1.45 means that the most affluent neighbourhood 
has 1.45 percentage points more quality than the most deprived neighbourhood, allowing for 
the gradient in between.  And the negative trend of -0.34 coloured green means that the SII 
fell significantly since last year by 0.34 percentage points.  Finally, the overall equity trend 
arrow is pointing upwards, showing that equity is getting better.  This means that the relative 
index of inequality (RII) must have increased significantly since last year, as well as the SII. 
 
We now turn to the example local dashboard. 
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  National Indicator Notes   
  Indicator Definitions Inequality Measures   
  
1. Primary care supply: patients per full time equivalent GP, 
excluding registrars and retainers
a,b
 
The Deprived Population shows how many people in this CCG 
live in one of England's most deprived fifth of areas (with % of the 
CCG population in brackets). 
 
Equity Performance is the Slope Inequality Index (SII):  
the gap between the most and least deprived areas in England.  
A positive SII implies "pro-rich" inequality. 
 
 
 
 
 
The black diamond shows this CCG's SII with 95% CI.   
The vertical black line shows the SII for England. 
 
A clear overall equity trend requires a statistically significant 
trend in the same direction for both the SII and the RII ("Relative 
Inequality Index"): the SII divided by the mean. 
 
  
  
2. Primary care quality: clinical performance in the quality and 
outcomes framework (weighted by public health impact) 
  
  
3. Hospital waiting time: days from outpatient decision-to-treat to 
inpatient admission-for-treatment
c
 
  
  
4. Preventable hospitalisation: proportion of people with an 
emergency admission for an ambulatory care sensitive condition
a
 
  
  
5. Repeat hospitalisation: proportion of inpatients with subsequent 
emergency readmission the same year
a
 
  
  
6. Dying in hospital: proportion of deaths in hospital   
  
7. Amenable mortality: proportion of people dying from causes 
considered amenable to health care
a
 
  
  
8. Mortality: proportion of people dying from any cause
a
   
  
a
 Adjusted for age and sex each year 
b 
Adjusted for neighbourhood ill-health in 2007 
c 
Adjusted for treating consultant specialty each year 
The Inequity Gap shows the gap between this CCG and the 
England average, in terms of "real" units of improvement needed 
within its deprived population (e.g. hiring more GPs, preventing 
more deaths).  'No gap' means the deprived population in this CCG 
is already doing better than the England average. 
  
              
 
England 
Worst Best 
CCG 
(95% CI) 
25th 
percentile 
75th 
percentile 
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Notes on how to read the local equity dashboard 
 
Let us start, as before, with preventable hospitalisation.  The “Average” column shows 
overall performance for the CCG and England as a whole.  This CCG has 5.89 
hospitalisations per 1,000, which is slightly higher (worse) than the England average of 5.84.  
However, this is coloured yellow and so is not significant.  The spine plot shows that 
preventable hospitalisation is not significantly different from the England average – the 
confidence intervals overlap with the central spine representing the England average.  There 
is no overall equity trend.  Finally, the inequity gap is 693, showing that socioeconomic 
inequality is associated with 693 excess preventable hospitalisations in this CCG area. 
 
Now turning to primary care supply, the “Average” column shows that this CCG has 
significantly worse supply than the England average – 1,974 patients per GP compared with 
an England average of 1,687.  The spine plot, however, shows that this CCG is doing 
significantly better than the England average on equity in primary care supply – the point 
estimate is comfortably in the green zone to the left, and the confidence intervals do not 
overlap the England average spine.  
Finally, turning to primary care quality, this CCG has slightly but significantly worse primary 
care quality than the England average: an average of 76.4% compared to 77.4%.  
Furthermore, this CCG is doing significantly worse than the national average on equity in 
primary care quality – the point estimate is in the red zone to the right, and the confidence 
interval does not overlap the England spine. 
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Chapter 8 Discussion 
 
8.1 Summary of findings 
 
In this study, we have developed health equity indicators to help the English NHS discharge 
its duty to consider reducing inequalities in healthcare access and outcomes.  We have 
developed new methods for local NHS equity monitoring against a national NHS equity 
benchmark.  We have illustrated these methods by applying them to clinical commissioning 
groups in the year 2011/12, though they could also readily be applied to local authorities or 
other geographical areas comprising more than 100,000 people.  We have also developed a 
framework for monitoring national NHS indicators of equity at all main stages of the patient 
pathway.  This framework goes beyond the existing inequalities breakdowns in the NHS 
Outcomes Framework by including indicators of access as well as outcomes.  By producing 
these indicators from 2001/2 to 2011/12, we have provided the first comprehensive 
assessment of healthcare equity trends during a key period of sustained effort by the NHS to 
reduce health inequalities through primary care strengthening.  Finally, and importantly, we 
have developed a suite of visualisation tools for communicating equity indicator findings to 
national and local decision makers – including “equity dashboards” providing a one-page 
summary of both overall and equity performance on multiple indicators, and “equity 
chartpacks” providing more detailed information.  Clear communication is essential in this 
controversial area, as inequality is a complex concept and so headline statistics are even more 
liable than usual to be misleading when taken out of context. 
 
Our equity indicators and visualisation tools were selected and designed in consultation with 
a range of expert stakeholders, including NHS and public health officials at national and local 
levels and health indicator experts from a variety of disciplinary backgrounds.  We also 
consulted members of the public, because one of the main purposes of our indicators is public 
reporting for democratic accountability, as well as facilitating quality improvement efforts by 
national and local decision makers.  Members of the public were involved through a public 
consultation exercise in York, based on an on-line survey and a one day citizens’ panel 
meeting, and the two lay members of our advisory group. 
 
The main findings are summarised below under three headings:  
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(1) National equity findings in 2011/12 
(2) National trends during the 2000s 
(3) Local equity findings in 2011/12. 
 
National equity findings in 2011/12 
Our study presents the first comprehensive national picture of inequality in healthcare access 
and outcomes in the NHS.  Our findings for 2011/12 are summarised below, and a one page 
tabular summary is also provided in Chapter 7 the form of a prototype national “NHS equity 
dashboard”. 
 
 There was no evidence of “pro-rich” inequality in primary care supply. Deprived 
neighbourhoods had slightly more GPs relative to measured need than less deprived 
neighbourhoods.  However, the Carr-Hill formula may under-estimate need in deprived 
areas so there may still be some “pro-rich” inequality that we are unable to measure until 
more accurate and up-to-date measures of need for GP supply become available. 
 
 There was a small amount of “pro-rich” inequality in primary care quality, with an 
estimated gap of 1.45 percentage points (confidence interval 1.37 to 1.53) in population 
achievement of primary care quality between the most and least deprived neighbourhood 
in England. 
 
 There was a small amount of “pro-rich” inequality in overall inpatient hospital waiting 
time, with an estimated gap of 2.29 days waiting (confidence interval 1.95 to 2.62) 
between the most and least deprived neighbourhood in England. 
 
 There was substantial “pro-rich” inequality in preventable emergency hospitalisation, 
with an estimated gap of 6.50 hospitalisations per 1,000 (confidence interval 6.40 to 6.59) 
between the most and least deprived neighbourhood in England.  This implies a relative 
inequality gap of 111% of the national average hospitalisation rate, and that deprivation 
was associated with an inequity gap of 171,119 excess preventable hospitalisations in 
England (168,574 to 173,663). 
 
 There was substantial “pro-rich” inequality in repeat emergency hospitalisation, with an 
estimated gap of 6.97 percentage points of people hospitalised (confidence interval 6.85 
to 7.09) between the most and least deprived neighbourhood in England.  This implies a 
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relative inequality gap of 48% of the national average hospitalisation rate, and that 
deprivation was associated with an inequity gap of 289,140 excess repeat hospitalisations 
in England (284,192 to 294,089). 
 
 There was substantial “pro-rich” inequality in dying in hospital, with an estimated gap of 
5.95 percentage points of people dying in hospital (confidence interval 5.26 to 6.63) 
between the most and least deprived neighbourhood in England.  This implies a relative 
inequality gap of 14% of the national average hospitalisation rate, and that deprivation 
was associated with an inequity gap of 13,593 people in England dying in hospital rather 
than other settings (12,023 to 15,162). 
 
 There was substantial “pro-rich” inequality in mortality amenable to healthcare, with an 
estimated gap of 1.56 amenable deaths per 1,000 (confidence interval 1.50 to 1.62) 
between the most and least deprived neighbourhood in England.  This implies a relative 
inequality gap of 61% of the national average amenable mortality rate, and that 
deprivation was associated with an inequity gap of 41,123 excess amenable deaths in 
England (39,624 to 42,622). 
 
 There was substantial “pro-rich” inequality in overall mortality, with an estimated gap of 
5.17 deaths per 1,000 (confidence interval 5.03 to 5.31) between the most and least 
deprived neighbourhood in England.  This implies a relative inequality gap of 60% of the 
national average mortality rate, and that deprivation was associated with an inequity gap 
of 135,996 excess deaths in England (132,302 to 139,691). 
 
The observed inequalities in preventable hospitalisation, repeat hospitalisation and mortality 
amenable to healthcare are large.  However, as discussed in Chapter 1, this is partly because 
we were unable to adjust these healthcare outcomes for neighbourhood level morbidity and 
other risk factors outside the control of the NHS.  Our figures for inequality in healthcare 
outcomes thus over-estimate the extent of “pro-rich” inequity for which the NHS can be held 
accountable.  Although the NHS can be held responsible for reducing inequalities in these 
outcomes, it cannot be held responsible for completely eliminating them. 
 
Our healthcare outcome figures are adjusted for age and sex, however.  Age and sex are both 
observable risk factors largely outside NHS control.  The social patterning of births, deaths 
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and migration may partly be driven by NHS factors – for example, if NHS actions help to 
reduce circulatory death rates more rapidly in more deprived populations.  However, we 
believe that the age and sex adjusted figures are more useful for NHS purposes than the 
unadjusted figures, since changes in demographic structure are mainly driven by non-NHS 
factors.  This point is also relevant below when we consider national trends during the 2000s.  
As explained below, we focus on the age and sex adjusted trends, in order to hold the NHS to 
account for changes due to NHS action rather than changes due to demographic trends 
outside NHS control. 
 
National trends during the 2000s 
Below we provide a brief summary of the national trends in all the age and sex adjusted 
indicators that were presented in detail in Chapter 5, including trends in both average 
performance and equity performance. 
 
Average trends 
During the 2000s, health care access and outcomes improved for all socioeconomic groups on 
all indicators except repeat hospitalisation (as explained below).  The indicator series for 
primary care supply and quality (indicators 1 and 2) started in 2004/5 and continued until 
2011/12.  Average levels of primary care supply improved from 2004/5 until 2006/7 and 
remained stable thereafter.  Average levels of population achieved primary care quality 
continued rising throughout the period, though there were breaks in the data series in several 
years due to changes in data availability on exception reporting and indicator definitions (as 
explained in Chapter 5: Results and Appendix A1: Indicator Definitions).  All other indicator 
series started in 2001/2 and continued until 2011/12.  For waiting time (indicator 3), 
preventable hospitalisation (indicator 4) and overall mortality (indicator 8) the improvements 
began after 2003/4, following slight deteriorations the previous two years.  Waiting times fell 
dramatically until 2008/9 but rose slightly thereafter.  Preventable hospitalisation and overall 
mortality continued falling to the last observed year, 2011/12, though the decline in overall 
mortality slowed in the two years after 2009/10.  For dying in hospital (indicator 6), average 
improvements began from 2005/6 and continued throughout the period to 2011/12.  For 
amenable mortality (indicator 7) the improvements began from 2001/2 and continued 
throughout the period to 2011/12.  However, the pace of improvement picked up from 2003/4 
onwards for the most deprived two fifths of neighbourhoods. 
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In a striking exception to the general trend of improving outcomes, however, repeat 
hospitalisation (indicator 5) gradually increased in all socioeconomic groups from 2001/2 to 
the end of the period in 2011/12.  This may partly reflect an increase in premature discharges 
from hospital, as hospitals reduced length of stay in the 2000s in response to financial 
incentives and waiting time targets.
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  It may also reflect hospital payment reforms that gave 
hospitals financial incentives to increase emergency admissions.  And, especially towards the 
end of the 2000s, it may reflect reductions in social care supply and quality due to financial 
pressures on local authorities.  However, it is possible that this also reflects (i) increased 
morbidity in patients admitted for emergency inpatient treatment, due to people surviving 
longer with multiple chronic conditions, causing an increase in post-hospital adverse events 
and (ii) reduced post-hospital mortality, causing an increase in the proportion of post-hospital 
adverse events leading to re-admission rather than death.  So the increase in average levels of 
repeat hospitalisation may partly be a consequence of success in reducing mortality, rather 
than a signal of failure to improve the quality of co-ordinated primary, secondary and social 
care after emergency hospital admission. 
 
Equity trends 
For four of the eight indicators (primary care supply and quality, preventable hospitalisation 
and amenable mortality) there were significant and sustained reductions in absolute 
socioeconomic inequalities.  This began after 2003/4 for indicators 4 and 7 and was observed 
from the start of the series in 2004/5 for indicators 1 and 2.  For primary care supply and 
quality, socioeconomic inequalities decreased substantially in both absolute and relative 
terms, and measurable inequality was virtually eliminated by 2010/11.  Absolute inequality in 
preventable hospitalisation and amenable mortality rose from 2001/2 to 2003/4 but then 
gradually fell thereafter all the way to 2011/12.  This was a smooth fall for amenable 
mortality, but there was some year-on-year volatility around the underlying trend for 
preventable hospitalisation.  However, for both preventable hospitalisation and amenable 
mortality the reduction in absolute inequality did not translate into a reduction in relative 
inequality as a proportion of the mean, because the mean was also falling. 
 
The unadjusted trends in preventable hospitalisation and amenable mortality prior to 
adjustment for age and sex showed a larger reduction in absolute inequality, that was 
sufficiently large to translate into a reduction in relative inequality.  However, as noted in 
Chapter 5 this difference is due to demographic change during the 2000s – affluent areas 
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experienced population aging, whereas deprived areas experienced an influx of younger 
people.  We therefore prefer the age-sex adjusted figures, on the basis that demographic shifts 
are largely exogenous factors beyond the control of the NHS.  A counter-argument, however, 
is that it is possible NHS activities may have had some small influence on these demographic 
patterns by influencing socioeconomic trends in births, deaths and migration.  So we present 
both sets of figures, adjusted and unadjusted, so that readers can draw their own conclusions. 
 
Hospital waiting time showed a slightly “pro-poor” pattern for most of the period, with a 
negative slope index in 2001/2 that fell even further to 2003/4 but rose thereafter and 
ultimately became slightly “pro-rich” in 2011/12.  In 2003/4, at its most “pro-poor” point, the 
slope index fell to minus 5 days indicating that people in the most deprived neighbourhood 
were waiting on average up to 5 days less than people in the least deprived neighbourhood.  
There was no reduction in either absolute or relative inequality in dying in hospital, despite 
the reduction in average levels from 2005/6 onwards.  For repeat hospitalisation, both 
absolute and relative inequality steadily increased from 2001/2 to 2011/12.  Finally, for 
overall mortality there was no sustained pattern of decline in the absolute inequality gap from 
2003/4, in contrast to amenable mortality.  Rather, there were statistically significant one-off 
changes from 2005/6 to 2006/7 (an increase) and between 2008/9 and 2009/10 (a reduction).  
In terms of relative inequality, however, overall mortality showed a sustained increase from 
2001/2 to 2006/7 which stabilised thereafter, which is a similar pattern to amenable mortality. 
 
Local equity findings in 2011/12 
In 2011/12, it was possible to detect well over twenty percent of CCGs performing either 
significantly better or worse on equity than the national benchmark, including at least ten 
percent in each category, using annual data for the following five general indicators: (1) 
Primary Care Supply, (2) Primary Care Quality, (3) Hospital Waiting Time, (4) Preventable 
Hospitalisation, and (5) Repeat Hospitalisation.  This was not possible for the remaining three 
indicators.  For indicator (6) Dying in Hospital, only eight percent of CCGs were 
significantly different from average – three percent worse and five percent better.  For 
indicator (7) Amenable Mortality, eleven percent were significantly different from average – 
eight percent worse and three percent better.  Finally, for indicator (8) Overall Mortality, 
seventeen percent were significantly different from the national average, but most of these 
were significantly worse – only three percent were significantly better.  Pooling additional 
years of data did not improve substantially the ability to detect significant differences. 
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8.2 Strengths and weaknesses of the study 
 
Strengths 
We selected our health equity indicators and visualisation tools in consultation with members 
of the public, NHS and public health officials, and health equity experts from a range of 
disciplines.  We measured inequality at multiple stages of the patient pathway, including 
inequality in both healthcare access and healthcare outcomes.  We constructed 
comprehensive indicators spanning the entire range of activities of the healthcare system, as 
well as condition-specific indicators that only provide information about inequality in one 
particular disease area.  We developed the first methods for local equity monitoring against a 
national equity benchmark, and we provided the first comprehensive assessment of national 
trends in socioeconomic inequality in healthcare and outcomes during the 2000s.  We also 
developed a comprehensive new suite of visualisation tools for communicating health equity 
findings to decision makers.  Our equity indicator methods and visualisation tools are 
flexible, allowing different indicators to be incorporated and monitoring to be performed at 
different geographical levels that may be more appropriate for addressing particular aspects 
of variation in healthcare access and outcomes.
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  Our approach is also generalisable beyond 
the English NHS, since it can be applied to other countries with well-developed 
administrative health datasets and our methods for monitoring local equity against a national 
benchmark can in principle be applied to other public services.  With the exception of 
hospital waiting time and repeat hospitalisation, we used standard, well validated indicators 
that are already used for monitoring overall health care performance in England and other 
high income countries.  We used data on the entire population of England, including 
workload and quality data on virtually all primary care practices in England and outcomes 
data on virtually all individuals in England.  We structured these data in a consistent, 
longitudinal format that permits inequality comparisons over time and between indicators.  
We used inequality measures based on the entire socioeconomic gradient across all 32,482 
small areas of England, rather than gaps or ratios between two arbitrarily selected parts of the 
distribution such as the top and bottom fifth. We examined inequality in both absolute and 
relative terms, because absolute and relative inequality can change in opposite directions 
when the mean is changing over time.
157
  One of our measures – the relative index of 
inequality – can also be compared between indicators measured on different scales to help 
assess the relative magnitude of different kinds of inequality. 
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Weaknesses 
Our study does not include data on privately funded healthcare, which make up just over 15% 
of total health expenditure in the UK.
158
  We also lack detailed national data on changing 
patterns of multi-morbidity at small area level, and how multiple morbidity and disadvantage 
combine to generate additional healthcare needs.
159
  One consequence is that our study may 
under-estimate additional needs for primary care in deprived neighbourhoods, which are 
likely to suffer from a greater burden of multi-morbidity.
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  Another consequence is that, like 
all previous studies, we cannot disentangle how far observed national trends in preventable 
hospitalisation and amenable mortality are due to national trends in multi-morbidity outside 
the control of the NHS.  We therefore recommend the development of small area level 
measures of multi-morbidity as a research priority for the NHS, to enable more informative 
monitoring of healthcare outcomes and more accurate targeting of healthcare resources to 
meet healthcare needs.  Another limitation is that the administrative health datasets we use do 
not contain information on individual socioeconomic characteristics. We therefore used the 
index of multiple deprivation, a well-established method of assigning socioeconomic 
characteristics based on neighbourhood of residence. This method rests on the assumption 
that individuals conform to the socioeconomic profile of their residential neighbourhood, 
which is of course not always the case. However, the small areas we use are relatively small 
and homogeneous in size – around 1,500 people each with a minimum of around 1,000 and 
maximum of around 3,000 – and so our measurements are more accurate than those possible 
using the postcode geographies available in some other countries.  In general, use of larger 
geographical areas tends to find shallower socioeconomic gradients in health and healthcare, 
since population average differences in income and social advantage are diluted by the use of 
larger and more socioeconomically heterogeneous populations.  Finally, our measure of 
primary care quality is based on indicators drawn from the UK primary care pay-for-
performance scheme which only captures a limited part of clinical practice.
161
  Under this 
scheme improvements in quality were most rapid in practices with low baseline performance, 
and these practices were concentrated in more deprived areas.
162
  It is possible that aspects of 
primary care quality that were not financially incentivised and monitored did not follow the 
same pattern, and inequalities in these may have persisted or even widened.  A final 
limitation is the flip side of one of the strengths of our study, which is our use of general 
indicators that span the entire range of healthcare activity and thereby paint an overall picture 
of NHS equity performance.  A limitation of indicators of this kind, of course, is that they 
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cover a heterogeneous range of activities and so may mask differential patterns between 
different specialties and disease areas.  A final weakness is that we were unable to control for 
small area level variations in the supply and quality of social care.  At least two of our 
healthcare outcome indicators are likely to be sensitive to social care supply and quality 
outside the control of the NHS, as well as the quality of co-ordinated care for which 
healthcare staff are partly responsible.  Unfortunately data on social care supply and quality 
are not currently available at small area level, in striking contrast to the detailed 
neighbourhood statistics available for healthcare and other public services. 
 
8.3 Comparison with other studies 
 
Primary care supply 
Two previous national studies have examined variation in primary care supply between large 
administrative areas of England. Gravelle and Sutton
163
 found substantial and persistent 
between area variation in physician supply between 1975 and 1995. Goddard and 
colleagues
71
 extended this time series by adding the years 1996 to 2006 and found that 
variation between administrative areas increased between 1995 and 2006. Our results agree 
with these previous studies showing large and widening pro-rich inequalities up until 2006/7, 
after which we see this trend reverse with inequalities narrowing over the remainder of our 
study period, by the end of which we observe pro-poor inequality in need adjusted primary 
care supply. While the previous studies examined overall variation between large and 
socioeconomically diverse administrative areas, our study adds value by looking specifically 
at socioeconomic-related inequality between small areas.  We are able accurately to attribute 
GP supply to small areas, based on the location of patients registered to each GP practice, and 
so can paint a much more fine-grained picture of the socioeconomic distribution of the 
primary care workforce than has previously been possible. 
 
Primary care quality 
One previous national study examined trends in socioeconomic inequality in primary care 
process quality from the UK pay-for-performance programme.
162
  This study only covers the 
first three years of our eight year study period (2004/5 to 2006/7) but agrees with our findings 
of reductions in socioeconomic inequality. We find that this reduction in inequality continued 
but slowed down thereafter and levelled off from 2010/11 to 2011/12. 
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Waiting time 
Most previous studies of inequality in waiting time have used disease-specific indicators 
focusing on particular specialties or procedures, rather than general indicators covering the 
whole range of hospital activity which are then adjusted for disease-specific differences in 
waiting times.  To our knowledge, the only other previous study using a general indicator was 
a cross sectional study using individual level data on men aged 67 and over from Norway in 
2004/5, which found very little evidence of socioeconomic differences in waiting time after 
adjusting for all primary and secondary diagnoses, severity and hospital supply.
164
  By 
contrast, previous disease-specific studies have generally found pro-rich inequality in waiting 
time for publicly funded inpatient hospital treatment in a range of high income countries with 
universal health systems.
165, 166
  Previous disease-specific studies have also found a trend of 
reducing socioeconomic inequality in the English NHS during the 2000s, for a handful of 
common non-emergency hospital procedures such as hip replacement, knee replacement 
cataract, heart bypass and coronary angioplasty.
166, 167
  Our findings using a general waiting 
time indicator are thus diametrically opposed to previous findings using disease-specific 
waiting time indicators.  Our indicator did adjust for differences in waiting times between 
specialties, though not for within-specialty differences between procedures or disease 
categories.  The disease-specific studies are more reliable, since they focus cleanly on a fairly 
homogeneous procedure and some of them also include controls for waiting time 
prioritisation by severity (the number and type of diagnoses) and for cross sectional 
differences in hospital supply (hospital fixed effects).  However, the disease-specific studies 
are more vulnerable to selection bias because they have only examined a selected handful of 
specific hospital procedures which may not be representative of waiting time differentials 
across all areas of hospital activity.  Both types of study are also subject to selection bias 
relating to the decision to seek privately funded care, which is partly motivated by the desire 
to gain a shorter waiting time than publicly funded NHS care.  
 
Preventable hospitalisation 
One previous national study examined socioeconomic inequality in preventable 
hospitalisation in England covering years 2001/2 to 2012/13.
168
  This study found similar 
trends to those we observe, showing a gradual decrease in the rate of chronic ambulatory care 
sensitive emergency admissions for the average patient and substantial and persistent 
socioeconomic inequalities in ambulatory care sensitive emergency admissions over the 
period. 
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Repeat hospitalisation 
To our knowledge, no previous study has examined socioeconomic inequality in repeat 
emergency hospitalisation within the same year, or time trends therein.  However, many 
disease-specific studies of 30-day emergency re-admission rates have used socioeconomic 
status as a control variable in regressions performed for purposes other than measuring 
socioeconomic inequality.  These studies have consistently found substantial and significant 
cross sectional associations between socioeconomic status and 30-day emergency re-
admission following both emergency and non-emergency hospitalisation.
169, 170
  The selection 
of an appropriate duration for this indicator illustrates a tension between capturing the quality 
of co-ordinated care across different primary and acute care providers over a long time 
period, versus pinpointing precisely at which point on the patient pathway inequality arises – 
i.e. which primary or acute service provider is responsible for generating inequality at what 
point in time. 
 
Dying in hospital 
Previous cross sectional studies have found socioeconomic inequalities in dying in hospital, 
and interpreted this as an indicator of differences in the quality of end-of-life care.
171
  To our 
knowledge, however, no previous study has examined trends in these socioeconomic 
inequalities over time. 
 
Amenable mortality 
One previous national study examined socioeconomic trends in amenable mortality
172
 in 
England from 2001/2 to 2011/12.  However, this study was conducted at a large area level 
(324 local authorities) which may potentially mask changing patterns of inequality within 
these large areas, and it excluded mortality in people aged over 75.  This study found both 
average levels and absolute measures of inequality in amenable mortality to have fallen over 
this period. Our finer grained analysis looking at much smaller areas (32,482 LSOAs) and 
including amenable mortality in those over 75 years of age confirms this basic pattern, 
though reveals a widening of relative inequality that was not apparent in the previous study.  
Furthermore, our inclusion of this older section of the population results in a higher overall 
rate of amenable mortality and the more detailed level of analysis we employ reveals wider 
socioeconomic inequalities. 
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Overall mortality 
Numerous studies have found socioeconomic inequality in overall mortality and life 
expectancy in low, middle and high income countries.
32, 173, 174
  Previous studies have found 
reductions in absolute socioeconomic inequality in overall mortality in England in the 
2000s
175
 and reductions in both absolute and relative inequality in life expectancy.
176
   This is 
all in line with our findings.  The reason that relative inequality in life expectancy and 
mortality moved in different directions during the 2000s is that the means of these two 
variables were moving in different directions.  Mortality is a shortfall measure (more is 
worse) which is falling over time, whereas life expectancy is an attainment measure (more is 
better) which is rising over time.
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8.4 Implications for clinicians and policymakers 
 
The 2000s was a period of sustained large-scale expenditure growth in the English NHS
178
 
during which tackling health inequality was a high priority for the NHS.
35, 174, 179
  As has been 
documented in previous studies, this decade saw substantial increases in overall NHS 
capacity and utilisation, and the average patient experienced significant improvements in 
healthcare access, quality and outcomes.
180
  Our study shows that the NHS also succeeded in 
achieving substantial reductions in inequality in primary care supply and quality from 2004/5 
to 2011/12.  By 2010/11, measured pro-rich inequity in primary care supply relative to need 
had been eliminated and measured pro-rich inequity in primary care quality had been nearly 
eliminated.  Plausibly, these changes can partly be attributed to the substantial investments in 
primary care in the mid to late 2000s, including the pay-for-performance programme from 
2004/5 and the additional funding for new GP practices in “under-doctored” areas of the 
country in the form of the Equitable Access to Primary Medical Care programme announced 
in 2006.
162, 181
  However, these two measures are imperfect and so we cannot conclude there 
is no remaining important pro-rich inequality in primary care supply and quality.  There may 
remain a degree of pro-rich inequity in primary care supply, because the Carr-Hill formula 
only allows for morbidity but does not examine how multiple morbidity and disadvantage 
combine to generate additional healthcare needs.  So the Carr-Hill formula is likely to under-
estimate need in deprived neighbourhoods.  There may also remain a degree of pro-rich 
inequality in primary care quality because QOF indicators do not capture all important 
aspects of primary care quality. 
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The NHS also succeeded in making small reductions in absolute socioeconomic inequalities 
in healthcare outcomes from 2003/4 to 2011/12.  Absolute inequalities in preventable 
hospitalisation and amenable mortality decreased from 2003/4 to 2011/12, and the rate of 
increase in relative inequalities slowed from the mid 2000s, but substantial inequalities 
remained in 2011/12.   
 
Although small, the observed reductions in absolute inequality in healthcare outcomes during 
the 2000s are real and impressive for two reasons.  First, there is some evidence of widening 
socioeconomic inequalities during the 2000s in the clustering of smoking, poor diet, physical 
inactivity and other unhealthy behaviours among lower socioeconomic groups.
58
  This would 
have made it more difficult to reduce absolute inequality in both preventable hospitalisation 
and amenable mortality.  Second, there were no comparable reductions in absolute 
socioeconomic inequality in non-amenable mortality during the period.  This makes it 
plausible to attribute the reductions to the sustained improvements in health care access and 
quality that occurred in the 2000s, rather than to wider trends in the social determinants of 
health outside the control of healthcare services.  It is hard to be certain about the causality, 
however, given that this is an observational study without a control group.  Furthermore, 
there is uncertainty about how long it takes for improvements in health care delivery to feed 
through into reductions in preventable hospitalisation and amenable mortality.  It is 
reasonable to expect some short term impact within a year or two,
77
 though the length of lag 
is likely to vary by disease and type of intervention – for example, reductions in mortality due 
to improved management of heart disease and diabetes may be more rapid than reductions 
due to earlier diagnosis and referral for suspected cancer. 
 
It may not be surprising that the reductions in absolute inequality in healthcare outcomes 
were small, given what is already known about the social determinants of health and the role 
of healthcare as just one input into the production of health.
7, 8, 32, 33
  Socioeconomic 
inequalities in healthcare outcomes are not only due to inequalities of access to healthcare, 
but also to socioeconomic-related differences in morbidity, patient self-care and lifestyle 
behaviour, home and work environments, social care and other public services that impact on 
health.
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Our study therefore provides further confirmation that reducing inequality in healthcare 
outcomes is more complex and challenging than reducing inequality of access to 
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healthcare.
183
  Further reductions in socioeconomic inequalities in healthcare outcomes are 
likely to require complex interventions to improve the co-ordination of care between 
specialties, between primary and acute care settings, and between healthcare and social care 
providers.  There is a growing body of evidence about effective interventions to reduce 
preventable hospitalisation and amenable mortality.
168, 183-186
  Effective interventions may 
tend to reduce inequalities, if they disproportionately benefit “high need service users” in the 
more deprived end of the socioeconomic spectrum who are most in need of co-ordinated care.  
On the other hand, effective interventions may increase inequalities if they rely heavily on 
changing people’s self-care and lifestyle behaviour and if individuals in deprived 
neighbourhoods are less likely to change their behaviour.
187
  Unfortunately, however, 
evidence about the impacts of interventions on socioeconomic healthcare outcomes is limited.  
So further research is needed including rigorous evaluation of interventions designed to 
improve the co-ordination of care between primary care, secondary care and social care 
providers.  The indicators developed in this study can be used to facilitate evaluations of this 
kind, and to help develop the evidence base for reducing inequalities in healthcare outcomes 
through equity monitoring and quality improvement work at local, national and international 
levels. 
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Chapter 9 Conclusion and Research Recommendations 
 
9.1 Main conclusions 
 
We draw together our main conclusions below in this section, before turning to technical 
conclusions and recommendations for further research in the next two sections.  The overall 
research question of our study was: “Can changes in the socioeconomic patterning of health 
care utilisation and outcomes provide useful indicators of change in NHS equity 
performance?”  Our overall conclusion is: “Yes”.  We elaborate below, with the following 
more specific conclusions: 
1. NHS actions can have measurable impacts on socioeconomic inequality in both 
healthcare access and healthcare outcomes 
2. Expanding the primary care workforce and paying for quality may have small impacts 
on reducing inequality in healthcare outcomes, but further reductions will require new 
approaches and improved co-ordination between different service providers 
3. Local NHS equity monitoring against a national NHS equity benchmark can produce 
useful findings both to help managers improve quality and to enhance democratic 
accountability 
4. Currently, the most useful indicators for local NHS equity monitoring are primary 
care supply, primary care quality and preventable hospitalisation 
5. National NHS monitoring of change over time in NHS equity can usefully be done 
using a much wider range of indicators of healthcare access and outcomes, including 
disease-specific indicators 
6. Equity indicators are more useful to decision makers if they are presented together on 
the same page, alongside average performance indicators, and accompanied by graphs 
showing the underlying inequality patterns 
7. Variants on our equity indicators could be used for international comparisons of 
equity in healthcare and for evaluating the impacts of interventions on equity in 
healthcare 
 
 NHS actions can have measurable impacts on socioeconomic inequality in both 
healthcare access and healthcare outcomes 
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Prior to this study, there was good evidence that the introduction of universal health care – 
and, in particular, universal primary care – can help to reduce socioeconomic inequality in 
both healthcare access and outcomes.
9, 14
  However, it was less clear whether further actions 
taken by a universal health system such as the NHS can have a further measurable impact on 
either increasing or reducing socioeconomic inequality in healthcare access and outcomes.
36, 
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  Our study shows that by strengthening its primary care system in the 2000s, the NHS 
achieved substantial reductions in socioeconomic inequality in healthcare access (primary 
care supply and quality) along with real though modest reductions in absolute inequality in 
healthcare outcomes (preventable hospitalisation and amenable mortality). 
 
 Expanding the primary care workforce and paying for quality may have small 
impacts on reducing inequality in healthcare outcomes, but further reductions will 
require new approaches including improved co-ordination between different service 
providers 
Along with the substantial reductions in socioeconomic inequality of access to primary care 
between 2004 and 2011, we also found small reductions in absolute inequality in preventable 
hospitalisation and amenable mortality, and a slowdown in the increase in relative inequality.  
However, substantial socioeconomic inequalities in healthcare outcomes persist, despite the 
investments in healthcare made in the 2000s.  This partly reflects socioeconomic inequalities 
in morbidity and multi-morbidity that are beyond the control of the NHS.  Although we risk 
adjusted our healthcare outcomes for age and sex, we were unable additionally to adjust for 
morbidity due to lack of comprehensive individual level data on age and morbidity covering 
all individuals in England.  However, inequalities in health care outcomes also reflect 
socioeconomic differences in patient and provider behaviour, informal social support, and the 
use of formal social care and public services.  There is evidence that improved co-ordination 
of financing, planning and delivery between different services – for instance, between 
primary, secondary and community care providers, between specialties, and between health 
and non-health services – can help to reduce average levels of preventable hospitalisation and 
amenable mortality.
184, 191
  Although there is limited evidence about health equity impacts, 
and the impacts may go in either direction, it is plausible that some forms of improved care 
co-ordination – perhaps especially those that do not rely too heavily on patient behaviour 
change – may deliver larger absolute reductions in more deprived neighbourhoods with 
higher rates of preventable hospitalisation and mortality.  Furthermore, some behaviour 
change interventions can have small but important effects.  The NHS can influence both 
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provider and patient behaviour in various ways, including behavioural public policies or 
“nudges”192, such as effective ways of reminding people about appointments and encouraging 
them to take up preventive care; workforce training for service providers on how to deal with 
people who have different styles of communicating; and changes in the location and timing of 
service provision.
193
  However, evidence about the inequality impacts of interventions is 
limited and further research is needed. 
 
 Local NHS equity monitoring against a national NHS equity benchmark can 
produce useful findings both to help managers improve quality and to enhance 
democratic accountability 
Local equity monitoring is capable of detecting areas that are performing significantly better 
or worse than the national average at any geographical level containing populations greater 
than around 100,000 people, including Clinical Commissioning Group, Local Authority and 
Accountable Care Organisation.  In principle, local equity monitoring can be done using all 
five of the following general healthcare equity indicators: (1) Primary Care Supply, (2) 
Primary Care Quality, (3) Hospital Waiting Time, (4) Preventable Hospitalisation, and (5) 
Repeat Hospitalisation.  All of these indicators – or variants based on the same underlying 
data sources – could be produced annually, based on data collected during the financial year, 
and updated within six months of the end of the financial year.  The following general 
indicators are less useful for local NHS equity monitoring purposes: (6) Dying In Hospital, 
(7) Amenable Mortality and (8) Overall Mortality.   This is mainly because these indicators 
are less able robustly to identify local areas performing significantly better and worse than the 
national average, but also because they require use of ONS mortality data and so would suffer 
from data lags of around 15 months. 
 
 Currently, the most useful indicators for local NHS equity monitoring are primary 
care supply, primary care quality and preventable hospitalisation 
Indicator production and communication is costly, both in terms of money and scarce 
analytical capacity, and so the NHS will need to set priorities for indicator production.  We 
recommend three of our indicators as a high priority for local NHS monitoring against a 
national NHS benchmark: (1) Primary Care Supply, (2) Primary Care Quality and (4) 
Preventable Hospitalisation.  We recommend all three of these indicators because (i) they all 
capture important but distinct general elements of health care access and outcomes, (ii) NHS 
policy makers and managers have a reasonable understanding of what actions they can take to 
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shift these indicators, and (iii) they are all based on well validated technical indicator 
definitions.  Hospital waiting time and repeat hospitalisation also meet these first two criteria, 
and our public consultation exercise established that socioeconomic inequality in waiting 
time was of particular concern to members of the public.  However, these indicators are less 
well validated than the others and so we recommend further work to validate and refine these 
two indicators before using them for routine monitoring purposes. 
 
 National NHS monitoring of change over time in NHS equity can usefully be done 
using a much wider range of indicators of healthcare access and outcomes, including 
disease-specific indicators 
National monitoring of change over time in healthcare equity can be performed using all of 
the indicators we have developed, including the eight general indicators described in the main 
report and the six disease-specific indicators for coronary heart disease and diabetes 
described in Appendices A2 and A3.  Further general and disease-specific indicators can also 
be constructed for national monitoring, including indicators in the NHS Outcomes 
Framework.  However, most of these indicators cannot be used for local equity monitoring 
because small numbers of events at local level mean that performance in almost all local 
areas is statistically indistinguishable from the national average. 
 
 Indicators of equity are more useful to decision makers if they are presented 
together on the same page, alongside information about average NHS performance, 
and accompanied by graphs showing the underlying inequality patterns 
During our extensive piloting work with NHS and public health officials at national and local 
levels, and the equity experts on our advisory group, we learned three main lessons about 
effective ways of communicating health equity indicators to decision makers.  First, that 
equity indicators are more useful to decision makers, and likely to have more impact, if they 
can be summarised in the form of a single one-page “dashboard”.  A dashboard approach 
allows comparisons between multiple indicators of healthcare access and outcome at different 
stages of the patient pathway.  Furthermore, it also focuses attention on a small number of 
key indicators and reduces the risk of equity information getting buried in a “blizzard” of 
indicators.  This is important, since in reality equity objectives will always tend to have lower 
priority for healthcare managers than balancing the books and delivering high quality care for 
the average patient.  We found that that up to eight equity indicators can comfortably fit on a 
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single page or screen, but that beyond that the text becomes too small for comfortable 
reading.  Second, that equity indicators need to be accompanied by information on average 
NHS performance, so that decision makers can put equity findings into context.  For 
example, increasing inequality may be less worrying in a context of improving average 
performance in which all social groups are becoming better off.  Third, equity indicators need 
to be accompanied by graphs that reveal the underlying inequality patterns and trends over 
time.  Health equity is a complex concept, and headline equity statistics presented in isolation 
can be misleading.  So before drawing conclusions and taking action to remedy apparent 
problems, decision makers need to understand what is going on behind the headline statistics.  
We found that graphs using five deprivation quintile groups are generally sufficient to 
capture the main inequality time trends of interest, but that ten deprivation decile groups are 
more useful for presenting the basic cross sectional inequality gradient since the gradient in 
adverse healthcare outcomes often starts to become steeper within the most deprived tail of 
the social distribution. 
 
 Variants on our equity indicators could be used for international comparisons of 
equity in healthcare and for evaluating the impacts of interventions on equity in 
healthcare 
Variants on all of our indicators could be produced in Scotland, Wales and Northern Ireland, 
which have similar health information infrastructures to England including quality and 
outcomes framework data on primary care quality.  Variants on at least three of our general 
indicators of inequality in healthcare outcomes – (1) Primary Care Supply, (4) Preventable 
Hospitalisation and (5) Repeat Hospitalisation – could also be produced in other countries 
with comprehensive data on primary care supply and hospital activity linked to small area or 
individual level measures of socioeconomic status.  Crude versions of our indicators could 
also be produced in countries with comprehensive national data on hospital activity linked to 
large area deprivation measures, although these are less accurate than the small area level 
measures of deprivation available in England.  Our indicators can also be used to facilitate 
evaluation of the equity impacts of interventions through quasi-experimental studies of both 
national and local interventions.  Little is known about the equity impacts of interventions, 
and different studies use different equity metrics.  Our indicators can facilitate the 
incorporating of equity impacts into experimental and quasi-experimental studies, and may 
even help to improve the comparability of equity impact findings between different studies 
by providing a common set of metrics for equity evaluation studies. 
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9.2 Technical conclusions about equity indicator production and communication 
 
In this section, we draw technical conclusions about appropriate analytical methods for 
producing and communicating equity indicators.  Some of our conclusions apply to equity 
indicator methods used in any country, though some relate to the specific kinds of data 
available in England – for example, conclusions about how often it would be feasible to 
produce and report particular equity indicators given current data release cycles in England. 
 
 Visualisation: as well as producing a headline equity statistic (e.g. the slope index of 
inequality), we recommend visualising inequality levels and trends by producing 
“equity chartpacks” that include cross sectional scatter plots showing the shape of 
the social gradient, time trend line plots showing recent change in the social 
gradient, matrix plots showing the breakdown of equity patterns by age and sex 
group, and caterpillar plots showing how equity in your area compares with equity 
in other areas and against the national benchmark 
Equity is a complex concept that cannot be captured by any single summary statistic such as a 
slope index of inequality.  It is therefore essential to visualise the inequality patterns to give 
decision makers a clear understanding of what is going on underneath the headline findings.  
We have developed a suite of equity visualisation tools that we believe provide all the 
necessary underpinning information in a concise and easy-to-read format. 
 
 Periodicity and indicator year: we recommend updating both national and local 
equity indicators on an annual basis, based on the financial year 
Because the socioeconomic patterning of healthcare does not change rapidly there is limited 
value in updating equity indicators more frequently than once a year – though in principle 
half yearly or even quarterly updating can be performed for national equity indicators based 
on hospital data i.e. (3) Hospital Waiting Time, (4) Preventable Hospitalisation and (5) 
Repeat Hospitalisation.  The databases for different indicators become available at different 
points in the year, are based on data collected at different points in the year, and suffer from 
different data lags.  However, we recommend the financial year as the most appropriate 
indicator year, since (a) NHS budgeting and planning mechanisms operate to the financial 
year and (b) using the same indicator year facilitates comparisons between indicator findings.  
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The financial year is also the most appropriate period for Indicators 1 and 2 (primary care 
supply and quality) since the workforce census is taken in September each year, in the middle 
of the financial year, and QOF data are collected at the end of March relating to the previous 
financial year.  Indicators 3-5 can be produced for any indicator year, since the required 
hospital record data becomes available to NHS analysts via the SUS service within a few 
months.  If the indicators were to be produced by academic analysts using HES data, rather 
than NHS analysts using SUS data, they would also find the financial year convenient since 
HES is released by financial year.  However, indicators 6-8 require ONS mortality data which 
are typically released in early November for the previous calendar year.  Since the data lag 
for these indicators is already at least a year, it may be sensible to base these indicators on the 
calendar year rather than increasing the data lag to two years or more.   
 
 Data lags: it should be possible to release updated indicators for the previous 
financial year in autumn or spring each year 
The primary care workforce data required for indicator 1 are usually published in March 
relating to the previous September, so in principle this indicator could be produced and 
released by the summer.  However, indicators 3-5 based on hospital data for the previous 
financial year could not be released until the autumn.  This is because there would be a few 
months delay in the hospital data for the financial year becoming available, and further delays 
in data access and data analysis.  QOF data and ONS mortality data are generally released at 
the end of October.  So, allowing a few months delay for data access and data analysis, the 
earliest that indicators 2, 6, 7 and 8 could be released is spring.  This implies a data lag of 6 
months from the end of the financial year for indicators 1, 3, 4 and 5; a data lag of 9-12 
months from the end of the financial year for indicator 2; and a data lag of 15 months from 
the end of the calendar year for indicators 6, 7 and 8. 
 
 Inequality measures: we recommend using the slope index of inequality as the 
primary headline measure, supplemented by a battery of further measures including 
at least one relative measure such as the relative index of inequality and ideally both 
a relative shortfall measure and a relative attainment measure 
Measuring inequality is essentially a matter of boiling down a many-valued distribution of 
observations (in this case, more than 32,000 neighbourhoods) into a single number.
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  This 
can be done in numerous different ways, and there is no “one-size-fits-all” summary measure 
of inequality since different measures emphasise different aspects of a complex shape.  As a 
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primary equity measure we favour the slope index of inequality because it is both (i) fairly 
easy to understand and (ii) summarises the whole social gradient rather than arbitrarily 
focusing on two groups – such as the top and bottom fifth, or the bottom and middle fifth, or 
any other essentially arbitrary choice of two groups.  The slope index can be interpreted as 
the estimated gap between most and least deprived neighbourhood in England, allowing for 
the gradient in between.  However, this is an absolute measure and so needs to be 
supplemented with at least one relative measure, since absolute and relative inequality often 
move in different directions when the mean is changing.
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  Ideally, we also recommend 
presenting a further battery of inequality indices including (1) a relative attainment index as 
well as a relative shortfall index, and (2) a range of extreme group measures including the 
absolute and relative gap between top and bottom fifth, between the bottom and middle fifth, 
and between the top and middle fifth.  It is worth checking relative attainment as well as 
relative shortfall, since they can also move in different directions when the mean is changing 
– for instance, inequality in mortality (a shortfall concept) may be falling while inequality in 
survival (an attainment concept) is rising.
177, 196
  However, for indicators based on adverse 
events such as hospitalisation and mortality, it is only possible to do this when indicators are 
based on the proportion of people experiencing one or more events, rather than the rate of 
events including multiple events experienced by the same person.  This is because a 
proportion has an upper bound and so can be inverted between shortfall (the proportion 
experiencing the adverse event) and attainment (the proportion not experiencing the adverse 
event).  By contrast, an event rate has no non-arbitrary upper bound and so it is only possible 
to compute a shortfall measure.  Finally, it is worth presenting extreme group measures 
because these are the simplest possible way of presenting information on equity to members 
of the public and can be understood clearly and fully without any prior training in statistics.  
The slope index cannot be fully understood without delving into the meaning of the caveat 
“allowing for the gradient in between”, which in turn requires an understanding of linear 
regression modelling. 
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9.3 Recommendations for further research 
 
We list our recommendations for further research below. 
 
1. To investigate potential explanations for variation in healthcare equity performance 
between local NHS areas, so that healthcare managers can learn quality improvement 
lessons 
2. To perform experimental and quasi-experimental evaluations of the impacts of 
complex interventions on socioeconomic inequalities in healthcare access and 
outcomes, including interventions to improve system-wide co-ordination between 
different specialties, healthcare settings and public services 
3. To make international healthcare equity comparisons using these indicators of 
healthcare access and outcomes 
4. To develop better measures of small area level need for primary care, by investigating 
how multiple morbidity and disadvantage combine to generate additional healthcare 
needs 
5. To develop convincing methods for risk adjusting small area level healthcare 
outcomes for exogenous morbidity factors beyond the control of healthcare services 
6. To develop methods for monitoring other social dimensions of healthcare inequality 
7. To improve these indicator methods by refining and adding indicators, decomposing 
national inequality into between-area and within area components, and exploring the 
use of statistical process control methods, direct standardisation methods and non-
linear functional forms 
8. To develop sources of small area level data on the supply, utilisation, quality and 
outcomes of public and private social care and other goods and services that may 
influence healthcare outcomes.   
 
 To investigate potential explanations for variation in healthcare equity performance 
between local NHS areas, so that healthcare managers can learn quality 
improvement lessons.  If and when detailed and up-to-date local monitoring of health 
care equity commences, there will be a valuable opportunity for quality improvement 
research involving in-depth investigation of the potential explanations for variations in 
quality performance at local levels.  The aim of this research would be to understand why 
some areas do well and others badly in reducing social gradients in health care access and 
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outcomes compared with the national average.  The findings of this quality improvement 
research could then be used to help develop and implement best practice guidance that 
will help health care and local authority managers in local areas to deliver measurable 
reductions in healthcare inequalities. 
 
 To perform experimental and quasi-experimental evaluations of the impacts of 
complex interventions on socioeconomic inequalities in healthcare access and 
outcomes, including interventions to improve system-wide co-ordination between 
different specialties, healthcare settings and public services.  Rigorous evaluation 
studies using experimental or quasi-experimental designs are needed to gather robust 
evidence on the impacts of complex interventions on inequalities in health care access 
and outcomes.
197, 198
  This will need to include careful analysis of contextual factors and 
interactions, and careful analysis of causal pathways – including investigation of the 
causal links between inequality in healthcare access and outcomes at different points on 
the patient pathway.  This should include evaluation of complex interventions designed to 
improve care for people with multiple conditions by improving co-ordination between 
primary, secondary and social care settings, and between specialties, since these are likely 
to be of particular importance in achieving further reductions in inequalities in healthcare 
outcomes.  The findings of this research will help guide NHS policymakers in developing 
and implementing national and regional policies for tackling health care inequalities.  
 
 To make international healthcare equity comparisons using these indicators of 
healthcare access and outcomes.  Further research is needed to develop international 
comparisons and benchmarks for both national and local health care equity improvement 
efforts.  This can be done by producing some of our equity indicators in other high 
income countries with well developed health datasets linked to small area deprivation, 
such as Scotland, Wales, Northern Ireland, Canada and the Nordic countries.  
International comparisons of this kind will allow a step-change in public transparency 
about NHS performance on health care equity by providing a non-parochial assessment.  
They will also help the NHS to learn equity improvement lessons from other countries, 
both to find “win-win” interventions that simultaneously improve equity and average 
performance and also to identify potential trade-offs between equity objectives and other 
policy objectives. 
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 To develop better measures of small area level need for primary care, by 
investigating how multiple morbidity and disadvantage combine to generate 
additional healthcare needs.  The Carr-Hill workload adjustment for primary care need 
fails to allow for multi-morbidity and is now rather outdated, since it is based on data 
from the early 2000s.  Research is needed to develop more up-to-date need adjustments, 
which take account of how multiple morbidity and disadvantage combine to generate 
additional healthcare needs.  This research would help to inform the future development 
of geographical resource allocation formulae as well as being useful for monitoring and 
evaluation purposes. 
 
 To develop convincing methods for risk adjusting small area level healthcare 
outcomes for exogenous morbidity factors beyond the control of healthcare services.  
Further research is needed to find ways of risk adjusting health care outcome indicators 
for ill-health as well as age and sex.  For local equity monitoring, this will require 
individual level data on age, sex and ill-health for everyone in the country.  Perhaps the 
most promising suggestion is to use multi-morbidity from hospital records, as discussed 
at the end of Chapter Three: Indicator Selection.  Another suggestion is to use all-
cause mortality, although for local equity monitoring this would require a three to five 
year moving average due to small numbers of deaths at LSOA level.  A final suggestion 
is to develop an indicator of multi-morbidity using a patient level primary care dataset, 
such as CPRD, and then seek to roll this out on a national basis as and when patient level 
primary care datasets become available covering the whole of England.  This is a 
complex area, however, since the NHS can to some extent cause changes in morbidity 
through preventive care.  Ideally, since the aim is to adjust for “exogenous” risks that are 
not under the control of the health care system, one would only want to adjust for changes 
in morbidity risks that are not caused by healthcare. 
 
 To develop methods for monitoring other social dimensions of healthcare inequality.  
Policymakers and the public may be concerned with other kinds of social inequality in 
healthcare access and outcomes, including inequalities by ethnicity, age, sex, 
geographical location and host of other social variables – including variables with both 
health and social aspects such as mental health and disability.  In principle, our basic 
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small area level methods can readily be applied to ethnicity, which can be measured at 
neighbourhood level, though there are complications in particular the fact that ethnicity is 
not an ordered variable and so does not lend itself to the use of slope index methods.  
 
 To improve these indicator methods by refining and adding indicators, decomposing 
national inequality into between-area and within area components, and exploring 
the use of statistical process control methods, direct standardisation methods and 
non-linear functional forms.  Further research is needed to decompose national 
healthcare inequality into its component parts.  In principle, the national slope index of 
inequality can be expressed as a weighted average of the between-area and within-area 
slopes.  Decomposing the index in this way could be a useful way of disentangling the 
role of decisions about geographical resource allocation between different clinical 
commissioning groups and local authorities (which influences the between-area slope) 
versus within-area actions by particular clinical commissioning groups and local 
authorities.  Research is also needed to find ways of analysing and communicating 
information on the substantial variation at small area and practice level that is not related 
to small area deprivation, and comparing this to deprivation-related inequality.  This 
would be of particular value for indicators 1 and 2, since much of the non-deprivation-
related variation is likely to be systematic, and to persist over time, and so may reflect 
unfair inequality of policy concern.  Further research is also needed to explore ways of 
assessing the normal range of variation in local inequality indices, using statistical 
process control theory.  Research is also needed to explore ways of using direct 
standardisation for age and sex in equity indicator production, and the pros and cons 
compared with our indirect standardisation approach.  One advantage of direct 
standardisation is reduced computational burden and delay.  However, a disadvantage is 
that this will lose granularity at local level by requiring aggregation of data to larger 
population sizes, such as decile groups of small areas, to improve stability.  At national 
level, the slope index of inequality could then be estimated by using decile group level 
regression and simulating confidence intervals based on the estimated standard error 
around each decile group point, along the lines of an approach that Public Health England 
are considering for their indicators of public health inequality.  Further modification of 
decile regression with simulated confidence intervals would be required at local level, 
however, where fewer than ten national decile groups may be represented in the data.  
Finally, research is needed to explore the implications of non-linear functional forms for 
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computing slope indices of inequality, including the value judgements underpinning such 
approaches as well as the model fit and comparative sensitivity to change in healthcare 
access and outcomes and different parts of the socioeconomic spectrum. 
 
 To develop sources of small area level data on the supply, utilisation, quality and 
outcomes of public and private social care and other goods and services that may 
influence healthcare outcomes.  Healthcare outcomes are influenced by public, private 
and informal social care, and by other social determinants of health including the 
consumption of a wide range of market goods and public services that impact upon 
individual resilience and ability to recover from episodes of illness.  Improvements in the 
social care data infrastructure will greatly facilitate research in this area, in helping to 
tease out the causal pathways leading to healthcare outcomes and to help disentangle the 
role of social care and healthcare factors.  Since a substantial proportion of social care is 
privately funded and/or informally provided within the household, it will be important to 
develop data sources that include privately funded and informally provided care.  And 
since a wide range of other market goods and public services also impact upon healthcare 
outcomes it will be important to develop data sources on these as well. 
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Appendix 1 Indicator Definitions 
 
A1.1 Primary care supply 
 
Definition: 
Primary care supply is defined as the number of patients per full time equivalent (FTE) 
GP, excluding registrars and retainers, adjusted for age, sex and neighbourhood ill-health 
using the Carr-Hill workload adjustment. The numerator is the ONS estimate of the total 
resident population at the mid-point of the current calendar year, which includes the 
homeless and people living in institutions such as care homes, prisons and barracks.  The 
denominator is the number of FTE GPs excluding registrars and retainers attributed to 
each small area in the current indicator year. 
 
Technical details: 
Our data on primary care supply at GP practice level were obtained from the annual 
National Health Service General and Personal Medical Services workforce census, taken 
at 30
th
 September each year, midway through the financial year. In keeping with standard 
measures of the GP workforce, we exclude GP registrars and GP retainers from our 
measure. 
 
We used this data to construct whole-population national data sets at small area (LSOA) 
level by using the NHS Attribution Data Set of GP-registered populations to attribute 
FTE GPs from GP practices to LSOAs. The attribution dataset details the LSOAs in 
which the patients registered with the practice live. We use this information to determine 
the proportion of the FTE GP workforce attached to the practice to attribute to each of the 
LSOAs that the patients registered with the practice live in. Applying this attribution 
calculation to each GP practice and then aggregating the GP supply attributed from the 
different practices at LSOA level gives us our measure of primary care supply at LSOA 
level. We linked practice level data on primary care supply for the ten years 2004/05 
through 2011/12 with corresponding LSOA  level data on population and deprivation. We 
used data from all 9,092 general practices in the English NHS that were open for at least 
one year of the study period.  
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We then need-weighted the population for each small area for age, sex and IMD 2010 
health domain using the Carr-Hill formula workload adjustment (updated 2007 version, 
see Table 4 below).  This adjustment upscales populations that are expected to require 
more primary care and downscales populations expected to require less.
199, 200
  The Carr-
Hill formula is used for distributing funding to GP practices.  The version of the formula 
we use was recommended in 2007 by the Formula Review Group established by NHS 
Employers and the BMA, and though never implemented in practice it remains the most 
authoritative and up-to-date analysis of the determinants of primary care workload in 
England.  We do not adjust for temporary resident population, the fourth and final 
workload adjustment factor in the Carr-Hill formula, as the HSCIC were unable to 
provide us with the patient level data necessary to make this adjustment. 
 
An alternative would have been to use GP practice registered populations as the 
population numerator, rather than ONS estimates of resident population.  However, we 
did not do this for the sake of consistency with the other indicators.  We have chosen to 
use ONS mid-year population estimates for all our indicators, due to concern about GP 
practice list inflation.  This occurs, for example, when people leave an area without 
telling their local GP, and means that GP registers tend to over-estimate the total 
population. 
 
We believe that the Carr-Hill formula under-estimates additional need for primary care 
supply in deprived areas.  This is because it only allows for morbidity and not also for 
how multiple morbidity and disadvantage combine to generate additional healthcare 
needs. 
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Table 4 Component weights for the calculation of patient level overall workload weights 
Age-Sex weight Registration status weight IMD Health Domain 
score weight 
Band Weight Band  Weight Weight 
Male 0-4 years 2.354 Registered 
with practice 
for 12 months+ 
 
 
Registered 
with  practice 
in last 12 
months 
 
1.000 
 
 
 
 
1.689 
 
The weight is 
calculated as:  
 
1.054 to the power of 
the IMD Health 
Domain score 
associated with the 
patients postcode 
Male 5-14 years 1.000 
Male 15-44 years 0.913 
Male 45-64 years 1.373 
Male 65-74 years 2.531 
Male 75-84 years 3.254 
Male 85+ 3.193 
  
Female 0-4 years 2.241 
Female 5-14 years 1.030 
Female 15-44 years 1.885 
Female 45-64 years 2.115 
Female 65-74 years 2.820 
Female 75-84 years 3.301 
Female 85+ 3.090 
Source: Formula Review Group. Review of the General Medical Services global sum 
formula. London: NHS Employers and BMA, 2007. 
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A1.2 Primary care quality 
 
Definition: 
Primary care quality is a score between 0 and 100 defined as a weighted average clinical 
process quality score in terms of population achievement for 16 indicators in the national 
quality and outcomes framework (QOF). Each indicator measures the percentage of the 
relevant patient population for whom the quality target is achieved. The weights used to 
combine these indicators into a primary care quality score are proportional to importance 
of the individual indicators in terms of the estimated mortality reduction impact 
associated with improvement on the indicator. 
 
Technical details: 
The list of indicators is reported in table 5 below.  This list includes some “intermediate 
outcomes”, such as measures of blood pressure and glucose control, as well as “pure” 
clinical process quality indicators such as the proportion of patients with CHD receiving 
beta blockers. 
 
We measure “population achievement” on each clinical indicator.  The denominator is the 
number of patients diagnosed with the relevant condition, and the numerator is the 
number of patients for whom the indicator was met.  This is typically lower than 
“reported achievement”, which excludes from the denominator all patients declared as 
“exceptions” by the practice.  Population achievement is a more exacting target than 
reported achievement, and arguably provides a more consistent standard across different 
practices since some practices may engage in “gaming” of their exception reporting 
statistics in order to report higher achievement and thereby receive greater income.
201
 
202
  
However, in sensitivity analysis we also examined “reported achievement”. 
 
We started with a group of 20 QOF indicators identified by Ashworth and colleagues
83
 
based on available evidence on mortality reduction. We then selected 16 out of the 20 
indicators for which data were available throughout our period of analysis in a consistent 
format. Each indicator was then weighted based on importance in terms of the estimated 
number of lives saved per 100,000 patients. These weights were derived from Ashworth 
and colleagues who identified the highest level of evidence for risk reduction in all-cause 
217 
mortality and converted risk reduction estimates into estimated mortality reduction rates 
per 100,000 population per annum (see table 5 below for details). 
 
Numerators and denominators for the QOF indicators were attributed from GP practice to 
LSOA level in an identical manner to that used to attribute primary care supply as 
described above. The QOF indicators were then calculated at LSOA level and these were 
then combined using the weighting process described to give average performance in 
terms of primary care quality score at LSOA level. 
 
We do not need to risk adjust this indicator, since it is a nationally comparable quality 
measure that already allows for case mix by focusing only on the patient population 
diagnosed with the relevant condition. We do not additionally adjust for age and sex, on 
the basis of the value judgement that age and sex are not legitimate justifications for poor 
quality care. 
 
Table 5 List of conditions in the Quality and Outcomes Framework (QOF) 
QOF 
indicator 
Summary description of 
indicator 
Crude prevalence 
per 100,000 
registered patients, 
mean (SD) 
Annual mortality 
reduction, per 
100,000 registered 
patients 
DM18 Diabetes: influenza 
vaccination 
4420 (1881) 63.7 
CHD12 CHD: influenza vaccination 3448 (1487) 61.6 
BP5a Hypertension: BP ≤150/90 
mmHg 
13 548 (5117) 48.2 
CHD10a CHD: beta-blocker 
treatment 
3448 (1487) 45.9 
STROKE10 Stroke/TIA: influenza 
vaccination 
1649 (967) 28.1 
DM23a Diabetes: HbA1c ≤7.0% 4420 (1881) 26.5 
COPD8 COPD: influenza 
vaccination 
1626 (958) 24.9 
CHD9a CHD: aspirin or other 3448 (1487) 24.8 
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QOF 
indicator 
Summary description of 
indicator 
Crude prevalence 
per 100,000 
registered patients, 
mean (SD) 
Annual mortality 
reduction, per 
100,000 registered 
patients 
antithrombotic therapy 
CHD8a CHD: cholesterol ≤5.0 
mmol/l 
3448 (1487) 15.8 
STROKE12a Stroke (non-haemorrhagic): 
aspirin or other 
antithrombotic therapy 
1080 (649) 15.8 
DM12 Diabetes: BP ≤145/85 
mmHg 
4420 (1881) 13.5 
CHD6a CHD: BP ≤150/90 mmHg 3448 (1487) 11.3 
SMOKING4 CHD, stroke/TIA, 
hypertension, DM, CKD, 
COPD, asthma, psychosis: 
smoking cessation advice 
3903 (2525) 10.9 
DM25 Diabetes: HbA1c ≤9.0% 4420 (1881) 7.4 
DM15a Diabetes with proteinuria or 
microalbuminuria: ACEI or 
ARB therapy 
505 (513) 3.4 
CHD11a CHD (myocardial 
infarction): ACEI or ARB 
therapy 
572 (291) 1.5 
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A1.3 Hospital Waiting Time 
 
Definition: 
Hospital waiting time is defined as the mean number of days waited from outpatient 
decision-to-treat to inpatient admission-for-treatment.  This can be termed the “inpatient 
waiting time”, to distinguish it from the “outpatient waiting time” (from GP referral to 
specialist visit) and the “referral-to-treatment” waiting time (from GP referral to inpatient 
admission).  We allow for differences in waiting times by specialty by adjusting for the 
main speciality of the treating consultant.  We do not additionally allow for age and sex, 
on the basis of the value judgement that in most cases age and sex are not a legitimate 
justification for making people wait longer for needed treatment. Unlike most indicators, 
this is a mean rather than a ratio and so there is no numerator or denominator. 
 
Technical details: 
This indicator measures the number of days waited from outpatient referral to inpatient 
admission per person hospitalised during the indicator year. We exclude “planned” 
admissions for which waiting is medically appropriate rather than being due to research 
constraints – for example, due to regular chemotherapy cycle or the planned removal of 
an internal fixation after three months (see the description on this HSCIC website 
http://systems.hscic.gov.uk/data/nhsdmds/faqs/waiting/plannedad).  There is no evidence 
of substantial “gaming” of the coding of “planned” versus “unplanned” admissions that 
could lead to bias.
95
  Other than “planned” admissions, all patients who had an elective 
hospital admission during the indicator year were included, including young children and 
people over 75, either in NHS hospitals or in private hospitals with NHS funding.  
 
We measure hospital waiting time in terms of days from outpatient decision-to-treat to 
inpatient admission-for-treatment.  This is often termed the inpatient waiting time in the 
literature. Another commonly used indicator is the outpatient waiting time, defined as the 
period between referral from a general practitioner to the outpatient appointment with a 
specialist. A third and more comprehensive indicator used in the NHS since the late 
2000s is the referral-to-treatment waiting time, which measures the time from referral 
from a general practitioner to inpatient admission-for-treatment – including adjustment to 
allow for “clock stop” periods of waiting attributable to patient choices (e.g. not attending 
an appointment) rather than NHS supply.  This can be further divided into admitted and 
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non-admitted waiting times, by distinguishing patients who are admitted for inpatient 
treatment from patients whose course of treatment ends at the outpatient stage without 
requiring inpatient admission. 
 
However, we focus on inpatient waiting time because it is considerably quicker and easier 
to compute, and less subject to bias due to coding and linkage error.  Computing referral-
to-treatment times requires linking outpatient and inpatient hospital episode statistics at 
individual level across multiple years. However, this is time-consuming in terms of both 
coding time and computational time, has never previously been done across all possible 
procedures and specialties, and would be subject to an unknown degree of coding bias 
and selection bias due to linkage failures.  It would also be impossible using hospital 
episode statistics data to fully implement the complex “clock stop” rules required to 
replicate official NHS statistics on referral-to-treatment times; and so the resulting 
indicator would still not precisely match official NHS statistics.  Use of inpatient waiting 
time is also more internationally comparable, and is consistent with the definition of 
waiting time used in most OECD countries to measure health system performance. 
 
We calculate hospital waiting time for all elective (non-emergency) hospital admissions 
for each patient within each small area.  We drop all waiting times greater than 12 months 
and then calculate the small area mean.  The waiting times indicator is then indirectly 
standardised at LSOA level for specialty using the specialty code of the consultant under 
whose care the patient was. It is important to adjust for specialty because waiting time 
varies based by specialty.  We do not additionally allow for age and sex, on the basis of 
the value judgement that (at least in most cases) age and sex are not a legitimate 
justification for making people wait longer for needed treatment. Our indirect 
standardisation procedure is described in Chapter Four: Methods.  In brief, we compute 
the expected mean waiting time for a small area by multiplying the number of patients in 
the small area treated in each specialty by the national mean waiting time for that 
specialty, and then dividing by the total number of patients treated in the small area.  The 
standardised waiting time ratio is then the ratio of observed divided by expected mean 
waiting time.  The adjusted waiting time is the standardised waiting time ratio multiplied 
by the national mean waiting time.  Finally, we aggregate up this adjusted waiting time to 
quantile group level to present adjusted mean waiting time per CIPS for patients who had 
an elective hospital admission in each quantile group. 
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A1.4 Preventable hospitalisation 
 
Definition: 
Preventable hospitalisation is defined as the number of people per 1,000 population 
having one or more emergency hospitalisations for a chronic ambulatory care sensitive 
condition, adjusting for age and sex. This indicator could also be described as "emergency 
hospitalisation sensitive to primary care". 
 
The numerator is the number of people with emergency hospital admissions (both 
finished and unfinished admission episodes, excluding transfers) for specific long-term 
conditions which should not normally require hospitalisation. This is derived from the 
Hospital Episode Statistics (HES) Admitted Patient Care (APC), provided by the Health 
and Social Care Information Centre (HSCIC). 
 
The denominator is the total number of people alive at mid-point in the current financial 
year. The Office for National Statistics (ONS) mid-year England population estimates for 
the respective calendar years are used for this purpose. 
 
Technical details: 
This indicator measures the number of people having an emergency hospital admission 
per 1,000 of population for specific long-term conditions considered amenable to health 
care. This is often used as an indicator of the performance of primary care and the 
interface between primary and secondary care. We use the list of conditions defined in the 
NHS outcomes framework indicator 2.3i (see Table 6 below). Hospital admissions for all 
ages, including young children and people over 75, are included in this indicator. 
We calculate indirectly standardised emergency hospital admission rate for each small 
area to allow for differing age and sex structure by deprivation level. To do so, we start 
with individual level HES data on emergency admissions and aggregate up to small area 
level. We then compute the expected hospitalisation counts for each small area by 
applying national age-sex hospitalisation rates to small area level numbers of people in 
each age-sex group. We then compute the adjusted rate for each small area as the product 
of the ratio of observed over expected count for the small area and the national rate. We 
then compute the adjusted count for each small area as adjusted rate times the small area 
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population. Finally, we aggregate up this adjusted count to quantile group level to present 
adjusted count per 1,000 people in each quantile group. The calculations are set out in 
Chapter Four: Methods. 
 
We note that our definition of preventable hospitalisations focuses on individuals in the 
numerator (individuals who have had one or more hospitalisations) whereas the NHS OF 
definition focuses on events, as does the OECD definition of preventable 
hospitalisations.  We have chosen to do this differently because (a) we have a separate 
measure of repeat hospitalisation, and therefore keep the focus of this measure on the 
incidence of hospitalisation (the proportion of people hospitalised) rather than the 
intensity (the number of times each individual is hospitalised); (b) we think that a 
proportion of the population or a probability (x people per 1,000) is slightly easier for the 
public to understand than an event rate. 
 
We also note that our definition of preventable hospitalisation uses all ages in both 
numerator and denominator, like the NHS OF definition.  However, the OECD definition 
only includes age 15 and above - i.e. we include children but the OECD does not. 
 
Table 6 ICD-10 codes for chronic ambulatory care sensitive conditions
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This is based on the list produced by the ONS and adopted by the NHS Outcomes 
Framework. 
Infections 
B18.1 Chronic viral hepatitis B without delta-agent 
B18.0 Chronic viral hepatitis B with delta-agent 
Nutritional, endocrine and metabolic 
E10 Insulin-dependent diabetes mellitus 
E11 Non-insulin-dependent diabetes mellitus 
E12 Malnutrition-related diabetes mellitus 
E13 Other specified diabetes mellitus 
E14 Unspecified diabetes mellitus 
Diseases of the blood 
D50.1 Sideropenic dysphagia 
D50.8 Other iron deficiency anaemias 
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D50.9 Iron deficiency anaemia, unspecified 
D51 Vitamin B12 deficiency anaemia 
D52 Folate deficiency anaemia 
Mental and behavioural disorders 
F00 Dementia in Alzheimer disease 
F01 Vascular dementia 
F02 Dementia in other diseases classified elsewhere 
F03 Unspecified dementia 
Neurological disorders 
G40 Epilepsy 
G41 Status epilepticus 
Cardiovascular diseases 
I10X Essential (primary) hypertension 
I11.0 Hypertensive heart disease with (congestive) heart failure 
I11.9 Hypertensive heart disease without (congestive) heart failure 
I13.0 Hypertensive heart and renal disease with (congestive) heart failure 
I20 Angina pectoris 
I25 Chronic ischaemic heart disease 
I50 Heart failure 
I48X Atrial fibrillation and flutter 
J81X Pulmonary oedema 
Respiratory diseases 
J20 Acute bronchitis 
J41 Simple and mucopurulent chronic bronchitis 
J42X Unspecified chronic bronchitis 
J43 Emphysema 
J44 Other chronic obstructive pulmonary disease 
J45 Asthma 
J46X Status asthmaticus 
J47X Bronchiectasis 
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A1.5 Repeat Hospitalisation 
 
Definition: 
Repeat hospitalisation is defined as the proportion of people with any elective or 
emergency inpatient hospital admission in a given year who have one or more subsequent 
any-cause emergency readmission in the same year, adjusting for age and sex.  This is an 
indicator of the quality of post hospital care, including the quality of co-ordination 
between primary, secondary, community care and informal social support. This is a non-
standard indicator developed specifically for the purposes of this project, rather than a 
standard and previously validated indicator commonly used for monitoring average 
healthcare quality. 
 
The numerator is the number of people with one or more repeat hospitalisations from any-
cause in the indicator year. The denominator is the total number of people with an 
inpatient admission from any cause in the same year. Both numerator and denominator 
are derived from the Hospital Episode Statistics (HES) Admitted Patient Care (APC), 
provided by the Health and Social Care Information Centre (HSCIC). 
 
Technical details: 
This indicator measures the proportion of people with an inpatient hospitalisation during 
the indicator year who had a second or subsequent emergency rehospitalisation within the 
same indicator year.  The denominator included all patients who had a hospital admission 
during the indicator year, including young children and people over 75, either in NHS 
hospitals or in private hospitals with NHS funding. People with one or more repeat 
emergency hospitalisation from any-cause were included in the numerator, as long as it 
occurred in the same indicator year as the first hospitalisation. 
 
We calculate indirectly standardised all-cause repeat hospitalisation proportion for each 
small area to allow for differing age and sex structure by deprivation level. To do so, we 
start with individual level HES data on repeat hospital admissions and aggregate up to 
small area level. We then compute the expected repeat hospitalisation count for each 
small area by applying national age and sex-specific repeat hospitalisation rate to small 
area level number of people in each age and sex category. We then compute the adjusted 
repeat hospitalisation rate for each small area as the product of the ratio of observed over 
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expected repeat hospitalisation count for the small area and the national rate. We then 
compute the adjusted repeat hospitalisation count for each small area as adjusted rate 
times the small area population. Finally, we aggregate up this adjusted count to quantile 
group level to present adjusted proportion of repeat hospitalisation in each quantile group. 
The calculations are presented in Chapter Four: Methods. 
 
We note that we defined repeat hospitalisation within the year rather than computing 30-
day or 90-day repeat hospitalisation for the following reasons: (a) we are interested in 
whole system co-ordinated care, beyond the primary cause of hospital admission and the 
immediate post-hospital period; (b) all-cause repeat hospitalisation within the indicator 
year provides a larger number of events for the purpose of detecting statistically 
significant differences between CCG level and national level absolute inequality 
gradients. 
 
In addition, we used repeat hospitalisation within the indicator year rather than 12 month 
readmission because the latter requires following patients across years which is 
substantially more time-consuming in terms of coding and computational burden.  In 
addition, 12-month re-admission would result in a less up-to-date indicator by either 
imposing a one year data lag or a focus on patients admitted the year before the indicator 
year.  The drawback of our approach is that it may produce biased estimates of the 
national social gradient in 12-month re-admission, though this is unlikely substantially to 
hamper comparisons between CCGs and over time.  The advantage is that this is a 
simpler, less computationally expensive and more timely approach. 
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A1.6 Dying in Hospital 
 
Definition: 
Dying in hospital is defined as the proportion of deaths from all causes that occurred in 
hospital in a given year. The numerator for this indicator is the number of deaths from 
any cause that occurred in hospital in a given year, measured using HES data. The 
denominator is the total number of deaths from any cause in a given year, irrespective of 
the place of death, measured using ONS mortality data. 
 
Technical details: 
This indicator measures the proportion of people dying in hospital. This is an indicator of 
the quality of end of life care planning and the availability of palliative care and 
community nursing care at home. We include deaths from all causes and all ages in both 
the numerator and the denominator, with the numerator including only the deaths that 
occurred in NHS hospitals or in private hospitals with NHS funding. 
There are no adjusted results to present for this indicator, on the basis of the value 
judgement that age, sex and other patient characteristics are not legitimate reasons for 
differential rates of deaths in hospital. 
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A1.7 Amenable mortality 
 
Definition: 
Amenable mortality is defined as the number of deaths per 1,000 people from causes 
considered amenable to healthcare, allowing for age and sex. The numerator is the 
number of people who died in the current financial year due to a cause of death 
considered amenable to health care. The denominator is the total number of people alive 
at mid-point in the current financial year. 
 
Technical details: 
Amenable mortality was defined according to the conditions listed in the ONS Outcomes 
Framework (see table 7). This includes conditions that are responsible for at least 100 
deaths in a year and that have a clear link between the number of deaths and healthcare 
interventions. The classification takes account of appropriate age limits and each death is 
counted only once.  
 
We use ONS mortality data for this indicator which is based on 2001 version of ICD-10 
codes (ICD-10 v2001). From January 2010, ONS has adopted a new version of ICD-10 
codes (ICD-10 v2010). Since we use the data provided by ONS, our data is based on 
ICD-10 v2001 until 2010/11 and then on ICD-10 c2010 for 2011/12. While this change in 
coding from 2011/12 may have a small effect on classification of amenable mortality in 
the over 65s, we did not see any substantial impact of this coding change on the 
inequality trend in our overall amenable mortality trend from 2010/11 to 2011/12. 
 
We calculate indirectly standardised amenable mortality rate for each small area to allow 
for differing age and sex structure by deprivation level. To do so, we start with individual 
level ONS mortality data and aggregate up to small area level. We then compute the 
expected number of deaths in each small area by applying national age-sex mortality rates 
to small area level numbers of people in each age-sex group. We then compute the 
adjusted rate for each small area as the product of the ratio of observed over expected 
count for the small area and the national rate. We then compute the adjusted count for 
each small area as adjusted rate times the small area population. Finally, we aggregate up 
this adjusted count to quantile group level to present adjusted count per 1,000 people in 
each quantile group. The calculations are presented in Appendix A2. 
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We used the list of causes of death considered amenable to health care from the NHS 
Outcomes Framework (Indicator 1.1), which in turn is based on a list produced by the 
ONS. The NHS Outcomes Framework turns the resulting mortality counts into an 
estimate of “potential years of life lost” from premature deaths aged under 75. The OECD 
also applies a cut-off, by only including ages 0 to 74 in both the numerator and population 
denominator.  However, we have used a simple all-age mortality rate including deaths in 
those aged 75 and over, since (a) our approach is more comprehensive (people over 75 
experience by far the highest rate of amenable mortality) and (b) based on advice from 
two lay members of our advisory group and a media expert, we believe that mortality 
rates are easier for the public to understand than “potential years of life lost”.   
However, we recommend that in future work a cut-off of age 74 is applied to our 
indicator for both the mortality numerator and population denominator.  This is because 
using an all age population denominator artificially deflates the rates for some of the 
mortality causes, and may lead to artificial variation between areas with different 
proportions of elderly people over the age of 75.  
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Table 7 ONS list of causes of death considered amenable to health care
133
 
Note: ONS produce separate lists for “amenable” and “preventable” deaths, where the latter 
are considered preventable by wider public health activities outside the health care system.  
In line with the NHS Outcomes Framework, we use the former list i.e. “amenable”. 
 
 Condition group and cause  ICD-10 codes Age 
 Infections     
 Tuberculosis A15-A19, B90 0-74 
 
Selected invasive bacterial and protozoal 
infections 
A38-A41, A46, A48.1, 
B50-B54, G00, G03, J02, 
L03 
0-74 
 Hepatitis C B17.1, B18.2 0-74 
 HIV/AIDS B20-B24 All 
 Neoplasms     
 Malignant neoplasm of colon and rectum C18-C21 0-74 
 Malignant melanoma of skin C43 0-74 
 Mesothelioma C45 0-74 
 Malignant neoplasm of breast C50 0-74 
 Malignant neoplasm of cervix uteri C53 0-74 
 Malignant neoplasm of bladder C67 0-74 
 Malignant neoplasm of thyroid gland C73 0-74 
 Hodgkin's disease C81 0-74 
 Leukaemia C91, C92.0 0-44 
 Benign neoplasms  D10-D36 0-74 
 Nutritional, endocrine and metabolic     
 Disorders of thyroid gland E00–E07 0–74 
 Diabetes mellitus E10-E14 0-49 
 Neurological disorders     
 Epilepsy and status epilepticus G40-G41 0-74 
 Cardiovascular diseases     
 Rheumatic and other valvular heart disease I01-I09 0-74 
 Hypertensive diseases I10-I15 0-74 
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 Ischaemic heart disease I20-I25 0-74 
 Cerebrovascular diseases I60-I69 0-74 
 Respiratory diseases     
 Influenza (including swine flu) J09-J11 0-74 
 Pneumonia J12-J18 0-74 
 Asthma J45-J46 0-74 
 Digestive disorders     
 Gastric and duodenal ulcer K25-K28 0-74 
 Acute abdomen, appendicitis, intestinal 
obstruction, cholecystitis/lithiasis, pancreatitis, 
hernia 
K35-K38, K40-K46, K80-
K83, K85, K86.1-K86.9, 
K91.5 
0-74 
 Genitourinary disorders     
 
Nephritis and nephrosis 
N00-N07, N17-N19, N25-
N27 
0-74 
 
Obstructive uropathy and prostatic hyperplasia 
N13, N20-N21, N35, N40, 
N99.1 
0-74 
 Maternal and infant     
 Complications of perinatal period P00-P96, A33 All 
 Congenital malformations, deformations and 
chromosomal anomalies 
Q00-Q99 0-74 
 Injuries     
 Misadventures to patients during surgical and 
medical care 
Y60-Y69, Y83-Y84 All 
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A1.8 Overall Mortality 
 
Definition: 
Overall all-age all-cause mortality is defined as the number of deaths for all ages and all 
causes in a given year as a proportion of the total number of people alive at the start of the 
year. The numerator for this indicator is the number of deaths from any cause that 
occurred in a given year. The denominator is the total number of people alive at the start 
of a given year.  
 
Technical details: 
This indicator is expressed as the number of deaths from all causes at all ages per 1,000 
people alive. We use all-age all-cause mortality as a contextual indicator of inequality in 
health, to help interpret levels and trends in our seven healthcare equity indicators. Since 
the age and sex structure of each area can affect the mortality rate, we adjust the mortality 
rate by taking account of the age and sex structure of the population. 
 
We calculate indirectly standardised all-cause all-age mortality for each small area to 
allow for differing age and sex structure by deprivation level. To do so, we start with 
individual level ONS mortality data for all ages and aggregate up to small area level. We 
then compute the expected number of deaths for each small area by applying national age 
and sex-specific mortality rate to small area level number of people in each age and sex 
category. We then compute the adjusted mortality rate for each small area as the product 
of the ratio of observed over expected mortality count for the small area and the national 
rate. We then compute the adjusted mortality count for each small area as adjusted rate 
times the small area population. Finally, we aggregate up this adjusted count to quantile 
group level to present adjusted proportion of all-cause mortality per 1,000 people in each 
quantile group. The calculations are presented in Chapter Four: Methods. 
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Appendix 4 Trimming Analysis 
 
Figure 61 Kernel density plots by indicator, showing 6 standard deviation trim points in 
2011/12 
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Figure 62 Bar charts by indicator, showing percentage trimmed by deprivation vingtile 
in 2011/12 using 6 standard deviation trim points 
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Figure 63 Percentage of LSOAs trimmed by year for each indicator, using 6 standard 
deviation trim points 
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Figure 64 Kernel density plots by indicator, showing 3 standard deviation trim points in 
2011/12 
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Figure 65 Bar charts by indicator, showing percentage trimmed by deprivation vingtile 
in 2011/12 using 3 standard deviation trim points 
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Figure 66 Percentage of LSOAs trimmed by year for each indicator, using 3 standard 
deviation trim points 
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Appendix 5 Advisory Group Members 
 
 
Centre for Health Economics 
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Appendix 6 Public Consultation Materials 
 
Recruitment Materials for the Citizens’ Panel exercise 
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Consent Form for the Citizens’ Panel Event 
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Rating question about the most unfair inequalities in health and healthcare 
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Screenshot from the online questionnaire 
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Appendix 7 Letters of Support 
 
Email from Ray Avery, NHS England Equality and Health Inequalities Unit 
 
 
Richard Cookson <richard.cookson@york.ac.uk> 
 
Health Equity Compass 
1 message 
 
Avery Ray (NHS ENGLAND) <ray.avery@nhs.net> 9 November 2015 at 15:57 
To: "Richard Cookson (richard.cookson@york.ac.uk)" <richard.cookson@york.ac.uk> 
Dear Richard, 
Thank you for engaging with the equality and health inequalities unit.  It has been a 
pleasure to be able to see how the research work on the health equity dashboard/compass 
has developed over the last year. 
It is important that NHS investment in research can then add further value through 
operationalisation. We will, subject to resources, seek to develop key aspects of the work 
in our approach to measuring progress on health equity.   The Equality and Health 
Inequalities Programme Board supported the attached paper which references this 
approach.  
 Kind regards, 
 Ray Avery 
Lead -  Health Inequalities 
Equality and Health Inequalities Unit 
Commissioning Strategy 
NHS England  
4E44| Quarry House| Quarry Hill| Leeds| LS2 7UE 
0113 825 1063 
07876 851873 
ray.avery@nhs.net 
www.england.nhs 
 “High quality care for all, now and for future generations.” 
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Email from Dan Roper, Chair of Hull CCG 
 
 
Richard Cookson <richard.cookson@york.ac.uk> 
 
NHS equity indicators 
1 message 
 
Roper CCG Daniel (NHS HULL CCG) 
<daniel.roperccg@nhs.net> 
13 November 2015 at 
08:18 
To: Richard Cookson <richard.cookson@york.ac.uk> 
  
The Hull CCG would formally like to express its support for the work that Richard 
Cookson and his colleagues have been undertaking at the University of York on NHS 
Equity Indicators. 
  
As we move towards delegated commissioning for Primary Care Services in Hull and 
also develop new models of care in the City the detail, breadth and significance of this 
intelligence about what is happening on the ground is of vital importance for us as we 
look at assessing the needs of the population of our city. 
  
We had a presentation of the work at our co-commissioning board in June and as a group 
of clinicians and non-clinicians we found the information of great interest and we look 
forward to its further development and possible dissemination. 
  
Other health economies I am sure will find it as useful as we do and we feel that these are 
exactly the sort of statistics that should be produced as they are directly applicable to the 
commissioning decisions we have to make. 
  
  
Dr.Dan Roper 
Chair 
Hull CCG 
Wilberforce Court  
Alfred Gelder Street 
Hull  
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Letter from Dr Mark Hayes,  
Chief Clinical Officer, Value of York CCG 
 
 
 
Ref  MH/HN-ms 
  
 
 
Professor Richard Cookson 
Centre for Health Economics 
University of York 
York  
YO10 5DD 
West Offices 
Station Rise 
York,  
YO1 6GA 
 
Tel: 01904 555870 
  RNID typetalk: prefix-18001 
 
Email: valeofyork.contactus@nhs.net 
 Website: www.valeofyorkccg.nhs.uk 
 
 11 November 2015 
Dear Professor Cookson 
 
RE: Prototype Health Equity Indicators 
 
I am writing in support of the prototype NHS equity indicators that you demonstrated earlier 
this year to a group of colleagues across the health system in York. We found the rationale 
for the selected indicators convincing, and in covering the end-to-end patient journey gave a 
wide range of points of comparison.  
 
It was clear from the presentation and data that these indicators, available on a national basis 
and updated annually, would provide a firm foundation for health equity monitoring and for 
improvement purposes, as well as for planning and delivering local health services. We 
would be interested in working with these indicators in conjunction with local authority and 
public health colleagues to understand where effective interventions can be made on the basis 
of this data, and hope that full consideration is given to rolling out this approach at national 
level. 
 
Yours sincerely 
 
Dr Mark Hayes 
Chief Clinical Officer 
 
 
 
 
  
NHS Vale of York Clinical Commissioning Group 
Chair: Keith Ramsay Chief Clinical Officer: Dr Mark Hayes 
